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Abstract 
Phyllaemblic acid is a spirocyclic acetal-containing natural product isolated from Phyllanthus 
emblica. A total synthesis of phyllaemblic acid has yet to be reported. The spirocyclic acetal 
portion of phyllaemblic acid is structurally similar to that found in the natural products 
phyllanthocin and breynolide. The introduction of this report discusses the literature 
methods used in the preparation of these spiroacetals, which might be applied in a synthesis 
of phyllaemblic acid.  
Previous work in the Grainger group has approached the synthesis of phyllaemblic acid 
through disconnection to a meso 4-carbomethoxy-2,6-dihydroxy-substituted cyclohexanone, 
masked as a dioxabicyclononanone, prepared in turn through an α,α’-annulation reaction of 
2-substituted 1,3-dioxan-5-ones with methyl α-bromoacrylate. Epimerisation of the resulting 
ester gives the stereochemical array found in the carbocyclic ring of phyllaemblic acid.  
This project attempted to address the current limitations of this approach, namely the lack 
of reactivity of the cyclohexanone carbonyl towards intermolecular nucleophilic addition 
reactions. An approach based on an intramolecular keto-alkyne cyclisation was first 
investigated, followed by the use of a Meyer-Schuster rearrangement to attempt to 
overcome the problems encountered in the conversion of the cyclohexanone to an enone. 
Finally, an approach to the perhydrobenzothiophene ring system found in breynolide using 
the meso 4-carbomethoxy-1,2-dihydroxy-substituted cyclohexanone was investigated.  
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Chapter 1 Phyllanthocin, Breynolide and Phyllaemblic acid 
Introduction 
A spiroacetal is a structural subunit found in many naturally occurring molecules including 
marine, insect and plant derived natural products. Spiroacetals, sometimes described as 
spiroketals, are defined as cyclic acetals in which two rings are joined by a single atom. This 
central atom, known as the spiro atom, is flanked by two oxygen atoms that each belong to 
one of the rings.1 The most common ring sizes of spiroacetals are 6,6 (eg-1), 6,5 (eg-2) and 
5,5 (eg-3)(Figure 1).2, 3 4 
 
This review will focus on methods for the formation of 6,5-spiroacetals in the natural 
products breynolide and phyllanthocin, and the ways that these syntheses may be adapted 
in studies towards a first total synthesis of phyllaemblic acid.  
A key factor that controls the structure and stability of a spiroacetal unit is the formation of 
either the thermodynamic or kinetic product. Generally, a substituent on a six-membered 
ring system would be expected to reside in an equatorial position so as to minimise 
unfavourable 1,3-diaxial interactions (Figure 2).5 However, an oxygen substituent at the 
anomeric centre (C1) of a pyranose ring is found to reside preferentially in an axial rather 
Figure 1 
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than equatorial orientation, despite the unfavourable steric interactions. A stabilising 
interaction between the pseudo-axial lone pair on oxygen (n) and the σ* antibonding orbital 
of the C-O bond accounts for this observation. For this interaction to occur, the lone pair on 
the oxygen must be in an antiperiplanar orientation with respect to the C(1)-O bond.5  
 
Figure 2  
If the anomeric oxygen is in an equatorial position, there is no low-lying acceptor orbital of 
correct orientation to achieve overlap with the ring oxygen lone pair. 
Spiroacetalisation in phyllanthocin synthesis  
In 1977 Kupchan et al. isolated an extract from Phyllanthus acumintus.6 The extract was 
found to inhibit growth of the p388 leukaemia system in mice. Subsequent investigation led 
to the isolation of (+)-phyllanthocin 4 (Figure 3)6 which possesses a 6,5 spiroacetal unit. To 
date there have been eight reported total syntheses of phyllanthocin. 
 
Figure 3  
In 1982 the first total synthesis of phyllanthocin was reported by Collum et al.7 The key 
spiroacetalisation step was initiated by treatment of 5 with ZnCl2 at -20 
oC (Scheme 1).7 This 
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produced two diastereoisomers 6 and 7 in a 48:1 ratio with a 69% combined yield. It was 
proposed that a thermodynamically driven acetalisation had occurred. Identical product 
distributions are obtained when re-subjecting 6 and 7 to the reaction conditions. In 1989 
Fraser-Reid used a radical cyclisation on an annulated furanose which significantly improved 
the route towards Collum’s key intermediate.8 
 
Scheme 1 
Two years later a second synthesis of (+)-phyllanthocin was successfully completed by 
Williams et al. (Scheme 2).9 Hydrolysis of the dithiane 8 gave ketone 9. Upon treatment of 
spiroacetal precursor 9 with trifluoroacetic acid, spiroacetals 10 and 11 were formed in a 6:1 
ratio. Williams reported that the acid promoted cyclisation step had clearly favoured the 
unnatural configuration of the spiro-centre, therefore concluding that the ring forming step 
must follow a kinetic pathway. However, it was found that treatment of the major product 
with certain Lewis acids, such as zinc bromide and stannic chloride, led to facile 
isomerisation to the desired natural spiroacetal. It was therefore concluded by Williams that 
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the Lewis acid complexation site may favour certain spiroacetal isomers by providing them 
with a more stabilised coordination site.9  
 
Scheme 2 
Martin et al. found that hydrogenolysis of a 2.8:1 ratio of 12 and 13 followed by treatment 
with certain acids gave spiroacetals 14 and 15 (Scheme 3). It was reported that 
camphorsulfonic acid gave 14 in a moderate yield but trifluoromethanesulfonic acid gave 14 
and 15 in a 68% yield in an 18:1 ratio. The spiroacetals 14 and 15 were further subjected to 
the spiroacetalisation conditions to determine whether an equilibrium existed between the 
two isomers under the reaction conditions. However, this led to decomposition, suggesting 
that the β-hydroxy ketone spiroacetalisation is a kinetically driven process.10 
 
Scheme 3  
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Burke et al. initially encountered problems with the spiroacetalisation step in their synthesis 
of phyllanthocin.11 The first spiroacetalisation (Scheme 4)11 was promoted by oxidative 
cleavage of the MPM ether in 16 with DDQ. The subsequent mixture of five-membered 
hemiacetals was treated with nBu4NF to cleave the TBS ether followed by trifluoroacetic acid 
to promote spiroacetalisation. This gave a 3.8:1 mixture of 17 and 18 in an overall yield of 
92%. It was found that the unwanted diastereomer 17 was the major product. A variant of 
Williams’ procedure was used to isomerise 17 to 18 in a 75% yield. Subsequently, a more 
direct method was discovered; cleavage of the TBS ether 16 using 5% aqueous HF in 
acetonitrile gave the desired spiroacetal 18 directly in a 97% yield.11  
 
Scheme 4 
Trost et al. have reported two approaches to phyllanthocin. The first involved coupling of 
two racemic starting materials to give a mixture of diastereoisomers 19 and 20 (Scheme 5).12 
The isomers were then subjected to a metal-catalysed reductive cyclisation to afford 21 and 
22 in yields of 86% and 78% respectively.12, 13 
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Scheme 5  
One year later, Trost reported an asymmetric synthesis of (+)-phyllanthocin.13 The same 
reductive cyclisation was used to obtain 21 and 22 in a combined 82% yield. Treatment of 21 
under Williams’ conditions (Mg(OCOCF3)2, CF3CO2H CH2Cl2, rt) gave 22 as a single 
diastereomer via equilibration to the thermodynamically favoured product. 
Smith et al. published their approach to phyllanthocin in 1991.14 A key premise of their work 
was that spiroacetal 24 adopts the required configuration at the spiro-centre and would be 
more stable than the diastereoisomer 23 (Figure 4).14 By considering the anomeric 
interactions of the furanone and pyranone oxygens, in conjunction with the rigidity of the 
perhydrobenzofuranone system, 24 certainly looked to be the more stable isomer. This 
indeed turned out to be the case; removal of the MEM protecting group from 25 with ZnCl2, 
followed by the addition of camphorsulfonic acid to induce spiroacetalisation, led to the 
desired spiroketal 24 in a 71% yield with a ratio of 26:1 over the unwanted diastereoisomer 
(Scheme 6). 
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Figure 4 
 
Scheme 6  
Ciufolini et al. found that spiroacetalisation of 26 gave a mixture of diastereoisomers 27 in a 
combined 71% yield (Scheme 7). However, the thermodynamic configuration at the spiro-
centre was almost exclusively formed. This relative configurational control is probably due to 
the preference of the tetrahydrofuran to be in the cis 2,5-dialkyl arrangement and also to 
the anomeric effect for the pyranone unit favouring placement of the THF oxygen at the 
axial position.15  
 
Scheme 7  
 
Spiroacetalisation in breynolide synthesis 
Breynins A 29 and B 30 are novel glycosides isolated in 1973 from the Taiwanese woody 
shrub Breynia officinalis. The natural products have displayed significant oral 
hypocholesterolemic activity in rats (Figure 5).16 Breynogenin 31 and breynolide 28 have 
been characterised as the aglycon hydrolysis products of breynin A.17 Breynolide was fully 
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characterised by Sasaki and Hirata through single crystal X-ray.16 To date there have been 
three total syntheses of breynolide and one of breynolide sulfone. 
 
Figure 5  
The first synthesis of (+)-breynolide was reported in 1990 by Williams et al.17 Following 
attack by sodium hydrogen sulfide on the terminal oxirane of a mixture of 32 and 33 in a 
75:1 ratio, an intramolecular SN2 reaction subsequently occurred at C-17 to form the 
tetrahydrothiophene core in 34a,b. Treatment of 34a,b with p-toluenesulfonic acid led to a 
kinetic acetalisation to give 35a,b which, followed by protection, gave an 85% yield of the 
diastereoisomers 36 and 37 in a 1:3 ratio (Scheme 8). Both 36 and 37 were each 
independently converted to breynolide through a subsequent five step sequence. 
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Scheme 8  
The second total synthesis of breynolide was reported two years later by Smith et al.18 
Intermediate 38 was treated with ZnBr2 to remove the MEM protecting group (Scheme 9). 
This was followed by treatment with p-toluenesulfonic acid to induce equilibration and give 
the desired spiroacetal configuration 39a in a 53% yield along with three minor products. 
Acetal 39b had the correct configuration at the spiro-centre, whereas 40 did not. Alcohol 39c 
was isolated in an 11% yield and was able to be converted to 39a after silylation. Subjecting 
39b and 40 to the reaction conditions regenerated the original ratio of 39a and 39b. 
Treatment of 39b with p-toluenesulfonic acid equilibrated the axial methyl into the more 
stable equatorial orientation. These transformations confirmed that cyclisation was 
thermodynamically controlled. 
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Scheme 9 
The third, and most recent, synthesis of breynolide was completed in 1998 by Burke et al.19 
Their asymmetric synthesis saw the use of the same thermodynamically driven 
spiroacetalisation employed by Smith et al. (Scheme 10). The key spiroacetalisation step 
started with 41 which was a (1:1) mixture of epimers at C-12. A thermodynamic 
spiroacetalisation was then attempted which resulted in predominantly the correct 
stereochemistry at both the C-9 and the C-12 positions. The MEM protecting group was 
removed with wet ZnBr2 and the crude product was then treated with pTSA in benzene for 
48 hours which produced a mixture of diastereomeric spiroacetals including 42 in a 68% 
yield. 
 
Scheme 10  
An earlier study is that of the synthesis of breynolide sulfone (Scheme 11).20 The alkene 
moiety in 43 was converted to the α-hydroxy ketone 44 using OsO4 in pyridine, followed by 
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Swern oxidation. Desilylation followed by treatment with camphorsulfonic acid at rt gave the 
two spiroacetals 45 and 46 in quantitative yield. Repeated acid-catalysed equilibration using 
camphorsulfonic acid in refluxing benzene converted 45 to 46 in greater than 95% yield. 
 
Scheme 11  
 
Phyllaemblic acid 
Phyllaemblic acid 47 was isolated along with its methyl ester 48 and three ester glycosides, 
phyllaemblicins 51, 52 and 53, from the roots of Phyllanthus emblica. There have been two 
reports on the uses of Phyllanthus emblica extracts which include phyllaemblic acid and its 
derivatives with regard to its antiviral properties. The roots, bark and leaves have been used 
for treating eczema, warts, diarrhoea and headaches. The fruit and its juice have been used 
widely for their biological activities including antibacterial, antioxidant, anti-inflammatory, 
antitumor and hepatoprotective effects.21, 22  
Although the biological activity of these natural products makes them attractive targets for 
synthesis, as yet there have been no reported total syntheses of phyllaemblic acid or any of 
its derivatives. In contrast, a total of eight syntheses of the structurally related phyllanthocin 
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4 and three syntheses of breynolide 28 have been reported. The full structure elucidation of 
phyllaemblic acid was first published in 2000 by Kouno et al.23, 24 
The rhizomes of a related genus, Glochiddion coccineum, were found to contain the 
structurally similar glochicoccins 49 and 50 (Figure 6). 
Recently Zhang et al.25 published a further 20 similar structures (54-73); these were all 
tested for their antiviral activities against five virus strains: CVB3, hepatitis B virus (HBV), 
herpes simplex virus type 1 (HSV-1), human enterovirus 71 (EV71) and influenza (H3N2) virus 
strain. Among these, 55-58, 61-63 and 68 all exhibited potential inhibitory activity against 
hepatitis B virus HBsAG and HBeAg. All of the structures are related to each other by the 6,5 
spiroacetal moiety within the molecules.  
  13 
 
 
 
  14 
 
 
Figure 6 
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Various aspects of the reported syntheses of breynolide and phyllanthocin discussed above 
may prove useful in solving some of the synthetic challenges afforded by phyllaemblic acid. 
Most notably, the challenging spiroacetal functionality is common to all three natural 
products and their derivatives. 
The Grainger group approach: Disconnection of phyllaemblic acid and the α,α’-annulation 
reaction 
Grainger et al. published the first approach towards a synthesis of phyllaemblic acid.26 Their 
strategy exploited a hidden symmetry element present in the natural product. The symmetry 
element can be easily identified after disconnection of the spiroacetal in 47 (Scheme 12).26 
Further disconnection of the carbon chain of 74 leads to the symmetrical meso compound 
75.  
 
Scheme 12 
Compound 75 contains three substituents on a cyclohexanone ring, the relative 
stereochemistry of which must be controlled to give the desired product. The alcohol groups 
must exhibit cis geometry with respect to one another and the ester must be placed on the 
opposite face to the alcohols. Ideally, all of the stereochemistry should be in place before 
continuation of the synthesis. The Grainger group achieved this through a stereoselective 
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α,α’-annulation reaction of a 1,3-dioxan-5-one followed by epimerisation of the resulting 
ester (Scheme 13).26 
 
Scheme 13  
Condensation of pyrrolidine with 1,3-dioxanone 76 gave 77 which was subsequently treated 
with 78 and Et3N. This induced an α,α’-annulation to give 79 which then gives rise to 80 after 
a separate epimerisation reaction. The stereochemical outcome of this annulation can be 
rationalised by considering the mechanism (Scheme 14). Allylation of enamines 77b,c gives 
rise to two possible iminiums 81b,c and 83b,c. These are in equilibrium with each other, via 
82b,c, and with enamines  84b,c and 85b,c. For C-C bond formation and cyclisation to occur, 
the enamines 84b,c and 85b,c need to adopt a boat conformation which places the acrylate 
acceptor in the axial position. This is disfavoured in 85b due to steric interactions between 
the flagpole Ph group and the pyrrolidine ring. Removing this steric clash, as in 84b, results in 
79b being the observed product. The steric interactions in 84c and 85c are not as strong but 
a further anomeric stabilizing effect, only present in 84c, favours formation of 79c. Finally, 
kinetic protonation results in an axially-orientated ester group. This is subsequently 
converted to the desired thermodynamically favoured equatorial ester via epimerisation 
using DBU. 
  17 
 
 
Scheme 14 
With the successful formation of these bicyclic systems in place, a rapid approach to the 
natural product was envisaged. Carbon-carbon bond formation was attempted at the 
bridged ketone on all three bicyclic ketones. However, it was found that intermolecular 
additions of various nucleophiles gave limited results (Scheme 15).    
  18 
 
 
Scheme 15  
It was hoped that nucleophilic addition would lead to the formation of a carbon chain (en 
route to 74 from 75, (Scheme 12)). Successful addition of TMSCN proceeded in yields >70% 
but unfortunately the stereochemistry for the major or minor products 87a, 87b, 87c could 
not be identified. Further treatment of the product with DIBAL, TBAF, H2O + MeOH or a 
Grignard reagent all led to no reaction or degradation of 87a, 87b, and 87c. A simple Wittig 
reaction was partially successful but low yielding, and again further transformation of the 
resulting alkenes 88a, 88b and 88c was difficult. Horner-Wadsworth-Emmons (HWE), 
Grignard and acetylide addition to 80 all produced no reaction (89-91) and starting material 
was recovered in each case.  
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Conclusions and summary 
Phyllanthocin and breynolide have been successfully synthesised a number of times by 
different groups; a review by Smith et al.27 highlights the challenging aspects and 
retrosynthesis of both phyllanthocin and breynolide. However, from the routes and 
conditions reviewed it is clear that the spiroacetalisation often gives different results in 
regards to the thermodynamic or kinetic product. Alternative pathways were discovered 
even when applying the same conditions used from previous investigations.  The reason for 
this is perhaps summed up best by Williams:9 
‘The Lewis acid complexation site may favour certain spiroacetal isomers by providing them 
with a more stabilised coordination site’ 
From this quote, and the observations of other researchers, it is concluded that the 
configurations of stereocentres and the protecting groups used on oxygen functionality  of 
the molecule will play a pivotal role in which spiroacetalisation conditions to use/ will work 
in future studies.  
In an approach towards phyllaemblic acid and related natural products, the Grainger group 
has so far successfully installed three of the four stereocentres on the cyclohexane ring in 
the spiroacetalisation precursor 74 (Scheme 12). Further disconnection back to 75 results in 
a carbonyl ready for intermolecular addition. Unfortunately, nucleophilic attack to this 
carbonyl has given low yields, and the resultant tertiary alcohol was likely placed cis to the 
oxygens instead of the desired trans configuration.   
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Chapter 2 Intramolecular cyclisation investigation 
Literature review of carbonyl-alkyne cyclisation reactions 
Based on the poor reactivity of the ketone in bicyclic system 80 described in chapter one 
(Scheme 15), a new approach to C-C bond formation based on an intramolecular keto-alkyne 
cyclisation was envisaged. This approach aims to overcome the two main problems of low 
reactivity and incorrect stereochemistry (Scheme 16). 
 
Scheme 16  
The key reaction in this new approach is the cyclisation between a carbonyl and alkyne 
moiety. Below is a review of various procedures for this type of reaction that could be 
relevant to this work. 
Malacria et al. reported a versatile preparation of 2-iodomethylene cycloalkanols (Scheme 
17). Cyclisation of 94 was initially attempted under thermal conditions using Bu3SnH, AIBN 
and PhH. Under these conditions there was no chemoselectivity in the stannyl radical attack 
and a complex mixture of products was formed. It was found that running the reaction in the 
presence of triethylborane at rt gave a clean mixture of vinylstannanes 97 and 98. These 
were characterised as the iodo derivatives 99 and 100 in a ratio of 75:25 in an overall yield of 
69%, with the major isomer having E geometry. 
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Scheme 17 
Conversion of vinyl stannanes 97 and 98 to the iodides occurs with retention of 
stereochemistry. Therefore, the ratio of 99/100 directly gives the selectivity of the radical 
cyclisation. This cyclisation was presumed to occur mainly through the intermediate 95 and 
not 96, in which the steric interaction between the stannyl and carbonyl group are 
minimised. This arrangement could also explain why only moderate stereocontrol is 
observed, as 95 still suffers from a 1,3-allylic interaction between the stannyl and the 
developing cyclohexane methylene group.28-32 
Radical cyclisation can be promoted by the generation of radical anions using dissolving 
metal conditions. This procedure was developed by Stork et al. using ketoalkyne substrates 
such as 101 (Scheme 18).33 Treatment of 101 with lithium metal in ammonia gave a mixture 
of products which could not be purified. However, analysis indicated that 102 was formed in 
50% yield based on 1H NMR yields.33 Other groups have adapted the methodology 
developed by Stork et al. by using other radical anion generators such as sodium 
naphthalide.34-37 
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Scheme 18  
Molander et al. used samarium diiodide to carry out an intramolecular reductive coupling 
reaction on 103 to cyclise to 104 (Scheme 19).38 High stereoselectivity was achieved when 
the acetylene bore a terminal TMS group; however, in the investigation that was undertaken 
only one substrate was found to be reactive (Table 1). Radical formation occurs after 
addition of SmI2 to form 105. A 5-exo-dig cyclisation then occurs to give 106. A further 
reduction then produces the anion 107 which is protonated to form 104. From the findings 
reported, it appears that the presence of an activating group on the alkyne terminus helps to 
facilitate the cyclisation.39, 40, 40-42 
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Scheme 19  
Entry R R’ R’’ Yield Selectivity 
1 Me Me TMS 51 200:1 
2 Me Me H 0 N/A 
3 Me Me CO2Et 0 N/A 
Table 1  
An alternative approach to the radical cyclisation, using photoinitiation, was reported by 
Cossy et al.43 The group used either neat HMPA or Et3N in CH3CN to cyclise acetylenic keto 
esters 108 through irradiation with UV light to yield 109 and 110 (Scheme 20). Radical anion 
111 is formed initially; this undergoes cyclisation via a 5-exo-dig process to give 112. 
Intramolecular cyclisation occurs much more rapidly than H-abstraction from the solvent 
which would lead to 113. The reaction has advantages over chemical or electrochemical 
reduction methods as the procedure can be performed under very mild and homogeneous 
conditions and no reproducibility issues were observed. When the reaction was carried out 
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in the presence of HMPA yields of 80% were recorded and with Et3N/ CH3CN yields of 86% 
were obtained.44-47  
 
Scheme 20  
Electroreduction of 114 was investigated by Shono et al. (Scheme 21).48  
 
Scheme 21 
The electroreduction of 114 at rt was achieved using a carbon electrode, anhydrous DMF as 
solvent and tetraethylammonium p-toluenesulfonate as a supporting electrolyte. A ceramic 
cylinder was employed as a diaphragm and the electrolysis was continued until 4 F/mole of 
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electricity had been used. Various substituents R1 and R2 were used and in all cases good 
yields of the cyclised product 115 were obtained (Table 2).  
R1 R2 Isolated yield % of 115 
H Me 94 
Me Me 99 
Me Et 95 
Me iPr 85 
Me nBu 89 
Table 2 
However, when a non-terminal alkyne 116 was used as the substrate, 118 was formed along 
with desired 117 in 60 and 25% yields respectively. The authors concluded that 118 probably 
formed through nucleophilic attack of the anionic species generated from 116 on 
tetraethylammonium tosylate.49 
Corey et al. developed a method for five-membered ring cyclisation involving free radical 
generation from ketones, such as 119, followed by addition to a π-bond of the alkyne 
moiety. The proposed mechanism is outlined below (Scheme 22).50 Reduction of 119 forms 
radical anion 121, which is trapped as the trimethylsilyloxy radical 122. 5-exo-dig radical 
cyclisation gives 123, which abstracts a hydrogen atom from the solvent to give 124. The 
reaction was carried out in the presence of 2,6-lutidine in THF in order to prevent either a 
zinc chloride or proton-mediated elimination of the tertiary trimethylsilyloxy group. 
Subsequent deprotection gave alcohol 120 in 74% yield. The group was also successful in 
forming 110 (Scheme 20) in 77% yield using the TMSCl-Zn-lutidine procedure. A more recent 
example has been reported by Bertrand and Feray et al.51  
  26 
 
 
Scheme 22  
Sato et al. developed a nickel-catalysed cyclisation between an alkyne and a carbonyl using 
Et3SiH and an NHC (N-heterocyclic carbene) ligand to produce a number of different cyclic 
compounds (Scheme 23).52-54 
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Scheme 23  
Treatment of 125 with five equivalents of Et3SiH in the presence of Ni(cod)2 (10 mol%) and 
PPh3 (20 mol%) in THF at rt gave 126 in 44% yield. After screening various conditions, it was 
found that the NHC ligand IPr gave quantitative yields for the cyclisation when R2 = Me. The 
group proposed a catalytic cycle (Scheme 23). Coordination of the alkyne and carbonyl in 
125 with a zerovalent nickel complex shown in 125a, is followed by an oxidative cyclisation 
to give the oxanickelacycle 125b. Cleavage of the nickel-oxygen bond by σ-bond metathesis 
of 125b with Et3SiH produces the hydridenickel 125c. Subsequent reductive elimination from 
125c then gives the cyclised product 126 as a single stereoisomer. 
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The effect of varying substituents was investigated (Table 3). It should be noted that the 
presence of a TMS group on the alkyne lowered the yield to 26%, whereas other 
substituents gave good yields even if they were more sterically demanding (e.g. Ph or 
CH2OTBS, entries 3 and 7 in Table 3). Alternative cyclic frameworks were also investigated; 
the most pertinent being the 1,3-dioxan-5-one 127 which cyclised to give 128 in 99% yield 
(Scheme 24).  
Run Substrate Time (hr) Yield% 
1 125b: R1 = R2 = H 0.5 126b : 83 
2 125c : R1 = H R2 = CH2OTBS 0.5 126c : 99 
3 125d : R1 = H R2 = Ph 0.5 126d : 97 
4 125e : R1 = H R2 = CO2Me 48 126e : 26 
5 125f : R1 = H R2 = TMS 40 126f : 26 
6 125g: R1 = R2 = Me 0.5 126g : Quant 
7 125h : R1 =CH2OTBS R
2 = Me 0.5 126h : 96 
Table 3  
 
Scheme 24  
As an alternative to nickel, palladium, platinum and rhodium were used by Tsukamoto et 
al.55, Han and Lu et al.56 Jang et al. 57 Tanaka et al.58 and Krische et al.59 The authors all 
worked on relatively similar substrates with the most pertinent work published by Han and 
Lu et al. (Table 4). 
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Entry Substrate Time (hr) Product Yield 
1 129a R1 = Me 24 130a 39% 
2 129b R1 = Ph 24 130b 47% 
3 129c R1 = TMS 2 130c 65% 
Table 4  
The group found that non-terminal alkynes cyclised more efficiently as this suppressed the 
tendency for dimerisation to occur. When a silicon group was placed on the terminus of the 
alkyne, a 65% yield was obtained and the reaction time was drastically reduced. A proposed 
mechanism is given in (Scheme 25). The active catalyst is assumed to be the palladium 
hydroxo complex A. This reacts with ethanol to produce the palladium ethoxide complex B, 
which subsequently generates the palladium hydride complex C via β-hydride elimination. 
Hydropalladation to 129 gives a vinylpalladium intermediate D. This is followed by 
intramolecular cyclisation to the carbonyl group to give E. Protonolysis of E forms the 
product and regenerates the palladium (II) catalyst A which completes the catalytic pathway. 
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Scheme 25 
Marek et al.60 used a diisopropoxy(η2-propene)titanium complex 132 to activate an alkyne 
and perform an intramolecular addition to a ketone to form a variety of cyclic alcohols of 
different ring sizes (Scheme 26). Both terminal and non-terminal alkynes undergo cyclisation 
using this method. 
  31 
 
 
Scheme 26  
In the above example (Scheme 26) treatment of 131 with stoichiometric amounts of Ti(OiPr)4 
and 2 eq. of iPrMgX at -78 oC leads to the cyclic product 136 after hydrolysis in a 78% yield. 
Organometallic derivative 134 is presumed to form via the titanacyclopropene derivative 
133 although it could not be isolated. The existence of 134 was probed by adding iodine at 
the end of the reaction. The vinyl iodide 135 was isolated in a 67% yield as a single isomer. 
Similar examples of keto-alkyne intramolecular cyclisations using a titanium or copper 
catalyst have been reported.61 62 63, 64  
In conclusion, a variety of methods are available for the proposed keto-alkyne ring closure 
outlined in the aims and objectives. It is noted that the presence or absence of large groups 
on the alkyne terminus may play a role in the cyclisation, and hence access to both terminal 
and non-terminal alkynes would be advantageous.65-67 
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Aims and Objectives 
As previously shown in chapter one (Scheme 15), intermolecular nucleophilic addition to 80 
has proven to be difficult with very low yields or no reaction often being observed. When 
sufficient reactivity was obtained, further elaboration was found to be problematic and the 
route was abandoned. It is assumed that the reason for the lack of reactivity of 80 is due to 
the acetal blocking the bottom face of the carbonyl. Top face addition is also unfavourable 
due to developing steric interactions as the carbon changes from being sp2 to sp3 hybridised 
in 137 (Scheme 27). 
 
Scheme 27  
The initial aim of this project was to investigate a new approach to C-C bond formation at 
the carbonyl carbon of a bicyclic acetal 138 to form 139. An oxidative cleavage to form 140 
and subsequent removal of the acetal group gives the spiroacetalisation precursor 74. The 
compound 138 will be prepared through α,α’-annulation reactions previously developed in 
the Grainger group.26 This approach draws on the successful installation of the three 
stereocentres on the cyclohexane ring already achieved through an α,α’-annulation (Chapter 
1, Scheme 13). The tertiary alcohol can then be formed through intramolecular addition, 
which should both overcome the lack of reactivity of the carbonyl towards intermolecular 
addition and also control the stereochemistry of the tertiary alcohol to be trans to the acetal 
(Scheme 28).  
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Scheme 28  
In a model study, dioxanone 141 will be subjected to an α,α’-annulation reaction; this could 
result in formation of either of the diastereoisomers 142 or 143 (Scheme 29). Previous work 
in the group has shown that the larger group at the acetal centre resides in a pseudo-
equatorial position on the boat conformation adopted by the dioxanone ring, with the 
smaller group in the flagstaff position (Scheme 13 and 14). Based on this precedent, it is 
expected that 142 would be the favoured diastereoisomer. If this is indeed the case, then 
the carbonyl and alkyne should be favourably orientated in space to undergo an 
intramolecular keto-alkyne cyclisation reaction (Scheme 30). 
 
Scheme 29  
If the cyclisation of 144 proves successful, then subsequent oxidative cleavage of the alkene 
in 145 would give ketone 146. Acetal cleavage would then reveal the hydroxyl groups in 147, 
analogous to the diastereotopic alcohols found in 74, as required in the synthesis of 
phyllaemblic acid 47. 
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Scheme 30  
 
Results and Discussion  
Model study for intramolecular studies 
Compound 141 has been assessed as a suitable dioxanone for an α,α’-annulation reaction26 
(Scheme 29), potentially providing a substrate 142 on which to test the desired keto-alkyne 
cyclisation reaction.  
In order to obtain the substituted 1,3-dioxan-5-one 141, 5-methyl-1-(trimethylsilyl)hex-1-yn-
3-one 150 was first synthesised (Scheme 31).68 Reaction with one equivalent each of 
isovaleryl chloride 148, BTMSA 149 and AlCl3 in CH2Cl2 at 0 
oC followed by warming to rt gave 
the desired product 150 in 98% yield. 
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Scheme 31  
TRIZMA 151 was expected to undergo acetalisation with 150 to form 152 (Scheme 32). 
Acetal 152 would then be subjected to an oxidative cleavage to form 141. Forbes et al. had 
used TRIZMA in their synthesis of 1,3-dioxan-5-ones, though they had first activated the 
carbonyl moiety by converting it to a dimethyl acetal.69 Initial attempts to form an acetal 
directly from 150 with TRIZMA proved problematic, possibly due to the low reactivity of the 
ketone. Therefore, a variation of Forbes’ procedure was investigated. 
 
Scheme 32  
Attempts were made to activate the ketone functionality of 150 by acetalisation via reaction 
with trimethyl orthoformate and pTSA in MeOH to form 153. The reaction gave two major 
products and some unreacted starting material which could only be partially purified by 
column chromatography. Small amounts of each compound were isolated for 
characterisation; the compounds isolated were found to be ketone 150, the desired 
dimethyl acetal 154 and the enol ether 155 (Scheme 33). 
 
Scheme 33  
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Further attempts to improve the purification of the products from this reaction were 
unsuccessful. As all three compounds isolated from the reaction mixture could potentially 
lead to the desired product 141, it was decided to use the partially purified material directly 
in the next step of the reaction sequence. 
Attempts were made to react the partially purified dimethylacetal 154 with TRIZMA to form 
acetal 152, followed directly by oxidative cleavage with NaIO4 to form 141 (Scheme 34). 
Following literature precedent, the crude amino alcohol 152 was used in the subsequent 
oxidation.69 However, the desired compound 141 was obtained in a consistently low yield, 
typically less than 6% over two steps. The TMS group was removed from 154 with TBAF to 
give 156 in 47% yield. It was hoped that this would lead, by analogy, to 158; however, the 
acetalisation with TRIZMA and 156 to give 157 was also unsuccessful.  
 
Scheme 34  
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Due to the oxidative cleavage of TRIZMA acetals being a known procedure, it was assumed 
that the poor yields of 141 were due to the problematic formation of 152. Attempts were 
made to try to isolate the amino alcohol 152 but this proved troublesome. Analysis of the 1H 
NMR of the crude reaction mixture, before and after workup, showed the presence of large 
quantities of impurities which obscured the product resonances. Monitoring the reaction by 
T.L.C. also proved difficult, as although dimethylacetal 154 looked as though it was being 
consumed, the consumption of TRIZMA and product formation were difficult to follow as 
both were very polar. Eventually it was found that the T.L.C. eluent CMAW (chloroform 65%: 
methanol 20%: acetic acid 10%: water 5%) would move TRIZMA and 152 off the baseline. 
Once suitable conditions had been found to enable T.L.C analysis of the reaction, various 
conditions were tested in an attempt to improve the efficiency of formation of 141 (Table 5). 
Various solvents, temperatures and extended reaction times did not improve the efficiency 
of the reaction and so this approach was abandoned. 
sm mmol eq. TRIZMA Solvent Temp Time Comments Yield of 141 
150 1.37 1.2 toluene reflux 24 hr A - 
150 1.37 1.2 benzene reflux 24 hr A - 
150 0.437 1 DMF 65 oC 2 days B - 
154 4.07 1.1 DMF 65 oC 20 hr C 3% 
154 24.02 1.1 DMF 65 oC 20 hr C 6% 
154 2.18 1 DMF 65 oC 2 hr D - 
154 37.9 1 DMF 65 oC 2 days E 2% 
154 0.437 2 DMF 65 oC- rt 24 hr F - 
154 0.437 5 DMF reflux 24 hr H - 
156 0.640 1 DMF 65 oC 24 hr - - 
156 2.56 1 DMF reflux 24 hr - - 
Table 5  
(A) Dean Stark setup, (B) DMF at 65
o
C dissolves TRIZMA, (C) after 20 hours NaIO4 cleavage undertaken, (D) 
attempted to isolate 152, (E) after 2 days NaIO4 cleavage undertaken, (F) after 18 hr rt 1 eq. of TRIZMA added; 
after 12 hr 1 eq. of TRIZMA added, (H) 5 eq. of TRIZMA added. 
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An alternative strategy to form 141 via oxidative cleavage of alkene 160 was proposed 
(Scheme 35). 2-Methylene-1,3-propane diol 159 was identified as a suitable precursor to 
acetal 160. 
 
Scheme 35   
1,3-Dichloro-2-methylenepropane 161 has been reported to undergo substitution with 
sodium pivalate to give 162, followed by methanolysis to obtain the desired diol 159 
(Scheme 36).70 However, the diol proved difficult to obtain via this route. DMF was used as 
the solvent but this led to problems during the work up; diol 159 could not be distilled away 
from the DMF. Extraction using brine and Et2O led to the diol preferentially residing in the 
aqueous layer. Distillation was attempted but unfortunately the diol was unable to be 
obtained. 
 
Scheme 36  
In order to overcome the problems caused by the use of DMF, diol 165 was synthesised via 
known literature procedures (Scheme 37).71, 72 This would have enabled access to acetal 166 
which after an oxidative cleavage would have led to the desired acetal 141. Refluxing 
dimethylmalonate, acetone and acetic anhydride in the presence of ZnCl2 gave 164 which 
was subsequently reduced to afford the diol 165. The literature reported a yield of 30% for 
165, however, yields of <1% were recorded. This appeared to be due to 1,4-hydride addition 
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occurring in competition with ester reduction. This approach was abandoned due to the very 
low efficiency of this reaction. 
 
Scheme 37 
Diol 159 is commercially available, albeit expensive. Since there were problems with 
synthesising it effectively, it was decided to purchase the diol and use it directly in the 
acetalisation reactions. 
 
Scheme 38  
Treatment of ketone 150 with diol 159 and catalytic amounts of pTSA proved to be fruitless 
and no reaction was observed (Scheme 38). Acetalisation using diol 159 and dimethyl acetal 
154 was also undertaken but again no reaction was observed. Therefore, attention turned to 
the use of a variation of a literature procedure reported by Noyori et al. (Scheme 39).73  
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Scheme 39 
The first step was conversion of 159 to the bis-TMS-ether 167. This was successfully 
achieved by reacting diol 159 with 2.1 eq. of TMSCl and Et3N in CH2Cl2 using the method of 
Veyrieres et al.74 This reaction gave 167 in yields greater than 95%. 1H NMR analysis 
indicated that the protected diol 167 was pure; however, T.L.C. analysis showed impurities 
present. Repeated washings of the product with water and brine gave 167 as a clear oil in 
91% yield. However, when 167 was reacted with 150 under literature conditions,73 no trace 
of 160 was obtained. Subsequent investigation found that addition of 167 and 150 to a 
solution of catalytic TMSOTf in CH2Cl2 at 0 
oC and subsequent warming to rt, gave the 
desired acetal 160 in a yield of 89%.  
Attention now turned to the conversion of the alkene moiety in 160 to a carbonyl in order to 
obtain the desired compound 141 (Scheme 40). Ozonolysis was initially chosen as the 
preferred technique for this conversion.  
 
Scheme 40  
Ozonolysis was initially attempted using CH2Cl2/MeOH as the solvent with O3 bubbled 
through the reaction mixture until a colour change from colourless to blue occurred. The 
reaction was quenched with dimethyl sulfide and concentrated under reduced pressure. 
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Column chromatography produced the desired compound 141 in 27% yield with no other 
material being isolated. It was thought that the moderate yield may be due to some 
hydrolysis of the acetal group. To minimise this problem, the same reaction was run in the 
presence of ten equivalents of sodium bicarbonate. This produced a mixture of products, 
including some material from which the TMS group had been removed. The reaction was 
repeated in the absence of sodium bicarbonate and a mixture of products was again 
observed. 1H NMR analysis indicated that once again the TMS group had been removed, 
despite the absence of sodium bicarbonate. 
The use of OsO4 with NaIO4 has received wide attention for the conversion of alkenes to 
aldehydes and ketones. The Johnson-Lemieux oxidation has been used since 1957,75 
however, the reaction often only produces moderate yields of between 60-65%. A number 
of years later Jin et al.76 reported an increase in yield by the addition of 2,6-lutidine. This 
suppressed alpha-hydroxy ketone by-product formation and increased the yield to around 
90%. 
Initial attempts to affect Johnson-Lemieux oxidation on compound 160 were focused on 
using both the traditional method and the 2,6-lutidine method (Scheme 41). As 160 contains 
a terminal alkene, α-hydroxy ketone by-product formation would not be an issue; however, 
α-hydroxy aldehyde may still form and hence 2,6-lutidine was used in some reactions to 
observe its effect (Table 6).   
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Scheme 41  
Entry sm mmol Temp Time 2,6-Lutidine Yield 
1 0.4 50 oC 1 hr No 62% 
2 0.4 50 oC 1 hr No 49% 
3 1.2 60 oC 2.5 hr No 50% 
4 4.0 50 oC 24 hr No sm only 
5 1.0 60 oC 12 hr No 19% 
6 1.2 60 oC 12 hr No sm only 
7 0.4 50 oC 12 hr 2 eq. -a 
8 0.4 rt 24 hr 2 eq. -b 
9 0.4 reflux 12 hr No sm only 
10 0.4 25-50 oC 12 hr No 33% 
11 0.4 50 oC 4 hr No 47% 
12 1.2 60 oC 4 hr No 32% 
13 4.8 50 oC 4 hr No 63% BRSM 
14 4.8 50 oC 4 hr No 50% BRSM 
15 5.2 50 oC 4 hr No 46% BRSM 
16 4.0 50 oC 4 hr No 61% BRSM 
17 4.4 50 oC 4 hr No 53% 
18 8.0 60 oC 4 hr No 59% 
19 5.1 50 oC 4 hr No 53% 
Table 6  
a
Acetal cleaved. 
b
No reaction, no recovered sm, (For entries 13-19, any solid material was filtered off 
before a basic work up) 
The reaction was first attempted for one hour at 50 oC (entries 1-2). This gave yields of 141 
in 62% and 49% respectively. However, starting material 160 was present in both reactions. 
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Increasing the reaction time to 2.5 hours showed no improvement, giving 141 in a 50% yield 
with 160 still present (entry 3). The reaction time was increased to between twelve and 
twenty four hours to attempt to increase the yield of 141 (entries 4-7). T.L.C. analysis 
showed that, once again, 160 remained present in the reaction. In some cases the yield was 
dramatically decreased (entry 5) and the acetal was cleaved (entry 7). The effect of 
temperature was investigated, varying from rt to reflux (entries 8-10). The entries showed 
that increasing temperature made no difference as 160 was observed and a low yield was 
obtained in entry 10. Throughout this investigation, inconsistent results were obtained with 
the yield ranging from 0-63%. The addition of 2,6-lutidine proved not to be beneficial to the 
reaction (entries 7, 8). To date, it has been found that four hours at 50 oC, followed by a 
careful work up and filtration step to remove any solid material, will give consistent yields of 
between 50-60% (entries 13-19). 
The reactions in Table 6 produced a variety of yields and on occasion inconsistent results 
(entry 12). Therefore, alternative solvents and oxidising agents were investigated in an 
attempt to improve the yield of 141 (Table 7). The Upjohn dihydroxylation was developed in 
1976 as a way to form 1,2-diols.77 The method employs cat. OsO4 and NMO in mixed solvent 
systems such as 5:5:2 acetone: water: tBuOH or 10:1 acetone: water. This  chemistry has led 
to a two-step procedure for the oxidative cleavage of alkenes, via formation of the 
corresponding diol, followed by addition of a second oxidant.78 This approach was 
investigated using various conditions. Treatment of alkene 160 with osmium tetroxide gave 
complete consumption of starting material by T.L.C. analysis. However, after NaIO4 was 
added no material could be isolated. A different solvent system was used along with 
stoichiometric 2,6-lutidine. Starting material 160 was again consumed but upon addition of 
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NaIO4 acetal cleavage occurred (entry 2). As the diol 168 appeared to be formed, and there 
was no trace of starting material, an attempt was made to isolate it. Unfortunately, it was 
not possible to recover any product (entry 3). An alternative method developed by Nicolaou 
et al.79 uses PhI(OAc)2 instead of NaIO4. This work showed promising results for the 
formation of ketones from 1,2-diols. Unfortunately, when applied to 160, only degraded 
material was obtained (entries 4 and 5). 
 
Entry sm 
mmol 
Solvent Tempd 
 
Time 
1 
Time 
2 
2,6-
lutidine 
Step 2 
Oxidant 
Result 
1 0.396 acetone: 
H2O: 
tBuOH 
5:5:2 
60 oC a 12 
hr 
No NaIO4       
4 eq. 
degraded 
material 
2 0.396 acetone: 
water 10:1 
50 oC a 2 
days 
Yes NaIO4      
 4 eq. 
degraded 
material 
3 0.396 acetone: 
water 10:1 
50 oC 3 hr - Yes -b no 
recovery 
4 0.396 acetone: 
water 10:1 
50 oC a 2 
days 
Yes PhI(OAc)2 
1.5 eq. 
degraded 
material 
5 3.96 acetone: 
water 10:1 
50 oC c 12 
hr 
Yes PhI(OAc)2 
1.5 eq. 
degraded 
material 
Table 7  
a 
Reactions monitored by T.L.C. until sm was consumed then continued to step 2. 
b
 Attempted to isolate diol 
instead of proceeding with oxidative cleavage. 
c
 Reaction proceeded after sm was almost completely 
consumed. 
d
 Temperature was maintained throughout step 1 and 2. 
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Attempted annulation reactions 
Although the yields of 141 obtained via the Lemieux-type approach were not ideal, sufficient 
material was obtained to enable investigation of the α,α’-annulation reaction. The 
methodology initially used was the same as for the formation of 80 (Scheme 13). However, 
the first attempt at this reaction gave a complex mixture of products. 1H NMR analysis of the 
crude reaction mixture suggested that the starting material 141 had been consumed, with 
the appearance of new alkene resonances. From this data it was tentatively concluded that 
after formation of 169 monosubstitution had occurred to give 170 (Scheme 42). 
Unfortunately, 170 could not be isolated and mass spectrometric analysis gave no evidence 
for or against the proposed structure. With this in mind, the reaction was repeated and 
subjected to reflux overnight. It was assumed that if monosubstitution had occurred, then 
the higher temperature may provide the energy needed to complete the annulation. The 1H 
NMR spectrum of the crude reaction mixture suggested formation of a new product with 
large amounts of impurities. Due to the difficulty in assigning the structures of the products, 
and the problems when trying to follow the reaction, it was decided to make sure the first 
step of the reaction sequence was proceeding. 
 
Scheme 42  
The formation of enamine 169 is key for the successful annulation reaction to occur (Chapter 
1, Scheme 29). As there was no evidence of an annulation occurring under standard 
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conditions, further investigation was undertaken to determine whether the condensation of 
pyrrolidine with 141 was taking place (Table 8). 
 
Entry sm 
mmol 
Pyrrolidine 
eq. 
Toluene 
conc. 
Temp Time Yield 
1 0.2 1 0.1 rt 12 hr -a 
2 0.2 1 0.1 rt-50 oC 48 hr -b 
3 0.2 2 0.1 50 oC 72 hr -c 
4 0.4 4 0.1 50 oC 72 hr 68% 
5 1.0 4 0.5 50 oC 24 hr 60% 
Table 8  
a
CSA used which promoted acetal cleavage. 
b
 Enamine observed by 
1
H NMR, no reaction until temp increased 
to 50 
o
C. 
c 
Enamine observed by 
1
H NMR, 1 eq. of pyrrolidine added after 48 hr. 
Traditional enamine formation using pyrrolidine often uses toluene as a solvent with 
catalytic pTSA at rt.80 Due to the presence of an acid sensitive acetal, the slightly milder acid 
CSA was used instead (entry 1). This unfortunately resulted in acetal cleavage. The use of 1 
eq. of pyrrolidine at rt gave no reaction, as shown by 1H NMR analysis of the crude reaction 
mixture. The reaction temperature was increased to 50 oC and after 48 hours enamine 169 
had started to form (entry 2). The reaction was then left for 72 hours at 50 oC. 1H NMR 
analysis of the crude reaction mixture showed enamine formation along with starting 
material in an approximate ratio of 50:50. Another 1 eq. of pyrrolidine was added and 1H 
NMR now showed that the desired enamine 169 was the major product (entry 3). The 
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reaction was set up on slightly larger scale with 4 eq. of pyrrolidine in an attempt to fully 
convert all of the starting material. After 72 hours enamine 169 was isolated in a yield of 
68% (entry 4). The solution concentration of 141 was increased to 0.5 M to increase reaction 
rate; after 24 hours 169 was isolated in a 60% yield (entry 5). 
After formation of 169 was confirmed, the annulation reaction was attempted to form 142 
(Scheme 29). 1 eq. of Et3N and methyl bromomethylacrylate were added to a solution of 169 
in MeCN and the reagents subjected to the same conditions previously investigated.26 1H 
NMR of the crude material showed that the methyl bromomethylacrylate and 169 had been 
consumed. Purification of the crude material proved problematic as there were multiple 
components of very similar polarity that could not be separated. The 1H NMR data from the 
crude material showed the presence of resonances corresponding to new alkene group(s). It 
was assumed from this that the alkylation step had worked; however, cyclisation was not 
proceeding to completion.  
It was thought that the presence of the TMS group may be interfering in the intramolecular 
addition, preventing the second ring from forming. In order to test this theory, it was 
decided to remove the TMS group.  
As 141 contains an acid sensitive acetal, it was decided to use MeOH and K2CO3 at 0 
oC to 
remove the TMS group. The deprotection initially worked well with 2 eq. of K2CO3 (Table 9) 
(entries 1, 2, 4 and 5), although leaving the reaction to warm above 0 oC led to degradation 
(entry 3). Scaling the reaction required increased reaction times which then led to problems; 
158 was observed by T.L.C. but by-products rapidly formed leading to degraded material 
(entries 6-8). TBAF was used as an alternative but this also resulted in degradation (entry 9). 
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The amount of K2CO3 was reduced in an attempt to control the rate of the reaction and 
prevent degradation (entries 10-12). With careful monitoring of reaction progress, followed 
by rapid workup, yields of 70% were obtained. However, consistent results were still difficult 
to obtain. Therefore, silyl deprotection was attempted at various points along the four step 
synthesis of 141. 
 
Entry sm mmol Solvent ratio 
4:1 
Reagent eq. Time Yield 
1 0.4 MeOH:H2O K2CO3 2 eq. 30 Min 42% 
2 0.4 MeOH:H2O K2CO3 2 eq. 15 Min 77% 
3 0.4 MeOH:H2O K2CO3 2 eq. 30 Min -
a 
4 1.0 MeOH:H2O K2CO3 2 eq. 30 Min 76% 
5 1.0 MeOH:H2O K2CO3 2 eq. 1 hr 80% 
6 1.7 MeOH:H2O K2CO3 2 eq. 3.5 hr -
b 
7 2.0 MeOH:H2O K2CO3 2 eq. 3.5 hr -
b 
8 2.0 MeOH:H2O K2CO3 2 eq. 1 hr -
b 
9 0.2 THF 0.1 M TBAF 1.2 eq. - -c 
10 1.0 MeOH:H2O K2CO3 1 eq. 45 Min 78% 
11 2.2 MeOH:H2O K2CO3 1 eq. 50 Min 51% 
12 3.0 MeOH:H2O K2CO3 1 eq. 1 hr 59% 
Table 9  
a
 Reaction failed when temp increased above 0 
o
C. 
b 
Scaling the reaction led to degradation. 
c 
Reaction 
monitored by T.L.C., degradation observed immediately, no product ever formed. 
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A few different conditions were attempted for the removal of the TMS group in 150 (Table 
10). All conditions used showed good results via T.L.C. analysis; however, the main issue was 
the high volatility of the product 171.  
 
Entry sm mmol Reagent Solvent Yield 
1 2.7  K2CO3 2 eq. MeOH/H2O -
 
2 1.3 NaF 1 eq. Ether: water with 0.1 eq. NBu4Cl  - 
3 1.4 TBAF 1.2 eq. THF - 
Table 10  
Due to the difficulty in isolating the ketone 171, it was decided to remove the TMS group 
after the Noyori acetalisation. The procedure for TMS removal from 160 proceeded 
smoothly  and reproducible results were now obtainable, with yields around 80% (Table 11). 
 
Entry sm mmol Reagent Solvent Yield 
1 0.54 K2CO3 1 eq. MeOH/H2O 66%
 
2 2.0 K2CO3 1 eq. MeOH/H2O 80% 
3 2.5 K2CO3 1 eq. MeOH/H2O 79% 
Table 11  
Subsequent oxidation of the alkene 172 to give 158 also proved to be relatively 
straightforward with reproducible yields of around 80% (Scheme 43). 
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Scheme 43  
Attention then turned to the formation of the enamine 173. The same conditions employed 
previously for the formation of enamine 169 were initially investigated (Table 12). After 
monitoring the crude reaction mixture by 1H NMR it was found that 173 was forming (entry 
1). The reaction was scaled up and left for 12 hours at 50 oC leading to enamine 173 being 
isolated in a 92% yield (entry 2). It was found that 173 formed faster than the previous 
enamine 169 when heated at 50 oC. Subsequent investigation showed that the yield of 173 
was not significantly impacted when carrying out the reaction at rt (entries 3-6). 
 
Entry sm mmol Time Temp Yield 
1 0.4 12 hr 50 oC -a 
2 0.5 12 hr 50 oC 92% 
3 0.9 2 days rt 86% 
4 0.8 12 hr rt 88% 
5 0.8 12 hr rt 69% 
6 3.4 12 hr rt 88% 
Table 12  
a 
Enamine formation observed by crude NMR. 
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With successful formation of enamine 173 in hand, the annulation reaction was attempted. 
As stated earlier, annulation of 169 was studied first; however, no product formation was 
observed under any of the conditions tested.  
 
Scheme 44  
Alkyne 158 reacted fully, but the product obtained was not the expected annulation 
compound 174. Instead compound 175 was isolated from a complex reaction mixture in 
modest yield. The structure of 175 was additionally proven by X-ray crystallography (Figure 
7). 
 
Figure 7   Crystal structure of molecule 1 of 175 with ellipsoids drawn at the 50% probability level. The structure contains 
three crystallographically-independent molecules.  
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Based on the formation of 175, it was concluded that α,α’-annulation to form 176 had taken 
place. After iminium hydrolysis of 176 to form 174 it is proposed that the resultant carbonyl 
and alkyne are in such close proximity that they undergo in situ cyclisation to form 175 
(Scheme 45). What remains unclear is how stepwise or concerted the reaction is. 
 
Scheme 45  
Before the structure was confirmed to be that of 175, the structure was tentatively assigned 
to be that of 174. When running the reaction it was noted by T.L.C. analysis that degradation 
was occurring. It was assumed that this was the main reason low yields were being obtained. 
In order to reduce reaction times and hopefully minimise degradation, the temperature was 
raised to 50 oC. Again, none of the desired alkyne 174 was obtained, but instead the vinyl 
bromide 177 had formed (Scheme 46).  
 
Scheme 46  
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Figure 8 Crystal structure of 177 with ellipsoids drawn at the 50% probability level.  
The structure of 177 was conclusively proven by X-ray crystallography (Figure 8). 
Interestingly this time a five-membered ring has formed instead of the six-membered ring in 
175. The formation of 177 again proves that an annulation has taken place. The 1H NMR 
taken of the product 177 had multiple multiplets and the majority of the coupling constants 
could not be resolved. When looking at the crystal structure this is perhaps unsurprising as 
the chair is quite twisted hence reducing the symmetry in the molecule.  
When thinking about the mechanism for the product formation it is again assumed that the 
alkyne is in close proximity to the iminium (Scheme 47). However, as this reaction is run at 
50 oC as opposed to room temperature, it is proposed that the water quench of iminium 176 
does not take place. Due to the higher temperature the system now has enough energy for a 
resultant bromide to form the observed vinyl bromide. 
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Scheme 47  
At first glance it may seem that the tricyclic systems obtained (175, 177) can be utilised in a 
synthesis of phyllaemblic acid. However, after further consideration of the precursor 74 
needed for spiroacetalisation it becomes apparent that taking these systems on further 
would be problematic (Figure 9).   
 
Figure 9  
In the first case, product 175 has the correct stereochemistry and functionality; however, a 
six-membered ring was obtained where a five needs to be present in order to obtain the 
alpha-hydroxyketone moiety in 74. In the case of the reaction run at 50oC, product 177 has 
the five-membered ring system; however, a pyrrolidine ring now resides in place of the 
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alcohol. This would be very difficult to functionalise further, therefore it was concluded that 
the keto-alkyne cyclisation was not a viable pathway towards the total synthesis of 
phyllaemblic acid. 
An extensive search of the literature was conducted in the hope that this novel approach to 
these interesting tricyclic systems can be used in target synthesis. However, to date there 
has been no natural product or organic analogue identified that could benefit from the 
products formed by this apparent proximity effect. 
A photomediated approach towards C-C bond formation in bicyclic systems 
Literature review on the Norrish reaction.  
Norrish et al.81 were the first to report details of the photo-activation of carbonyl 
compounds which results in either Norrish type 1 (Scheme 48) or type 2 (Scheme 49) 
reaction pathways. 
 
Scheme 48  
The Norrish type 1 reaction is the homolysis of a ketone 181 resulting in two radical 
fragments 183 and 184. The carbonyl group is excited to a photochemical singlet state. 
Through intersystem crossing (ISC) a triplet state can also be formed. After cleavage from 
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either the singlet or the triplet state, the two radical fragments 183 and 184 are obtained. 
Once the radicals have formed several reaction pathways are available. These include: 
recombination, with the formation of a new C-C bond and loss of CO; recombination, 
resulting in racemisation on the alpha substituent; the formation of an aldehyde and an 
alkene or the formation of a ketene and an alkane.  
The Norrish type 2 reaction has the same principle as a type 1. However, after photo 
activation of 185 and hydrogen abstraction to give 186, a secondary reaction can occur 
known as a Norrish-Yang reaction. This results when 1,5-hydrogen abstraction occurs from 
the gamma position, leading to a diradical species forming and recombining to give a 
cyclobutane ring 187. An alternative pathway would result in the formation of 188 and 189; 
however, the abstraction of a gamma proton would normally be the preferred route.  
 
Scheme 49  
The Norrish-Yang cyclisation has been utilised in several natural product syntheses. Tochtrop 
et al.82 irradiated 190 to create the four-membered ring in 191 in their approach towards 
bryonolic acid (Scheme 50).  
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Scheme 50  
Whilst creating analogues for a methodology study Yoshioka et al.83 also used the Norrish-
Yang reaction on 192 to form a cyclobutane fused to an aromatic ring in 193 (Scheme 51).  
 
Scheme 51  
Kawai et al.84 utilised a Norrish pathway in their novel synthesis of physalin-R. Interestingly, 
the photo-activation of 194 led to the formation of a six-membered ring 195 rather than a 
four-membered ring. This is possibly due to the bridged ether which shuts down the classic 
Norrish-Yang mechanism (Scheme 52).  
 
Scheme 52  
Wanger et al.85 reported the photo-cyclisation of o-alkoxy phenyl ketones. The work detailed 
the successful cyclisation of several analogues resulting in the formation of five-membered 
rings. What is particularly interesting about this work is that after photo-activation of the 
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carbonyl in 196, hydrogen is abstracted from a methoxy group. The resultant radical 
subsequently cyclises to give the product 197 (Scheme 53).  
 
Scheme 53  
Paquette et al.86 used the Norrish type 2 cyclisation to successfully synthesise the natural 
products punctatin A and D. The key step in their approach was to take the cyclic ketone 198 
and irradiate with a 450-W Hanovia lamp for 10 h; which gave the cyclobutyl alcohol 199 in 
62% yield (Scheme 54).  
 
Scheme 54  
Mayo et al.87 synthesised cuparene 203 using a photochemical method to form the five-
membered ring88. This is a particularly interesting reaction as the Norrish-Yang cyclisation 
was undertaken on thioketone 200. It was found that reaction of thioketones are dependent 
on the excitation wavelength and therefore afford a five-membered ring 201 even with the 
presence of a gamma hydrogen. This eventually led to the natural product 202 (Scheme 55).  
 
Scheme 55 
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Results and discussion  
Photo-activation of bicyclic ketones. 
Bicyclic ketones 79 and 80 were easily obtainable and it was thought that it may be possible 
to activate the carbonyl and trigger a cyclisation using the methoxy attached to the 
orthoacetal. 
Looking at the bicyclic ketone 79, diradical formation and subsequent 1,7- hydrogen 
abstraction in 203 could set up a C-C bond formation process to occur through the 
recombination of the primary and tertiary radical in 204. This would then set up the required 
stereochemistry at the tertiary alcohol needed to continue investigations to functionalise 
205 (Scheme 56).  
 
Scheme 56  
It was decided to subject both the bicyclic ketones 79 and 80 to photo irradiation (Table 13).  
Entry Bicyclic 
ketone 
Solvent Reaction 
vessel 
Yield 
1 79 MeCN Pyrex 29% of 206 
2 79 MeCN quartz degradation 
3 79 MeOH Pyrex degradation 
4 80 MeCN Pyrex 17% of 207 
Table 13   
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Unfortunately, there was no evidence of the desired intramolecular reaction. However, 
major products 206, 207 were isolated with interesting stereochemical outcomes (Scheme 
57).  
 
Scheme 57  
 
Scheme 58  
In the first example (Scheme 58) the stereochemistry of 206 was easy to identify from NOE 
analysis. The hydrogen on carbon 4 was clearly cis to the hydrogen on carbon 3 as 
demonstrated by a strong NOE between them. Irradiating these hydrogens led to no signal 
  61 
 
observed for the hydrogen on carbon 6. This clearly indicates that the ester is trans to the 
alcohol and the acetate.  
The stereochemistry of 207 was slightly harder to confirm. Again a strong NOE signal was 
found between the two hydrogens on carbons 4 and 3. However, these hydrogens gave a 
very weak NOE to the hydrogen attached to carbon 6. Confirmation of the stereochemistry 
was completed by irradiation of Ha on carbon 7. Ha also showed a strong NOE to the 
hydrogen on carbon 6. This gave clear evidence that the ester was cis to the alcohol and 
acetate.  
The photochemical decomposition of cyclic ketones to cyclic alkanes is a known procedure in 
the literature. This phenomenon was first documented by Norrish et al. and further 
investigated by Benson et al.89 
However, the loss of CO presents several problems for a mechanistic explanation for the 
observed products (Scheme 57). Assuming loss of CO occurs through photolysis, the 
remaining di radical species would then ring close to give a five-membered ring (Scheme 59). 
This process was first reported by Blacet et al.90 who observed cyclohexanone decomposing 
to cyclopentane under photochemical conditions.    
 
Scheme 59  
Looking at the molecules 206b/207b it is difficult to envisage how cleavage of the acetal 
occurs. The reaction was performed in Pyrex glassware, so no further part of the molecule 
should be photo-activated. The position of the ester further adds to the complexity of the 
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unknown reaction pathway. In both cases the ester appears to have undergone an 
epimerisation which under the reaction conditions should not occur. To date the 
mechanistic pathway of these unusual reactions remains unclear. The loss of CO from 79/80 
resulted in the decision that a photo mediated approach on the bicyclic system was not a 
viable route towards the natural product.  
Conclusions and summary 
In chapter two, two routes have been investigated in order to determine if an intramolecular 
addition reaction could overcome the lack of reactivity of the ketone 80 towards 
intermolecular addition and lead to the correct stereochemical array shown in 74 (Scheme 
12). The first investigation focused on a proposed keto-alkyne cyclisation. This work led to 
the synthesis of novel 1,3-dioxanones 141 and 158 which were subjected to α,α’-annulation 
reactions. Keto-alkyne cyclisation studies were unable to be attempted due to the formation 
of tricyclic systems 174 and 175. The mechanistic pathway for their formation is not fully 
known; however, the close proximity of an alkyne to a reactive electrophilic carbon is 
thought to attribute to the observed reactivity. Ultimately, this led to the conclusion that an 
intramolecular keto-alkyne cyclisation is not a viable pathway towards phyllaemblic acid. A 
new intramolecular addition was attempted using the readily available bicyclic ketones 79 
and 80. The proposed cyclisation reaction used light to initiate an excited carbonyl to then 
abstract a hydrogen and ring close. This investigation was based on literature precedent set 
by Norrish and Wanger. Unfortunately, this led to the formal loss of CO from the bicyclic 
system to form 206/207. Although there is literature precedent for the formal loss of CO, the 
mechanistic pathway for the subsequent epimerisation and removal of the orthoacetal still 
remains unclear.  
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Chapter 3 Reinvestigation of intermolecular addition on monocyclic 
ketones 
Introduction 
The Grainger group approach to phyllaemblic acid, as discussed in chapter two, requires the 
spiroacetalisation precursor 74 to be synthesised with all six stereocentres set (Scheme 60). 
 
Scheme 60  
In the approaches investigated so far, three of the stereocentres on the cyclohexane ring 
have been set by the α,α’-annulation reaction followed by epimerisation. The resulting 
ketone 80 was found to be unreactive to a variety of nucleophiles. When reaction had 
occurred, it had proceeded in low yield with the undesired stereochemistry required for the 
natural product; the tertiary alcohol is cis to the oxygen atoms 209 and not in the required 
trans configuration 208 (Scheme 61).  
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Scheme 61  
It was thought that the reason for the low reactivity of 80 and the observed undesired 
stereochemistry was due to nucleophilic addition occurring at the more accessible top face.  
This leads to a developing steric clash with the flagpole R’ group due to the boat chair 
conformation adopted by the bicyclic ring (Scheme 62).  
 
Scheme 62  
Previous work in the group sought to overcome the low reactivity of ketone 80. Acetal 
deprotection gave 210 and was followed by reprotection to produce the bis-TBS ether 211.  
It was hoped that the transformation of the ketone 80 from a constrained bicyclic structure 
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to a more flexible monocyclic form would facilitate nucleophilic attack and increase 
reactivity (Scheme 63). 
 
Scheme 63  
Unfortunately, poor reactivity of the ketone in 211 was again observed and further 
functionalisation of the products was problematic (Scheme 64).  
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Scheme 64  
The ideal transformation would have been the HWE from the monocyclic ketone 211 to 
produce 212. If this reaction had occurred, adding further functionality to phosphonate 214 
would have led to the spiroacetalisation precursor 74 in two steps. Unfortunately, the HWE 
was extensively investigated and could not be achieved on 21191, presumably due to low 
reactivity of the ketone (Scheme 64).  
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Reaction with a more reactive phosphonate was examined to give 215. It was proposed that 
the vinyl sulfone could eventually lead to an α-hydroxy aldehyde, but again no reaction was 
observed (Scheme 64).   
A Sakurai reaction was successfully carried out on 211 to produce 216 in 58% yield. 
However, top face addition occurred, resulting in the undesired stereochemistry i.e. OH cis 
to the OTBS groups (Scheme 64). This was presumably due to the steric bulk of the OTBS 
groups flanking the ketone. 
Finally, aldehyde 217 was formed from 211 in good overall yield. This was achieved by a 
simple Wittig reaction, followed by dihydroxylation. This set up the required 
stereochemistry, i.e. the tertiary OH is trans to the OTBS groups. Swern oxidation of the 
primary alcohol gave aldehyde 217 (Scheme 64).91  
Unfortunately, further transformation of the aldehyde 217 was found to be difficult. 
Addition of a dithiane anion would have potentially led to a system 218 where 
spiroacetalisation studies could be investigated. However, the aldehyde proved to be 
unreactive to this type of chemistry (Scheme 64).91 
Aims and Objectives 
Previous investigations found that a methylene could be introduced into 211 in moderate 
yield via a Wittig reaction to form 219. Based on this observation, it was postulated that the 
issue of no reactivity towards HWE was due to the large TBS protecting groups flanking 
either side of the carbonyl in 211. This caused the carbonyl to be sterically hindered and 
hence prevented the formation of 212 (Scheme 65).  
  68 
 
 
Scheme 65  
Despite these unpromising prior results, it was decided to reinvestigate intermolecular 
additions on a monocyclic system. Specifically focusing on the HWE, it was postulated that 
using a different protecting group would allow the desired transformation to take place.  
Results and Discussion 
Attempted protection of the diol 
The ideal protecting group would be electron-withdrawing and small in size as this would 
reduce the steric hindrance and increase the reactivity of the ketone towards the desired 
HWE reaction.  
A simple acyl group was chosen as the ideal candidate to meet both of these criteria and 
form 220 (Scheme 66).  
 
Scheme 66 
  69 
 
Table 14  
However, installing acyl groups proved to be problematic (Table 14) and monitoring the 
reaction proved difficult, as the diol that is formed in situ was not able to be visualised in a 
wide variety of T.L.C. stains. Neither product nor starting material could be isolated in 
entries 1-3.  
Successful formation of 220 was achieved in (entry 4); however, the acyl groups were found 
to migrate in situ which led to the isolation of 223 in 46% yield. It is proposed that enol 
formation occurs to form 221 which then initiates an acyl group transfer 222. Elimination of 
the acetate group then forms the conjugated ketone 223 (Scheme 67). The migration of acyl 
groups and elimination of acetate groups is well known92-94 but no related examples for 
comparison to the system below could be found. 
Entry Ac2O Pyridine Et3N DMAP Acetyl 
Chloride 
Temp Solvent Yield 
1 2.2 eq.  2.2 eq. 10 mol%  reflux CH2Cl2 - 
2   2.0 eq.  2.0 rt-reflux THF - 
3 3 eq.     rt-reflux pyridine - 
4 4.4 eq.   10 mol%  rt pyridine 46% 
223 
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Scheme 67  
After the unsuccessful attempt at installation of the acyl groups, attention turned to a 
variety of different protecting groups that were expected to be compatible with a 
subsequent HWE reaction. 
Dimethylthiocarbamate (DMTC) is a relatively unusual protecting group but Falck et al.95 
showed it to be stable to a wide variety of conditions and reagents. The DMTCs can be 
removed with NaIO4 or H2O2 in the presence of other common alcohol protecting groups. It 
would be ideally suited as a protecting group for the alcohol functionalities of 210 as it is 
small and electron-withdrawing, which should favour a subsequent HWE reaction. The 
literature method for DMTC protection uses a 5 mmol solution in THF with 5.1 eq. of NaH 
and 0.1 eq. of NaI. It was expected that the THF used could be switched to DMF, without 
compromising the installation of the DMTC group, in order to aid solubility of diol 210. Even 
with the diol fully dissolved in DMF, the conditions used still resulted in no formation of 224. 
The inability to follow the reaction made it difficult to identify reasons as to why no reaction 
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was observed (Scheme 68). Frustratingly, isolation of starting material was also problematic 
as diol 210 was largely lost during aqueous work-up.  
 
Scheme 68  
Carbonyldiimidazole with NaH in DMF was used to try and form the bicyclic system 225. It 
was hoped that the installation of another carbonyl would lead to a dipole interaction 
pushing the two carbonyls away from each other and providing more space for a nucleophile 
to attack. Unfortunately, no material could be isolated from this reaction. As with the DMTC 
protection, monitoring the reaction was difficult and it was assumed that no reaction was 
taking place (Scheme 69). Again, starting material was largely lost during aqueous work-up. 
 
Scheme 69  
Although not particularly small or electron-withdrawing, the use of benzyl groups were 
investigated as it was hoped that they would orientate in a conformation to open up the 
carbonyl for nucleophilic addition 226. There are two main sets of conditions to try when 
attempting a benzyl protection.96, 97 The first uses a base such as NaH and benzyl bromide; 
this was ideally suited for our system as DMF is often used as the solvent. Unfortunately, 
were unable to protect the diol to give 226 using basic conditions. Again, problems with 
monitoring the reaction persisted so an attempt was made to obtain 1H NMR of the crude 
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reaction mixture. The data obtained from the crude 1H NMR showed no evidence of product 
formation or remaining starting material and the spectrum contained multiple resonances 
indicating a complex mixture of products. This may indicate that compound 210 is unstable 
to strongly basic conditions, decomposing in various ways such as ester hydrolysis or 
elimination to give an α,β-unsaturated ketone. Attempts were made to obtain a 1H NMR of 
the  crude diol before investigating various reaction conditions; however, the data obtained 
for the diol was consistently poor in quality. This meant that NMR spectroscopy could not be 
used to monitor the reaction and it is unclear why basic benzylation conditions were 
unsuccessful.  
The second route uses benzyl trichloroacetimidate in the presence of an acid; unfortunately, 
this method cannot be performed in DMF. Despite the very low solubility of 210 in 
alternative solvents, acidic benzylation in CH2Cl2 was attempted. However, presumably due 
to this poor solubility, no reaction occurred (Scheme 70).  
 
Scheme 70 
Monti et al.98 successfully formed a lactone on a system that is structurally similar to 79. This 
was achieved via refluxing 227 in toluene in the presence of TsOH. This promoted an 
intramolecular addition to remove the TBS group and promoted formation of lactone 228 
(Scheme 71). 
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Scheme 71  
Previous work in the Grainger group successfully installed TBS groups on 211 and so there 
was good precedent for lactone formation to give 230 if 229 could be protected with TBS 
groups. The TBS groups were successfully installed on 229; however, after their removal, the 
equatorial ester would not undergo intramolecular cyclisation in the presence of pTSA in 
refluxing toluene. A small amount of starting material was recovered, and the remaining 
material was assumed to have converted into diol 210 which was lost in subsequent work-up 
(Scheme 72). 
 
Scheme 72 
Finally, the smaller silicon protecting groups TMS and TES were investigated. TMS 
installation occurred smoothly, but unfortunately this protecting group was found to be 
highly labile, resulting in 231 reverting back to starting material (Scheme 73).  
 
Scheme 73  
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TES protection was successfully achieved to afford 232 in an 82% yield, a comparable yield to 
the already known TBS protection to form 87 (Scheme 74)91  
 
Scheme 74  
Reinvestigation of HWE reaction 
A TES group is similar in size to a TBS group; however, a HWE reaction was still attempted in 
the hope that an enone could be formed. If this was the case then the previous route shown 
in Scheme 64 could be reinvestigated with this slightly smaller silicon protecting group.  
In order to have a fair comparison to the TBS system, the same ylide 214 was used as in the 
previous HWE investigations on 21191. The synthesis of 214 was relatively straightforward, 
using the anion of phosphonate 233 to cleave lactone 234, and was achieved in a modest 
54% yield (Scheme 75).  
 
Scheme 75  
Phosphonate 214 was then used to investigate the HWE on 232 (Scheme 76). Two main 
solvents and bases were used; however, no trace of 235 was isolated in any of the reactions 
with staring material being recovered (Table 15). This is consistent with the conditions 
attempted on the TBS protected system by a previous member of the group.91 
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Scheme 76  
Entry Phosphonate eq. Base Solvent Temperature Yield 
1 1.2 NaH 1eq. DMF -78oC- reflux - 
2 1.2 NaH 1eq. THF -78oC- reflux - 
3 1.2 nBuLi 1eq. THF -78oC- reflux - 
Table 15  
The least sterically demanding system toward nucleophilic addition would be on the diol 
210. Conveniently, diol 210 has poor solubility in most solvents but good solubility in DMF. 
This gives rise to the opportunity of performing an in situ HWE reaction on the diol to form 
enone 236 (Scheme 77). This proposed route would open up the possibility of using different 
protecting groups in the subsequent stages to form the natural product.  
The same conditions were used as described above in Table 15 but, unfortunately, no 
desired material 236 was isolated (Scheme 77). 
 
Scheme 77  
To confirm that the phosphonate 214 is able to undergo a HWE reaction, a test reaction was 
carried out on cyclohexanone 237. Surprisingly, again no reaction was observed. Using 
benzaldehyde 239 as a more reactive electrophile saw conversion to the enone 240 in good 
yield (Scheme 78). It was concluded that the phosphonate is a poor nucleophile as it would 
not react with cyclohexanone to form 238. This shows that 214 is generally not compatible 
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with secondary/ cyclic ketones, and goes some way to explaining why neither 210 nor 211 
were able to react with this substrate. This result led to the conclusion that the direct HWE 
route is not viable due to the low reactivity of the phosphonate. 
 
Scheme 78  
 
To complete the study, it was envisaged that a stabilised ylide could potentially give us the 
desired enone functionality and form 241. Therefore, this reaction was attempted using 
methyl (triphenyl)phosphoranylidene)acetate. Again, after careful monitoring of the 
reaction, only starting material was isolated (Scheme 79). 
 
Scheme 79  
 The Barton-Kellogg99 reaction between a thiocarbonyl and a diazo compound has been used 
to prepare sterically hindered alkenes. 
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A new approach was therefore envisaged based on first converting ketone 80 to  thioketone 
242.100 The first attempts to convert the ketone in 80 to a thioketone  used the classic 
Lawesson’s reagent (Scheme 80).101  
 
Scheme 80  
The reaction unfortunately yielded none of the thioketone 242. This may be due to the 
issues with intermolecular addition to 80 as discussed previously.  
However, a more elegant way of preparing the thioketone 244 was postulated based on 
previous studies (Scheme 13). It was proposed that during the quench at the end of the α,α’-
annulation reaction, the iminium ion 243 could be converted to a thioketone in the presence 
of a sulfur nucleophile. This would then yield the bicyclic thioketone 244 and by-pass the 
unreactive bicyclic ketone 80 (Scheme 81). 
 
Scheme 81  
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The first attempts to quench the iminium (Table 16) used a large excess of sodium sulfide in 
MeOH (entry 1). Na2S has poor solubility in most organic solvents and only partial solubility 
in MeOH. The omission of water from the reaction was desired and so MeOH was used as 
the solvent. This led to complete degradation of the system and nothing was recovered from 
the reaction. A 1:1 eq. ratio of iminium to Na2S was used with the Na2S dissolved in water; 
this again led to degradation (entry 2). Literature precedent suggested that the use of H2S in 
the presence of pyridine would be able to facilitate the transformation.102 The equipment for 
the use of H2S gas was not available therefore commercially available H2S in a 20% THF 
solution was used. However, when applied to quench 243, only degradation occurred (entry 
3). It is postulated that the methyl ester may not be compatible with the H2S, causing 
degradation to occur.  
Entry dioxanone mmol Quench reagent Yield 
1 9.2 Na2S 32.5 mmol in 100 mL of MeOH degradation 
2 3.4 Na2S 3.4 mmol 5 mL water degradation 
3 10.3 12.8 mmol H2S 20% THF degradation 
Table 16  
Conclusions and summary 
This chapter has revisited the HWE approach that was previously investigated by the group. 
The HWE reaction would be the most direct route towards the desired spiroacetalisation 
precursor 74. The route was reinvestigated in detail because 211 would not undergo a HWE 
transformation but it could form a methylene upon treatment under Wittig reaction 
conditions. It was concluded that the reason for this was the large TBS groups flanking either 
side of the ketone; these were large enough to preclude attack by the HWE reagent but not 
the Wittig reagent. Based on this conclusion small electron withdrawing acyl groups were 
installed; however, the product quickly re-arranged to form 223 (Scheme 67).  
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Different protecting groups were studied to try and find a suitable candidate that was 
compatible with a HWE reaction. Unfortunately, it became apparent that diol 210 has poor 
solubility and so the number of different protecting groups which could be successfully 
installed was limited. Further complications included the inability to follow the reaction and 
the difficulty in isolating the starting material.  
The smaller silicon protecting group TES was successfully installed to form 232 which was 
used in a HWE reaction with the phosphonate 214. This was the same phosphonate used in 
the previous investigations on 211 and, unfortunately, gave the same outcome of no 
reaction.  
An in situ HWE on diol 210 was attempted to overcome the problems of protecting the diol. 
Unfortunately, again no reaction was observed.  
The phosphonate 214 was found to have poor reactivity towards cyclohexanone, indicating 
that reacting this type of phosphonate with hindered ketones is generally challenging. A 
stabilised ylide also failed to react with the ketone on 211 and so it was concluded that an 
enone could not be formed under the conditions investigated.  
An alternative approach involved converting the ketone in 80 to a thioketone (Scheme 80).  
Lawesson’s reagent was first investigated, but presumably due to the already documented 
steric problems again no reaction was observed. A novel idea was postulated, namely 
attempting to quench the iminium with a nucleophilic sulfur source as work-up of the α,α’-
annulation reaction (Scheme 81). This would have led to a system with a thioketone in place 
of the ketone. Unfortunately, only degradation occurred and this route towards phyllaemblic 
acid was abandoned. 
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Chapter 4 The Meyer-Schuster rearrangement and other alkyne-based 
routes 
Introduction 
Enone functionality, as discussed in chapter three and exhibited in 245, could provide 
convenient access to the spiroacetalisation precursor 74 in three steps, ready for subsequent 
investigation towards phyllaemblic acid (Scheme 82). A HWE approach was unsuccessful 
(chapter three) so an alternative route based on a Meyer-Schuster rearrangement was 
envisaged. 
 
Scheme 82  
The Meyer-Schuster rearrangement is an acid-catalysed rearrangement of secondary and 
tertiary propargyl alcohols (Scheme 83). It was developed in 1922 and results in the 
formation of an enone.103  
 
Scheme 83  
More recently gold and several other metals have been used to promote the Meyer-
Schuster rearrangement, which has significantly increased the scope of the reaction. A 
recent review by Dudley conveniently summarises these approaches.104 
The problem with this route towards an enone such as 245 is that it still relies on a 
nucleophilic addition to the ketone in 211.  
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Aims and Objectives  
Alkynyl anions had yet to be tested as nucleophiles against ketone 211. Alkynyl anions are 
small and reactive and addition to 211 would result in the required propargyl alcohol 
functionality 248, allowing a potential Meyer-Schuster rearrangement to 246.103 
Intermolecular addition of an acetylide would alleviate the problem of the tertiary alcohol 
residing cis to the OTBS groups. A Meyer-Schuster rearrangement, followed by subsequent 
dihydroxylation, would give the required trans geometry (Scheme 84). The same previously 
discussed methodology in chapter three (Scheme 64) would then apply to form diketone 
247. 
 
Scheme 84  
 
Results and Discussion  
Intermolecular addition of an alkyne 
Alkyne addition was first attempted on bicyclic ketone 80, using TMS-acetylene as a model 
alkyne to give 249 but as expected, and consistent with previous results, no reaction was 
observed (Scheme 85).  
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Scheme 85  
Attention therefore turned to reaction of the monocyclic bisTBS ether 211. Addition of 
hexyne as a model alkyne containing a carbon chain successfully gave propargyl alcohol 250 
(Scheme 86). However, reproducibility was a problem. Various conditions were attempted to 
find the optimum procedure; however, an average yield of 35-45% was obtained for the 
formation of the propargyl alcohol (Table 17).  
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Scheme 86  
Entry Alkyne mmol nBuLi 
mmol 
211 eq. Solvent Temp Time Additive Yield 
1 hexyne 0.24 0.24 1 THF -78 oC- rta 2 hr - 83% 
2 hexyne 0.59 0.59 1 THF -78 oC-rtb 2 hr - 69% 
3 hexyne 0.24 0.24 1 THF -78 oC- rta 2 hr - 51% 
4 hexyne 0.59 0.59 1 THF rt 2 hr - 51% 
5 hexyne 0.24 0.24 1 THF -78 oC-rtb 2 hr - 34% 
6 TMS-
Acetylene 
0.23 
0.23 0.8 THF -78 oC- rta 2 hr - 35% 
7 hexyne 0.59 0.59 1 toluene -78 oC- rt 1.5 hr - 31% 
8 hexyne 0.88 0.88 0.8 toluene -78 oC- rta 2 hr - 46% 
9 hexyne 2.39 2.39 0.8 toluene -78 oC- rta 2 hr - 39% 
10 hexyne 2.66 2.66 0.8 toluene -78 oC- rtc 3 hr CeCl3 32% 
Table 17  
a
Anion formation kept at -78 
o
C for 1 hr, 211 added, then allowed to warm to rt stirred for 1 hr. 
b
Anion formed at -78 
o
C for 
1 hr warmed to rt then electrophile 211 added, left for 1 hr. 
C
 Anion formation at -78 
o
C for 1 hr, CeCl3 1.1 eq. then added at 
-78 
o
C and left for 1 hr, then electrophile 211 added and allowed to warm to rt. 
THF gave the best results (Table 17 entries 1-3). Toluene was used as the main solvent in 
entries 7-10 due to problems with the THF drying equipment.  CeCl3 was used in an attempt 
to improve the yield; however, this had no effect (entry 10). Using TMS-acetylene (entry 6) 
or modifying the equivalents of reagents (entries 1-10) had little effect on the yield.  
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The bis-TES ether 232 was also subjected to the same conditions as 211 but again 
inconsistent and relatively moderate yields were obtained. The best yield obtained for 251 
was 41% using 1 eq. of nBuLi and hexyne with THF as the solvent (Scheme 87). 
 
Scheme 87  
Based on previous results from nucleophilic additions on 211, the expected configuration 
was for the alcohol to be cis to the two TBS groups (Scheme 88). It was also assumed that 
the ring in 251 had adopted a chair conformation with the ester sitting in an axial position. 
 
Scheme 88  
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Figure 10  
The GHOESY results for 250 and 252 (Figure 10) show a strong NOE signal (NOE 1) on both 
250 and 252 from Hb to the alcohol Ha. Hb also have a strong NOE signal (NOE 2) between 
themselves and Hc on the adjacent CH2 groups. A weak NOE signal (NOE 3) is observed 
between Hb and Hd indicating that they are on opposite sides to each other, which is to be 
expected in the assumed chair conformation. To confirm the rest of the configuration, an 
NOE was run from the CH attached to the ester, He. This gave a weak NOE signal (NOE 4) to 
Hc on the CH2 and a strong NOE signal (NOE 5) to Hd on the same carbon. This also indicates 
that the ring may be sitting in the conformation shown in (Scheme 88) 
From these data, the stereochemistry of the alcohol was assigned as trans to the OTBS 
groups. However, no NOE signal was observed from the alcohol Ha to Hb (NOE 1 in reverse). 
This contradicted the evidence that a trans configuration had been obtained.   
Due to the contradictory results from the NOE experiments, a crystal structure of 253 was 
obtained once the alcohol had been protected with a TBS group (Scheme 89) (Figure 11).  
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Scheme 89  
 
Figure 11 Crystal structure of 253 with ellipsoids drawn at the 50% probability level.  
The crystal structure shows that the compound adopts a chair conformation with an axial 
OTBS group and an equatorial alkyne group. The three silicon-oxygen bonds are all 
approximately 1.65Å in length which is at the limit of a silicon oxygen bond 1.55-1.65Å with 
the normal value about 1.59Å.105 After acetylide addition, the resultant alcohol is cis to the 
OTBS groups and not trans as required for phyllaemblic acid. This was disappointing as if the 
alcohol was trans after alkyne addition it would have led to the possibility of oxidation of an 
alkyne to the desired diketone functionality (Scheme 90). This would have resulted in 
spiroacetalisation studies which could have led to the natural product.  
 
Scheme 90  
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The successful addition of an alkyne to 211 did allow the potential of a Meyer-Schuster 
rearrangement to be explored. This would then result in the desired enone functionality 
(Scheme 84).  
Attempted rearrangement and formation of enones 
A classic Meyer-Schuster rearrangement involves the use of high temperatures and strong 
acids; this obviously would not suit the proposed system 250. However, Zhang et al.106 
demonstrated Meyer-Schuster rearrangements can be performed under mild conditions 
using gold catalysis once the propargyl alcohol has been converted to an acetate (Scheme 
91).  
 
Scheme 91  
As a TBS group was used to successfully protect the tertiary alcohol in 250, acylation of the 
same alcohol was assumed to be relatively straightforward. However, the attempted 
acetylation of 250 proved to be problematic under a variety of conditions (Table 18). Classic 
conditions of acetic anhydride, pyridine and DMAP were used107, along with acetyl chloride 
and Et3N.
108 Unfortunately, the tertiary alcohol was unable to be protected as an acyl ester 
(Scheme 92). A carbon-oxygen bond cf. ~1.43Å109 is shorter than an oxygen-silicon bond cf. 
1.59Å105. Therefore, the shorter bond length in the tetrahedral intermediate may be a main 
factor in not being able to protect the sterically hindered tertiary alcohol to form 257. 
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Scheme 92  
Entry Ac2O Pyridine Et3N DMAP Acetyl 
Chloride 
Temp Solvent Yield 
1     1.2 eq. -70 oC- 
reflux 
THF sma 
2   1.2 
eq. 
 1.2 eq. rt THF degradation 
3 2.2 
eq. 
1 mL  10 
mol% 
 rt pyridine sm/ 
degradation 
Table 18  
a
Propargyl alcohol formed then the crude reaction worked up by adding acetyl chloride and Et3N. 
Sheppard et al.110 had taken unprotected tertiary propargyl alcohols and converted them to 
enones. This was achieved by in situ protection of the alcohol using either MeOH or 
phenylboronic acid in the presence of AuPh3NTf2 (Scheme 93).  The proposed mechanisms 
for both pathways are similar. Gold activates the alkyne to form 260. The addition of 
methanol then gives 261, followed by proton transfer to give 262. Subsequent elimination of 
water forms the allenyl ether 263. Finally, hydrolysis of 263 which may involve activation by 
the gold catalyst, gives the enone 267. The pathway for enone formation from the boronic 
acid-mediated route can also yield the β-hydroxyketone 266. It is proposed that 267 and 266 
are produced via the cyclic enol boronate 265. Initial formation of the boronate half ester 
264, with subsequent cyclisation and protodeauration leads to the cyclic enol boronate 265. 
The β-hydroxyketone 266 can then form after direct hydrolysis of 265 and 267 can form 
after a concerted rearrangement. 
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Scheme 93  
It was assumed that the TBS protecting groups on 250 were blocking the alcohol from being 
protected with an acyl group. Using this new method, it was predicted that MeOH would be 
able to activate the system in situ and the rearrangement could take place. 
Initial attempts to make the reported literature compounds were problematic, as 
elimination of the tertiary alcohol was occurring (Scheme 94). It was determined that the 
concentration of the solution must be 1M in order for the Meyer-Schuster rearrangement to 
successfully take place (Scheme 95). 
 
Scheme 94  
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Scheme 95  
The methodology was then applied to the propargyl alcohols 250, 251 and 252 (Table 19). 
Entry mmol of propargyl 
alcohol 
Additive 
mmol 
Gold 
loading 
Temp Time Yield 
1 0.13 of 250 MeOH 0.13 5% rt overnight 12% of 273 
 
2 0.2 of 250 MeOH 0.2 5% rt overnight 24% of 272, 
5%  of 273 
3 0.1 250 PhB(OH)2 
0.02 
5% rt overnight 13% of 274 
4 0.2  250 PhB(OH)2 0.2 5% rt overnight 64% of 274 
5 0.4 250 PhB(OH)2  0.4 5% 200 
oC 2 hr 40% of 274 
6 0.07 275 PhB(OH)2  
0.014 
5% rt overnight sm 
7 0.13 of 250 PhB(OH)2 
0.13 
- rt overnight sm 
8 0.13 of 250 - 5% rt overnight sm 
9 0.07 251 PhB(OH)2  
0.07 
5% rt overnight degradation 
10 0.32 251 PhB(OH)2  
0.32 
5% rt overnight 17% of 278 
Table 19  
It was assumed that MeOH would be the best additive to use as this is small, allowing the 
alcohol to be activated ready for rearrangement. However, when this chemistry was applied 
in entries 1 and 2, only the beta-hydroxy ketone 273 or the furan 272 were isolated. Large 
amounts of degradation were also present, making the crude mixture difficult to purify 
(Scheme 96) (Scheme 97). The reactions were repeated several times, but enone formation 
was not obtained and the yields of 272 or 273 could not be improved. 
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Scheme 96  
 
Scheme 97  
The formation of the furan 272 will be discussed later on with a similar compound. The 
formation of the beta-hydroxy ketone 273 is thought to resemble a classic hydration of an 
alkyne via mercury catalysis.111 A recent report by Zhang et al. has shown it possible to 
hydrate alkynes in the presence of gold at room temperature.112 
Phenylboronic acid was used as an alternative to MeOH which again resulted in no enone 
formation; however, the first successful synthesis of a cyclic enol boronate 274 using gold 
catalysis was achieved (Table 19 entries 3-4 Scheme 98). 
 
Scheme 98  
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The formation of the cyclic enol boronate 274 was also successfully achieved in a microwave 
reactor (entry 5). The purpose of this reaction was to see if the enone formation could be 
achieved at higher temperatures. Surprisingly, 274 proved stable up to 200 oC for 2 hours 
although it is noted that the yield of the reaction was reduced.   
A very small amount of 275 was isolated as a minor compound in a significantly scaled up 
formation of 250. The propargyl alcohol, with the alcohol trans to the OTBS, was subjected 
to the same conditions used to form 274 (entry 6). Interestingly, no reaction was observed 
(Scheme 99).  Again, this gives further evidence that the TBS groups are blocking access to 
the alkyne, preventing the reaction from starting.  
 
Scheme 99  
Two test reactions were carried out with the omission of either boronic acid or the gold 
catalyst (Scheme 100). Only starting material was isolated in both cases (entries 7 and 8). 
 
Scheme 100  
  93 
 
Although the formation of a cyclic enol boronate was frustrating as it was hampering enone 
synthesis, it was a rather exciting discovery. This was the first time this functionality had 
been formed using gold catalysis and there are only two references in the literature on cyclic 
enol boronates.113, 114   
When analysing the data for 274, 1H NMR showed the enolic proton is found at 
approximately 4.5 ppm, the literature shows similar structures with these values have been 
reported; however the 11B NMR shift of 10.8 ppm for 274 does not match literature data 
(Figure 12 Table 20)114.  
 
Figure 12 
Entry R R’ 1H NMR shift for alkene 11B NMR 
1 Me Me 4.53 ppm 30.0 ppm 
2 iPr Me 4.46 ppm 31.0 ppm 
3 tBu Me 4.61 ppm 32.0 ppm 
4 Me CF3 5.34 ppm 33.0 ppm 
Table 20 
Another key feature of this functionality is the alkene IR stretch, 1696 cm-1, comparable to 
the literature value of 1695 cm-1.113 A crystal was successfully grown which led to the first 
crystal structure of a cyclic enol boronate (Figure 13).  
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Figure 13 Crystal structure of 274 with ellipsoids drawn at the 50% probability level. The structure contains two 
crystallographically-independent molecules. 
 
The bond lengths surrounding the cyclic enol boronate are all in the normal ranges for 
carbon-boron (1.59-1.72 Å)109 and boron-oxygen (1.28-1.43 Å)115 bonds.  The X-ray depicts 
that a chair conformation is present for the cyclohexane ring, presumably locked in place by 
the large TBS groups. The cyclic enol boronate is planar with the boron and its empty p-
orbital is orthogonal to the ring. 
The crystal structure clearly shows the TBS groups are surrounding the cyclic enol boronate. 
This gave an indication of how this type of product could form from the reaction (Scheme 
101).  
 
Scheme 101  
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Sheppard et al. postulated that the gold complex helps to form the cyclic enol boronate in 
situ. Water then approaches to release the boronate and gold, with the system collapsing 
into enone 267 (Scheme 93). Following gold activation in 276, cyclisation occurs to give 274. 
It is assumed that the TBS groups flanking either side of the boron and alkene are blocking 
the water from activating the system, preventing the system from collapsing to enone 277. 
The propargyl alcohol 251 has slightly smaller silicon protecting groups compared to the TBS 
groups in 250. It was postulated that with the TES protection in place enough space would 
be present for the boronate to collapse to the target enone. The system 251 was found to be 
more reactive than 250, demonstrated through multiple Rf. products observed upon T.L.C. 
analysis (Table 19, entries 9 and 10). This further complicated the purification. 1H NMR 
analysis of the crude reaction mixture suggested that an enone had formed. The conditions 
were repeated several times but no enone could be isolated. Eventually, a scaled up reaction 
led to the isolation of furan 278 in a 17% yield (Scheme 102). Unfortunately, this was the 
only product that could be isolated from the reaction and so it was decided that even if the 
enone was being formed it was not a viable method. 
 
Scheme 102  
The formation of the two furans 272 and 278 has shown two different product outcomes for 
the resulting alcohol or methyl ether. The first example run with MeOH shows a methyl 
ether present on the ring in 272, whereas, an alcohol is present on the ring in 278 when the 
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reaction was carried out in the presence of PhB(OH)2. The stereochemistry for the methyl 
ether in 272 or alcohol in 278 was confirmed using coupling constants (Scheme 103). The 
substituents at position (a) in both compounds were determined to be pseudo-axial; the 
axial proton at position (b) has two large coupling constants: one for the geminal protons 
~13.9 Hz and one for the trans di-axial coupling constant, with position (c) ~12.5 Hz. A final 
coupling of ~3.2 Hz is then obtained which is indicative of the proton at position (a) being 
pseudo axial. 
 
Scheme 103  
It is assumed that the formation of 278 is due to the TES group being sufficiently labile in the 
presence of boronic acid.  
The formation of 272 in the presence of MeOH is challenging to explain because of the 
retention of stereochemistry. A 26% yield of the diastereomer was isolated so it is 
conceivable that the other diastereomer was being formed but unable to be isolated.  
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The paper by Okada et al.113 detailed that cyclic enol boronate 279 could be converted to  
enone 280 by refluxing in toluene and pTSA (Scheme 104). 
 
Scheme 104 
This led to an investigation of potential transformations to functionalise the cyclic enol 
boronate 274 (Table 21).  
Entry Mmol of 
enol 
boronate 
Reactant Time Temp Yield 
1 0.14 pTSA 0.14 12 hr reflux trace amount of 273 
2 0.041 pTSA 0.041 12 hr rt 48% 273 
3 0.38 0.38 boronic acid 
and 10% gold 
12 hr rt 48% of 274 
4 0.041 TBAF 0.041 2 hr 0 oC-rt degradation 
5 0.041 - 2 hr 200 oC sm 
6 0.041 NBS 0.082 3 days rt degradation 
7 0.041 mCPBA 0.08 1 hr 0 oC-rt trace amount of 273 
8 0.041 H2O2 0.041 15 min 0 
oC degradation 
9 0.041 butyraldehyde 4 hr rt-100 oC trace amount of 273 
Table 21  
A trace amount of beta-hydroxy-ketone 273 was observed when 274 was subjected to pTSA 
in toluene at reflux (entry 1). Running the reaction at rt led to a 48% yield of 273 (entry 2) 
but, unfortunately, no enone was formed. The cyclic enol boronate 274 was formed in situ 
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and worked up with a solution of 1 M HCl (entry 3). It was expected that the acidic work up 
would convert the cyclic boronate to an enone; however a 48% yield of the enol boronate 
274 was recovered.  
TBAF was used in an attempt to either cleave the boronate or remove the TBS groups to 
allow for the rest of the system to collapse to an enone. The reaction started with 1 eq. of 
TBAF with the intention to add more as the reaction progressed. However, this quickly led to 
degradation after only 2 hours and 1 eq. of TBAF (entry 4).  
It was decided to confirm the stability of the cyclic enol boronate by placing pure 274 in a 
microwave and taking the system up to 200 oC. After 2 hours, the reaction gave all of the 
starting material back (entry 5).  
NBS was used to halogenate the alkene (entry 6); this was based on unpublished work from 
Tom Sheppard. It was proposed that the halo-boron enolate could then be oxidised but 
unfortunately degradation occurred.  
mCPBA and H2O2/NaOH were both used in an attempt to oxidise the boron, based on 
literature precedent by Sheppard et al.116 (entries 7-8), but again only degradation occurred.  
Enol boronates can be used in aldol reactions.117 Therefore, it was decided to probe the 
reactivity of the cyclic boron enolate 274 with butyraldehyde. Although this would not have 
been a helpful reaction towards the synthesis of the natural product, there was the 
possibility of developing new novel methodology within the aldol literature using the cyclic 
enol boronate 274. When attempting this type of chemistry, no aldol products were 
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obtained. Degradation mainly occurred; however, trace amounts of the beta-hydroxy ketone 
were observed (entry 9).    
Hall et al.118 reported the use of (2,3,4,5-tetrafluorophenyl)boronic acid 281 as a catalyst for 
the Meyer-Schuster rearrangement on unprotected tertiary alcohols without the presence 
of gold. Therefore, it was decided to attempt this chemistry on 250 and 251 due to the 
problems of protecting the tertiary alcohol. 
After the boronic acid 281 was synthesised, the chemistry was successfully tested on a 
simple test substrate 282 giving 283, thus confirming the paper’s findings (Scheme 105).   
 
Scheme 105  
Application to 250, however, resulted in no enone formation. The TBS protected system 250 
gave only starting material even after increasing the temperature and adding up to twelve 
equivalents of the catalyst. After two days degradation started to appear in the T.L.C. and so 
the reaction was worked up and the majority of starting material was isolated (Scheme 106). 
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Scheme 106  
Using TES as an alternative protecting group 251 led to the mono protected version 284 in a 
30% yield (Scheme 107).  Presumably this was due to how labile TES is compared to TBS in 
the presence of the boronic acid.  
 
Scheme 107 
From the data obtained it was assumed that the silicon protecting groups are once again 
blocking the approach of the catalyst, therefore stopping the reaction. 
Spiro epoxide formation 
Due to the inability to perform a Meyer-Schuster rearrangement on 250 or 251, an 
alternative rearrangement route was investigated. The idea was postulated that the 
propargylic alcohol on 250 could be converted to form an allene. This in turn could then be 
transformed to the desired hydroxy-1,2-diketone functionality. This was introduced by 
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Crandall et al.119, using the Murray methodology120, allowing them to access various 
substituted spirodioxides from substituted allenes. One spirodioxide 285 was of particular 
interest as after addition of DMSO it spontaneously decomposed to form hydroxy-diketone 
286 (Scheme 108).  
 
Scheme 108  
A similar report by Williams et al.121 converted an allene 287 into an alpha-hydroxy-halo-
ketone 288; one step away from being converted into a hydroxy-diketone. 
 
Scheme 109  
It was proposed that if propargyl alcohol 250 could be converted to the mesylate 289, 
reduction could yield allene 290. Based on the previously proven concept that OsO4 adds to 
the top face of the alkene 219 (Chapter 3, Scheme 64), it is assumed that DMDO will form 
the spirodioxide 291. Subsequent oxidation will then present the resultant alcohol as trans 
to the OTBS groups in 292 (Scheme 110). 
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Scheme 110  
In order to attempt this kind of chemistry a mesylate must first be formed on propargylic 
alcohol 250. Unfortunately, this was very problematic and so the proposed synthesis of 289 
could not be carried out (Scheme 111).  
The equivalents of MsCl and Et3N were increased from 1.1 to 12 in order to form 289 but no 
product was observed (entry 1, Table 22). nBuLi was used to deprotonate the alcohol, 
followed by addition of MsCl and Et3N, but again only starting material was isolated (entry 
2). MsCl was added to quench the alkoxide anion of 250 after addition of hexyne to ketone 
250 but again no trace of 289 was identified (entry 3).  
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Scheme 111  
Entry Propargyl 
Alcohol 
MsCl Et3N 
nBuLi Solvent Temperature Yield 
1 0.06 mmol 1.1 eq. 1.1 eq.  CH2Cl2 0 
oC- rt sma 
2 0.06 mmol 2 eq. 2 eq. 1 eq. THF -78 oC- rt smb 
3 0.24 mmol 2 eq. 2 eq.  THF -78 oC- rt 30%c 
Table 22  
a
 Equivalents of MsCl and Et3N increased to 12. 
b
-78
o
C for 
n
BuLi addition at -78 
o
C followed by MsCl and Et3N. 
C
Propargyl 
alkoxide formed in situ followed by MsCl and Et3N as a quench 30% yield of propargyl alcohol. 
An alternative approach to form an allenic system by a 2,3-sigmatropic rearrangement of a 
propargyl sulfenate to an allenic sulfoxide was proposed; first introduced by Braverman and 
Stabinsky et al.122 Their work showed that many different propargyl alcohols could be 
rearranged via a sulfenate (Scheme 112).  
 
Scheme 112  
If the rearrangement was carried out on 250 or 251, then a similar approach to the allenic 
system above (Scheme 110) could be envisaged to access the diketone functionality (Scheme 
113).  
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Scheme 113  
As previously described, the attachment of a mesylate and an acyl group to the tertiary 
alcohol in 250 were unsuccessful. The reasons for this are difficult to explain as although 
there is a lot of steric hindrance around 250, a TBS group was successfully installed in good 
yield (Scheme 89). It is assumed that one of the primary reasons a TBS group attaches is due 
to the Si-O bond being longer than a C-O bond. It was hoped that as a O-S in a mesylate c.f. 
1.56 Å109 is comparable in length to an O-Si 1.59Å bond and conversion to a mesylate would 
take place.  
 
Scheme 114  
A test reaction was first carried out using propargyl alcohol 294 which gave the 
trichloromethanesulfinyl 295 in good yield. This confirmed that the chemical transformation 
was able to be carried out, and that the reagent ClSCCl3 was of good quality (Scheme 114).   
Attention then turned to the conversion of propargyl alcohol 250/251 to the allenic 
sulfoxide. Both TES and TBS protected diols were subjected to the reaction conditions. 
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Unfortunately, 250 or 251 could not be converted to either of the substrates 293 or 296 and 
it is proposed that this is due to the unsuccessful in situ formation of sulfenate 297.   
 
Scheme 115  
 
Alternative disconnection approach 
Introduction  
Due to the Meyer-Schuster rearrangement failing to deliver the required enone, along with 
the failed attempts to make an allene, an alternative strategy was developed. Alkyne 
addition had been shown to give the incorrect stereochemistry needed for the natural 
product. However, the alkyne functionality offered convenient access to a diketone via a 
single step (Scheme 116).  
 
Scheme 116  
The most successful route to date towards a synthesis of phyllaemblic acid is via a simple 
Wittig reaction to install a methylene group to give 219. This was stereoselectively 
dihydroxylated to form diol 298, which positioned the tertiary alcohol trans to the two OTBS 
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groups. The primary alcohol was then oxidised to give the aldehyde 217. This route gave 
access to all four stereocentres found on the cyclohexane ring in phyllaemblic acid (Scheme 
117).  
 
Scheme 117 
However, this approach suffered from low reactivity of the resulting aldehyde and the Wittig 
reaction gave yields of around 50%. 
A new disconnection and approach 
Despite the low reactivity of aldehyde 217, a new approach was envisaged. If the aldehyde 
could be transformed into alkyne 299, this would lead to a new disconnection where all four 
stereocentres are already in place, as opposed to only three in the previous approach. The 
problematic electrophile would be replaced with an alkyne that can be deprotonated and 
used as a nucleophile (Scheme 118). 
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Scheme 118  
 
Results and Discussion  
To confirm the low reactivity, an alkyne addition and a simple Wittig reaction were 
performed on aldehyde 217. As expected, neither of the reactions worked well. The alkyne 
addition reaction was only able to be semi-purified to give 300, and the Wittig reaction gave 
the alkene 301 in a 14% yield with starting material being recovered (Scheme 119). 
 
Scheme 119  
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For this synthesis to be successful the yield of 219 must be improved to make the route 
viable and form 299 (Scheme 117).  
As the epimeric propargyl alcohol 253 had been successfully prepared, it was decided to 
undertake a model study in order to see if the alkyne could be oxidised to form the diketone 
302123 (Scheme 120). 
 
Scheme 120  
The oxidation proceeded with a modest 52% yield. Encouraged by this, work began to form 
299 with the requisite trans stereochemistry between the tertiary alcohol and the OTBS 
groups.  
When repeating work to form 219 it was noted that a clean conversion was always obtained 
by T.L.C. analysis, but the same poor isolated yields of 30-45% were obtained. This can be a 
common problem for Wittig reactions and is often attributed to the formation of 
triphenylphosphine oxide, trapping the compound during purification via column. This 
problem was overcome by using a method published by Gilheany et al.124 The group used 
oxalyl chloride to make a chromatography-free purification method for a host of reactions 
that produce triphenylphosphine oxide as a by-product (Scheme 121).  
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Scheme 121  
The method is straightforward; the oxalyl chloride converts triphenylphosphine oxide 303 to 
a chlorophosphonium salt 305, which can then be easily removed by filtration and an 
aqueous wash. When applying this relatively unused method to alkene 219 the yield 
improved from 52% to 78%. 
The rest of the route followed as expected and the aldehyde 217 was obtained in a 98% 
yield. Investigations now turned to converting the aldehyde 217 into alkyne 299.125 
The first method used was the Colvin rearrangement126 using trimethylsilyldiazomethane in 
the presence of LDA to convert aldehydes into alkynes. This method unfortunately could not 
be applied to aldehyde 217 as no reaction took place. Therefore, the Ohira-Bestmann 
reagent was synthesised and employed to convert aldehyde 217 into alkyne 299 in a 62% 
yield (Scheme 122). 
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Scheme 122  
A crystal structure of 299 showed that the alcohol is now trans to the TBS groups (Figure 14). 
This has potentially alleviated the problems of nucleophilic addition to ketone 211 as the 
alkyne 299 can be used as a latent nucleophile with all four of the stereocentres set on the 
cyclohexane ring. The spacefilling model also gives an indication that the alkyne should be 
accessible to deprotonation and react with an electrophile.  
 
Figure 14 Crystal structure of 299 with ellipsoids drawn at the 50% probability level. 
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Figure 15 
Investigations turned towards synthesising the rest of the carbon linkage in order to perform 
a convergent synthesis of the desired spiroacetalisation precursor. A paper by Takayama et 
al.127 gave the synthesis of epoxide 306 as a 1:1 mixture of diastereoisomers. Also reported 
was the reaction of 306 with TMS acetylene to give the pair of diastereoisomers 307 and 308 
that could be separated by column chromatography (Scheme 123).   
 
Scheme 123  
If alkyne 309 reacted with epoxide 306 there is potential to separate the diastereomers 
310a, 310b by column chromatography. Approximately 50% of the mixture would have the 
desired stereochemistry for the natural product. Subsequent benzoyl protection of the 
resultant alcohol and oxidation of alkyne 311 would give the precursor 74 (Scheme 124). 
Atom efficiency can be achieved by taking the remaining 50% of the unwanted diastereomer 
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310b through a Mitsunobu inversion128 which would protect the alcohol as the desired 
benzoyl group and convert it to the required S configuration 74. 
 
Scheme 124  
Repeating the literature was straightforward and the epoxide 306 was obtained as a 1:1 
ratio of diastereoisomers (Scheme 125).  
 
Scheme 125 
The literature stated that in order to perform the oxidation of propargyl alcohols to 
diketones, the tertiary alcohol needs to be protected (Scheme 126).  
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Scheme 126  
Tertiary alcohol 299 was found to be relatively unreactive when compared to the similar 
compound 250 and required twelve equivalents of TBSOTf and 2,6-lutidine in order to obtain 
a 72% yield. Obviously, this is not particularly efficient; however, it is assumed that the 
equivalents could be drastically reduced when scaling up the reaction, as the concentration 
of the reaction mixture is assumed to have an effect.    
With the stereochemistry confirmed and the tertiary alcohol now protected, attention then 
turned to the crucial combining of fragments 309 and 306 for a convergent synthesis 
towards the spiroacetalisation precursor. Unfortunately, the epoxide was unable to be 
opened with the acetylide of 309; a variety of different conditions were used (Table 23).  
Entry Alkyne eq. Epoxide eq. Base Lewis acid Other Yield 
1 1 eq. 1 eq. LDA 1.1 eq. BF3.Et2O - sm 
2 1 eq. 1 eq. nBuLi 1.1 eq. BF3.Et2O - sm 
3 2 eq. 1 eq. nBuLi 2 eq. Et2AlCl  
2 eq. 
- sm 
4 1 eq. 1 eq. nBuLi 1 eq. BF3.Et2O  
2 eq. 
Me3Al 1 eq. sm 
5 tertiary 
alcohol 
unprotected 
1 eq. nBuLi 2 eq. BF3Et2O 
 2 eq. 
- sm 
Table 23  
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First attempts used LDA and nBuLi (entries 1 and 2); no epoxide opening was observed, and 
starting material was recovered. Concerns were raised that no acetylide was forming after 
deprotonation of the alkyne, so a test reaction was undertaken using MeOD as a quench 
after addition of nBuLi (Scheme 127). 
 
Scheme 127  
The reaction clearly showed that deprotonation was occurring as the 1H NMR spectrum of 
the crude reaction mixture showed the disappearance of the signal for the proton on the 
terminus of the alkyne consistent with formation of 312. With this information in hand it was 
obvious that the reactivity of the system needed to be increased in order to open the 
epoxide with 309.  
Pagenkopf et al.129 showed the differences in reactivity of alanes and aluminates towards 
the opening of epoxides. Although the report was mainly focused on the regioselectivity of 
epoxide opening, it was thought that these systems should be more reactive. Unfortunately, 
neither the alane (entry 3) nor the aluminate (entry 4) gave the increased reactivity needed 
and alkyne starting material was recovered. The unprotected tertiary alcohol 299 was used 
with 2 equivalents of base but again only starting material was recovered from the reaction 
(entry 5). Finally, the epoxide 306 was opened via the known literature reaction using TMS-
acetylene, giving 307 and 308 in 75% yield. Therefore, it was concluded that the alkyne on 
309 was too hindered to open up the epoxide 306 due to the presence of the large OTBS 
groups.  
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Conclusions and summary 
This chapter concentrated on the use of the Meyer-Schuster rearrangement in order to 
obtain the desired enone functionality. First attempts at this reaction involved protecting the 
tertiary alcohol in 250 as an acetate, ready for subsequent gold-catalysed rearrangement. 
Unfortunately, the alcohol was unable to be protected as an acetate. It was concluded that 
the C-O bond formed in an intermediate may be too short for reaction to occur in the 
sterically hindered environment.  
The alkyne of the propargyl alcohol 250 was activated with Ph3PAuNTf2 in the presence of 
either MeOH or phenylboronic acid, but this did not lead to the formation of an enone. 
However, alternative products were isolated: the β-hydroxyketone 273 in 24% yield, the 
furan 272 in a 12% yield and most interestingly, the cyclic enol boronate 274 in a 63% yield; 
the first synthesis of this kind of functionality by a gold-catalysed method.  
The smaller silicon protecting group TES was used for the propargyl alcohol 251. This was 
subjected to the same gold catalysis methods, using phenylboronic acid as an additive. These 
reactions turned out to be more difficult to purify and although 1H NMR of the crude 
reaction mixture gave evidence of enone formation, only a 17% yield of furan 278 could be 
isolated. 
The catalyst (2,3,4,5-tetrafluorophenyl)boronic acid was used as an alternative to gold. 
Again, this route required no protection of the tertiary alcohol. Propargyl alcohols with TBS 
250 and TES 251 protection were used but no desired products were obtained. A test 
reaction carried out on a simple propargyl alcohol gave the expected enone in good yield. 
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A new approach was postulated based on the elimination of the tertiary alcohol to an allene, 
with subsequent reactions to yield the desired diketone functionality. This route was quickly 
abandoned when it became apparent that the formation of a mesylate from the alcohol 
could not be achieved. 
A final attempt at converting the alcohol to a sulfenate, followed by a sigmatropic 
rearrangement, was also attempted but again the tertiary alcohol proved to be unreactive. A 
test reaction showed that on a simpler system propargyl alcohol 294 was converted to 
sulfoxide 295 with good yield. 
The TBS groups flanking either side of the tertiary alcohol presented a problem in each of 
the routes discussed above, preventing reaction due to steric hindrance.  
An alternative approach to the spiroacetalisation precursor 74 was envisaged based on a 
new disconnection (Scheme 118). The route towards the synthesis of aldehyde 217 was 
improved by increasing the yield of alkene 219 using the method developed by Gilheany et 
al. The Ohira-Bestmann reagent was then used to convert aldehyde 217 into alkyne 299. This 
compound now had the required stereochemistry on the cyclohexane ring to be taken 
forward into a synthesis for the spiroacetalisation precursor. Epoxide 306 was successfully 
synthesised in good yield which set up a potential convergent synthesis towards the natural 
product. Unfortunately, the two compounds could not be used in a convergent synthesis. 
Acetylide formation was confirmed using a deuterium quench and the epoxide was opened 
with TMS-acetylene using a literature procedure. This confirmed that 309 and 306 were not 
compatible and, unfortunately, showed that this was not a viable route towards 
phyllaemblic acid. 
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Chapter 5 Studies towards the tetrahydrothiophene ring in breynolide  
Introduction 
Literature review of the synthesis of a tetrahydrothiophene ring 
Breynolide 28 is the hydrolysis product of breynin A which was isolated in the 1970s from 
the Taiwanese woody shrub Breynia officinalis (Figure 16).16 It has potent oral 
hypocholesterolemic activity.27 
 
Figure 16  
As described in chapter one, there have been three total syntheses of breynolide and one of 
breynolide sulfone; all of which have employed various approaches at synthesising the 
perhydrobenzothiophene ring system highlighted in red (Figure 16).  
The first total synthesis of breynolide was reported by Williams et al.17  The three 
heterocyclic rings were formed from the precursors 32 and 33. Attack by sodium hydrogen 
sulfide on the terminal epoxide was followed by an intramolecular SN2 at C17 to form the 
sulfur heterocycle in 34. Treatment of this compound with p-toluenesulfonic acid led to a 
kinetic acetalisation to give an 88% yield of the diastereoisomers 36 and 37 in a 1:3 ratio. 
Each of the spiroacetals were then independently taken through a five-step sequence to 
make breynolide. After protection with MEMCl, a Swern oxidation gave 313. This was then 
followed by an intramolecular aldol to form the carbocyclic framework for breynolide. A 
Mitsunobu inversion to the newly formed secondary alcohol in 314 gave the perhydro 
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benzothiophene ring system with the correct stereocentres needed for the total synthesis to 
be completed (Scheme 128).  
 
Scheme 128  
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In the Smith et al.14 synthesis of breynolide, the perhydrobenzothiophene ring formation 
was initiated by a 1,4-addition of thiolacetic acid to 315 to give 316 in  86% yield as a mixture 
of epimers at C4 and C17. Fortunately, the desired product had formed as the major isomer 
due to attack anti to the hydroxyl group. The sulfur heterocycle was then completed after 
cyclisation induced by NaOMe to give 317 (Scheme 129). 
 
Scheme 129  
The main problem with the Smith synthesis arose when attempting to reduce the ketone in 
317. Due to the convex character of 317, hydride reduction was expected to give the 
undesired isomer from attack at the more accessible convex face. However, after X-ray 
analysis of 317, it was believed that the desired epimer should also be accessible. In total, 14 
different hydride sources/conditions were investigated but all gave undesired isomer 318 as 
the major product. The obvious solution was an inversion; attempts at either Mitsunobu 
inversion or formation of mesylate 319, followed by intermolecular addition of various 
oxygen nucleophiles, resulted in the vinylic episulfide 320 (Scheme 130). 
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Scheme 130  
Formation of the episulfide 320 was ascribed to intramolecular alkylation of the sulfur to 
give 321, followed by fragmentation of the resultant sulfonium ion 322 (Scheme 131).  
 
Scheme 131  
Eventually, this problem was overcome by oxidising the sulfur in 317 to a sulfoxide in order 
to reduce the nuleophilicity of the sulfur atom. Oxidation to the sulfoxide by the Davis 
phenyl oxaziridine, followed by reduction with NaBH4 gave 323, again with the major 
product being the undesired isomer. Attempted inversion of the alcohol via Mitsunobu 
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yielded the unexpected but still useful vinyl sulfoxide 324. Following reduction to yield 325, 
the desired alcohol 326 was obtained after hydroboration (Scheme 132).  
 
Scheme 132  
The most recent total synthesis of breynolide was completed by Burke et al.19 in 1999 
(Scheme 133). The perhydrobenzothiophene ring formation was based on a related 
tetrahydrothiophene construction by Whitney et al.130  
 
Scheme 133  
Diol 327 was initially protected as an acetonide, followed by displacement of the primary 
mesylate 328 with sodium sulfide. This then underwent in situ intramolecular attack to open 
the epoxide, forming the cis-fused tetrahydrothiophene ring system in 329. 
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In 1989 Yamamura et al.20 reported the first successful synthesis of breynolide sulfone. The 
group were attempting the first synthesis of breynolide but ran into problems in the later 
stages. However, they successfully synthesised the perhydrobenzothiophene ring (Scheme 
134).  
 
Scheme 134  
Opening of epoxide 330 with Na2S, followed by intramolecular displacement of the bromide, 
formed the heterocyclic ring system 331.  
Martin et al.131 published their novel approach to breynolide in 1993. The group successfully 
synthesised a perhydrobenzothiophene in six steps starting with the commercially available 
sulfolene 332. This was transformed into a chlorohydrin followed by elimination and 
protection with benzyl bromide to give 333. The Diels-Alder reaction with Danishefsky’s 
diene132 334 was then carried out in a sealed tube with dienophile 333. The crude material 
was treated with pyridinium p-toluenesulfonate which resulted in the silyl enol ether 
hydrolysis, with concomitant loss of methanol, affording a mixture of cycloadducts 335 and 
336 in a 1:1.2 ratio. Reduction of the sulfone in the desired isomer using DIBAL, followed by 
subsequent oxidation to give the ketone, yielded the enone 337 ready for further 
elaboration (Scheme 135). 
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Scheme 135  
Linderman et al.133 published a synthesis in 1994 of the perbenzothiophene ring system in 
their approach towards breynolide. Initial attempts focused on a model study to confirm the 
validity of the approach. Formation of the epoxide 339, from commercially available triol 
338, was followed by conversion of the alcohol to the mesylate 340. Addition of Na2S 
resulted in the formation of the tetrahydrothiophene 341 in modest yield. The yield of 341 
was improved by formation of a carbonate 342. This was advantageous as the carbonate 
could potentially be taken through as a protecting group in a synthesis towards breynolide, 
whereas the epoxide 340 could not. The carbonate was treated with Na2S which led to a 
good yield of a tetrahydrofuran, rather than the tetrahydrothiophene 341. It was proposed 
that this is due to the hydroxide present in Na2S which competes at either the carbonate 
carbonyl or primary carbon of the cyclic carbonate. This is then followed by intramolecular 
displacement of the mesylate by the primary alcohol. To overcome this, the group used 
Harpp’s reagent (Bu3Sn)2S which gave the tetrahydrothiophene 341 in a reasonable 67% 
yield (Scheme 136). 
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Scheme 136  
Grainger et al134 successfully synthesised a cis-fused perhydrobenzothiophene in five steps 
starting from ethyl benzoate 343. Birch reduction, followed by quenching with methyl 
iodide, gave the 1,4-diene 344 in good yield. The ester was reacted with tbutyl methyl 
sulfoxide to give the β-keto-sulfoxide 345. A stereoselective reduction gave the alcohol 346 
as a single diastereoisomer. This was then subjected to the thermolysis conditions first 
proposed by Jones et al.135 to give 347 and 348. The group found that protecting the alcohol 
in 346 with different sized groups could affect the product yield and ratio significantly. In 
essence, the overall process generates a perhydrobenzothiophene with four contiguous 
stereocentres starting from a simple sulfoxide starting material (Scheme 137).  
 
Scheme 137  
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Synthesis of 5-membered sulfur heterocycles through thiol conjugate addition and 
subsequent Dieckmann/ intramolecular aldol. 
 
The envisaged approach to the tetrahydrothiophene using the bicyclic ketone 79 will utilise a 
conjugate addition of a thiolate followed by a subsequent Dieckmann cyclisation/ 
intramolecular aldol. 
Davies et al.136 used a thiolate to perform a conjugate addition on tbutyl acrylate which then 
underwent an in situ dieckmann cyclisation to form the tautomers 351 and 352 in a 46:54 
ratio with an overall yield of 81%  (Scheme 138). 
 
Scheme 138  
Lin et al.137 performed a conjugate addition on 353 with methyl thioglycolate using catalytic 
amounts of piperidine to give 354 in almost quantitative yield. Cyclisation was then initiated 
with TiCl4 and triethylamine in CH2Cl2 to obtain the sulfur heterocycle 355 in approximately 
60% yield (Scheme 139). 
 
Scheme 139  
Carreira et al.138 guided by the work from Liu et al.139, 140 and Woodward et al.140 performed 
a one pot method to form the two ketoesters 357 and 358 after a conjugate addition to 356. 
These were then directly subjected to Krapcho decarboxylation to yield the sulfenyl ketone 
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359 in a 62% yield. This method again utilises a conjugate addition which is followed by an in 
situ Dieckmann cyclisation (Scheme 140). 
 
Scheme 140  
Risi et al.141 used the commercially available 1,4-dithiane-2,5-diol 360 as the thiolate source 
in a one-pot tandem reaction to make substituted tetrahydrothiophene derivatives. Based 
on the work from Southern et al.142 the group first used this dimer with a nitroethylacetate 
361 to form the hetrocycle 362 in a 65% yield. Several nitro derivatives were formed this 
way. The group then used the methodology as a route towards hexahydro-benzothiophene-
4-one, which is a scaffold towards several natural products. A suspension of 1,4-dithiane-2,5-
diol in CH2Cl2 with Et3N led to the conjugate addition to 363 which then cyclised to form 364 
and 365 in a 3:1 ratio (Scheme 141). Tao et al.143 also created the same tandem Michael-
intramolecular Henry products seen in the previous paper by using 1,4-dithiane-2,5-diol in 
the presence of a tertiary amine catalyst. 
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Scheme 141  
Perumal et al.144 recognised the solubility problems of 1,4-dithiane-2,5-diol and so screened 
a variety of solvents when performing a conjugate addition to an αβ-unsaturated ketone 366 
to give the diastereomers 367 and 368. The group found that water was the optimal solvent, 
furnishing the product in the highest yield (Scheme 142,Table 24). A related example can be 
found by Xu et al. 145  
 
Scheme 142  
Entry Base  Solvent Time hr dr Yield% 
1 Et3N  water 3 84:16 80 
2 Et3N  CH3CN 3 81:19 63 
3 Et3N  CH2Cl2 5 83:17 69 
4 Et3N  MeOH 5 79:21 77 
5 Et3N  EtOH 5 80:20 79 
6 Et3N  DMF 3 78:22 72 
Table 24  
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Delaude, Rodriguez and Coquerel et al.146 used a NHC.CO2 precatalyst in a Michael addition 
to form tetrahydrothiophenes 369 and 370. The catalyst was able to be used with both 
methyl thioglycolate and 1,4-dithiane-2,5-diol. A yield of 98% was reported for the formation 
of tetrahydrothiophene 370 which is the best reported yield for the conjugate addition and 
cyclisation using the dimer. It was also noted that no solubility problems were discussed 
(Scheme 143).  
 
Scheme 143  
Aims and Objectives  
As shown previously in the Grainger group approach to phyllaemblic acid, the bicyclic system 
79 can be obtained through α,α’-annulation of 1-3 dioxanones (Scheme 144).26  
 
Scheme 144  
It was envisaged that the bicyclic system 79 could be used in investigations towards the 
formation of the perhydrobenzothiophene ring found in breynolide (Scheme 145).  
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Scheme 145  
It was proposed that reacting bicyclic ketone 79 with LDA would form an enolate, which 
could then be quenched with PhSeBr. Oxidising the selenium would initiate selenoxide 
elimination and formation of the α,β-unsaturated ester 374. From this point two approaches 
are possible. Conjugate addition of methyl thioglycolate 377 would lead to a system that 
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could undergo a Dieckmann cyclisation 375. The proposed Dieckmann cyclisation approach 
should yield only one possible product, based on the rationale that only one pathway yields 
an acidic proton needed to drive the reaction to completion. 
Subsequent Krapcho decarboxylation is required to yield the carbonyl 376. Reduction would 
then furnish the alcohol 372 ready for Mitsunobu inversion. An alternative route towards 
alcohol 372 would require the conjugate addition of 1,4-dithiane-2,5-diol 361 which would 
lead to an in situ intramolecular aldol to yield 373. Reduction of the ester in 373, followed by 
a Barton McCombie decarboxylation, would yield the alcohol 372 that then requires 
Mitsunobu inversion. 
The final proposed step required to invert the stereochemistry of the alcohol 372 to 371 was 
proven to be problematic in Smith’s related system 320 (Scheme 130). However, the rigidity 
of the ring in 372 could facilitate the Mitsunobu inversion due to the alcohol residing close 
to the carbonyl 378 which may allow a different mechanistic pathway (Scheme 146). 
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Scheme 146  
 
Results and discussion 
The α,β-unsaturated ester was achieved by first forming the selenide 379 this was able to be 
synthesised in good yield (Scheme 147).  
 
Scheme 147  
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The selenide addition to 79 proceeded with complete stereocontrol through addition to the 
top face of the enolate 380. This is expected as the same scenario is seen in the annulation 
reaction when a kinetic protonation of the enolate forms the bicyclic ketone 79 (Scheme 14). 
Problems with the route started to materialise when investigating the oxidation of the 
selenide to form the α,β-unsaturated ester 381 (Scheme 148).147  
 
Scheme 148  
Yields were found to be highly variable when undertaking selenoxide elimination. It was 
found that the α,β-unsaturated ester 374 underwent a fragmentation followed by 
aromatisation to form the catechol 382 (Scheme 149).  
 
Scheme 149  
By-product 382 formed during every oxidation undertaken. It was found that keeping the 
reaction at 0 oC and not running the reaction to completion generally suppressed its 
formation but it could not be completely eradicated. Changing the equivalents of H2O2 only 
slowed formation of the desired product 381. It was concluded that enoate 381 was a very 
unstable molecule and decomposed easily. It was also found that during flash 
chromatography catechol 382 would form on the column; therefore, flash chromatography 
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had to be completed as quickly as possible. On this basis it is assumed that the formation of 
382 is an acid-catalysed process; although, it was later found that the alkene 381 would also 
decompose to 382 in a variety of different solvents. Formation of the catechol by-product on 
the column was easily identifiable as it would turn the column orange/brown.148 
Once a method was established to form 381 the conjugate addition of methyl thioglycolate 
was investigated (Table 25).  
 
Entry Alkene eq. Thioglycolate eq. Base Solvent Yield 
1 1 1.2 NaH 1.2 DME degradation 
2 1 1 DBU 2.5 MeCN 9% of 
catechol 382 
3 1 1 TBAF 10 mol% THF degradation 
4 1 1 TBAF 10 mol% CH2Cl2 6% catechol 
382  21% 383 
5 1 1 Et3N 1 eq. CH2Cl2 44% 383 
6 1 5 Et3N 5 eq. CH2Cl2 81% 383 
Table 25  
The first attempt (entry 1) at conjugate addition was followed by an in situ Dieckmann 
cyclisation inspired by Carreira et al.138 Unfortunately, this resulted in complete degradation 
of starting material. Entries 2-3 also resulted in large amounts of degradation with small 
amounts of catechol 382 being isolated. It was noted that 1H NMR of the crude reaction 
mixture often gave multiple resonances in the spectrum; it was suspected that the starting 
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material was unstable in the solvents used. Using CH2Cl2 led to the isolation of 383, albeit in 
21% yield (entry 4).149 Et3N was used in conjunction with methyl thioglycolate and gave the 
product in a 44% yield (entry 5). Using an excess of both reagents led to the successful 
synthesis of the conjugate addition product 383 in an 81% yield (entry 6).  
With the conjugate addition achieved, the stereoselectivity and configuration needed to be 
assigned before the Dieckmann cyclisation could be undertaken. It was assumed that the 
methyl thioglycolate 377 would add to the top face of 374 due to approach to the bottom 
face being blocked by the orthoester (Scheme 150).  
 
Scheme 150  
In order to confirm the structure as either 383 or 384 the configuration of the ester needed 
to be determined. This was difficult to assign as proton 9 overlapped with the protons at 
position 1 and 12 on the 1H NMR. The axial and equatorial protons at 7 were also not fully 
resolved and so it was difficult to unambiguously assign the stereochemistry of the ester at 
position 9 using coupling constants (Scheme 150). A crystal structure of 383 gave conclusive 
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evidence that the ester was in an axial position, thiol addition had indeed taken place on the 
top face of 374 with subsequent protonation also occurring at the top face (Figure 17). 
 
Figure 17 Crystal structure of 383 with ellipsoids drawn at the 50% probability level.  
Investigations then proceeded to the Dieckmann cyclisation as although the stereochemistry 
of the ester was incorrect epimerisation can occur in the presence of a base  (Scheme 151) 
(Table 26).   
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Scheme 151  
Entry Bicyclic ketone 
299 mmol 
Base/ Lewis 
acid 
Solvent Time Temp Yield 
1 0.14 tBuOK 2.2 
eq. 
toluene 1 hr rt trace of alkene 
374 
2 0.14 DBU 1 eq. toluene 1 hr rt 32% 
epimerisation 384 
3 0.14 DBU 1 eq. toluene 3 hr 60 oC 32% alkene 374 
63% catechol 382 
4 0.14 NaOMe 1 
eq. 
MeOH 2 hr rt trace of alkene 
374 
5 0.14 LDA 1.1 eq. THF 1 hr rt trace of alkene 
374 
6 0.14 NaH 1 eq. DME 2 hr rt degradation 
7 0.14 TiCl4 1 eq. DCM 1 hr rt 50% of 385 
Table 26  
Dieckmann cyclisation product 375 could not be isolated after various conditions were 
attempted. It was assumed that equilibrating conditions would be ideal in order to form the 
product. The first attempt used tBuOK; however, only trace amounts of alkene 374 were 
isolated indicating that the thioglycolate had been eliminated (Entry 1).150 Entry 2 showed 
that DBU promoted epimerisation of the ester at rt; however, only a 32% yield of 384 was 
obtained along with large amounts of degradation.151 Increasing the temperature to try and 
initiate a Dieckmann cyclisation only led to elimination and the catechol by-product 382 was 
again observed (Entry 3).  
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Stronger bases were used so the protons adjacent to the sulfide would deprotonate and 
allow a Dieckmann cyclisation to take place (Entries 4 and 5). However, only trace amounts 
of the alkene 374 were observed with a large amount of degradation.152  Entry 6 saw the use 
of Carreira’s138 method, but the use of DME as a solvent resulted in complete degradation; 
this is likely due to the alkene 374 forming and then degrading. It was thought that a Lewis 
acid may chelate between the two esters and promote a cyclisation. However, this 
promoted the removal of the ortho-ester and resulted in another aromatic compound 312 
(Scheme 152) (Entry 7).137 
 
Scheme 152  
As the investigation into the different conditions used for Dieckmann cyclisation was coming 
to an end, the crystal structure of 383 was obtained. This clearly showed that the sulfide and 
the ester were not in a configuration suitable for cyclisation to occur. However, the 
investigation did show that the compound 383 was not compatible with an epimerisation.  
Although the position of the ester was still unknown at this point in time, entries 2 and 3 
give a clear indication as to what is going on in solution. In the previous investigations of the 
formation of bicyclic systems 79 and 80, the hydrogen adjacent to the ester shifts 
significantly up field after epimerisation (Figure 18). Once the crystal structure of 383 was 
obtained the 1H NMR was also known. After a new compound was isolated from the DBU 
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reaction it became apparent that an epimerisation had occurred as the required proton 
resonances were present along with characteristic proton shift to 3.94 ppm. The J values 
were again difficult to interpret as the protons at position 7 in 384 were not fully resolved; 
however the proton at position 9 at 3.94 ppm did give a dt with J = 12.6 and 4.5 with the 
12.6 assumed to be a diaxial coupling between 7ax and 9. Based on this precedent it was 
concluded that an epimerisation had occurred in the presence of DBU to form 384.  
 
Figure 18  
The data obtained suggests that the proton alpha to the ester in 383 is the most accessible. 
This in turn is then promoting the epimerisation which would be desirable but is then 
followed by an elimination. As seen in the previous work the α,β-unsaturated ester then 
degrades readily.  The problem of elimination of a thiolate under basic conditions with the 
presence of a correctly orientated ester ready for Dieckmann cyclisation appears not have 
been reported before. The nearest example that was found was by Surveit et al.153 although, 
it should be noted that it was a sulfone that was eliminated and there was no ester present 
(Scheme 153).   
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Scheme 153  
Due to the evidence of deprotonation occurring at the methyl estera, it was decided to 
oxidise the sulfur on esterb to increase the acidity of the hydrogens on the CH2 adjacent to 
the sulfur. If this was successful then the Dieckmann cyclisation could be re-investigated 
using the conditions in (Table 26, Scheme 154). 
 
Scheme 154  
Unfortunately, the sulfide in 383 could not be oxidised and only degradation occurred. The 
reasons for this are not immediately clear. The reaction was repeated several times but no 
material 386 could be isolated. 
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In order to increase the reactivity of the system to favour cyclisation to give 373, it was 
decided to use dithiane 361 in an alternative approach for conjugate addition. This, in turn, 
would lead to the presence of an aldehyde instead of an ester, which may lead to an in situ 
cyclisation (Scheme 155).   
 
Scheme 155  
Entry Alkene Dithiane Et3N Temp Solvent Yield 
1 1 eq. 0.5 eq. 0.2 eq. rt CH2Cl2 44% of 374 
2 1 eq. 0.5 eq. 0.5 eq. rt EtOH degradation 
3 1 eq. 2.5 eq. 10 eq. reflux CH2Cl2 34% of 374 
Table 27  
As alkene 374 was unstable in a variety of different solvents, conjugate addition was, 
therefore, limited to using CH2Cl2.
141 It was found that dithiane 361 had poor solubility in 
CH2Cl2 which led to 44% of alkene being recovered (Entry 1). Entry 2 used EtOH as the 
solvent to dissolve the dithiane but as expected this resulted in degradation of the alkene. 
Entry 3 partially solubilised the dithiane and it was postulated that an increase in 
temperature may give the energy for conjugate addition rather than degradation. 
Unfortunately, again degradation occurred and 34% of alkene 374 was recovered.  
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Conclusions and summary 
It was hoped that bicyclic ketone 79 would be an excellent building block for the 
perhydrobenzothiophene ring found in the natural product breynolide. The poor reactivity of 
the ketone in 79 was now an advantage as the bicyclic ketone was successfully converted to 
the organoselenide 379 in good yield. After a small investigation the organoselenide was 
successfully converted into the novel α,β-unsaturated ester 374 ready for conjugate 
addition. Unfortunately, the alkene 374 was found to be unstable in most solvents which 
limited the scope of reactions to only using CH2Cl2 as a solvent.  
After the successful formation of the conjugate addition product 383, solvent effect issues 
were again observed when undertaking the Dieckmann cyclisation. This often led to 
elimination of the thiolate, yielding the problematic alkene 374, which decomposed to the 
catechol 382. A final attempt used mCPBA to oxidise the sulfur in 383 in order to try and 
suppress elimination when undertaking a Dieckmann cyclisation; however, this could not be 
achieved. 
An alternative strategy involved the use of dithiane 361. A conjugate addition was 
attempted which would have led to an aldehyde. It was hoped that this aldehyde could have 
undergone an in situ cyclisation. However, the thiolate could not be added to the alkene 
374. It was therefore concluded that 79 was not a suitable building block to form breynolide. 
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Conclusions and Closing comments  
The aim of this thesis was to achieve the first total synthesis of phyllaemblic acid and a new 
novel route towards the perhydrobenzothiophene ring found in breynolide.  
The first chapter of this thesis reviews the key spiroacetalisation step in the natural products 
phyllanthocin and breynolide. The spiroacetalisation steps used in the previous syntheses of 
phyllanthocin and breynolide give an invaluable insight into the possible conditions that may 
be used for similar structural systems such as phyllaemblic acid.  
Chapter one concludes by highlighting the current route towards phyllaemblic acid, 
specifically the key α,α’-annulation reaction which installs three of the four stereocentres 
found on the cyclohexane ring in the spiroacetalisation precursor (Chapter 1, Scheme 12, 
Scheme 13.) 
The problem with the α,α’-annulation is that the resultant carbonyl in 80 (Chapter 1, Scheme 
15) is unreactive to a host of nucleophiles and it was concluded that the spiroacetalisation 
precursor 74 (Chapter 1, Scheme 12) could not be formed via intermolecular addition to the 
ketone in 80.  
With this in mind a new intramolecular addition was envisaged (Chapter 2, Scheme 16). A 
literature review on keto-alkyne cyclisations was completed to review the various ways in 
which this intramolecular addition could be achieved. However, when formation of the 
desired keto-alkyne cyclisation precursor 174 was attempted via the α,α’-annulation on 
dioxanone 158 (Chapter 2, Scheme 44, Scheme 46), tricyclic systems 175 and 177 were 
isolated. After investigation it was concluded that a proximity effect between the ketone and 
the alkyne was taking place, resulting in an uncontrollable intramolecular addition.  
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Future work could investigate replacing the alkyne in 158 with a different functional group. 
However, this may have an impact on the stereochemical outcome in the α,α’-annulation, as 
the smaller group prefers to reside in the flagstaff position as described in (Chapter 1, 
Scheme 14). Ultimately, further chemical manipulation to obtain a useful functional group to 
reinvestigate intramolecular addition would present a major synthetic challenge.   
An intramolecular addition was also attempted using the annulation products 79 and 80; 
however, this resulted in the formal loss of CO from the cyclohexane ring. Although the 
products obtained were interesting (Chapter 2, Scheme 59) the application towards the 
synthesis of phyllaemblic acid is limited. Labelling studies using 18O would be useful in trying 
to determine the mechanistic pathway for these products.  
Chapter three reinvestigates the HWE reaction. In the previous investigations it was 
assumed that moving from a bicyclic to a monocyclic system would facilitate nucleophilic 
attack and increase reactivity (Chapter 3, Scheme 63). Subsequent investigations found that 
the resulting monocyclic system, protected with TBS groups 211, was still too sterically 
crowded to perform a HWE reaction. A variety of different protecting groups were trialled; 
however, the only alternative protecting group successfully installed was TES. The same 
HWE conditions previously used were attempted but no reaction was observed. Finally, the 
phosphonate was shown to be unreactive to a simple model system which gave conclusive 
evidence that the HWE based approach should be abandoned.  
Enone functionality continues to be explored in chapter four and when exhibited in a system 
such as 245, the spiroacetalisation precursor 74 could be achieved in just three steps 
(Chapter 4, Scheme 82). The Meyer-Schuster rearrangement gives the opportunity to install 
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an enone via a rearrangement of a propargyl alcohol. At this stage an alkynyl anion still 
remained unused in nucleophilic attack towards the ketone in 211 and so it was proposed 
that this could be used in a new route towards the formation of phyllaemblic acid (Chapter 
4, Scheme 84).  
The TBS and TES protected systems 250 and 251 were both subjected to different sets of 
conditions using AuPPh3NTf2 and substoichiometric amounts of either MeOH or PhB(OH)2, or 
the use of (2,3,4,5-tetrafluorophenyl)boronic acid. The most interesting result was obtained 
using AuPPh3NTf2 and PhB(OH)2 on 250 which achieved the formation of the novel cyclic 
enolboronate 274 in good yield (Chapter 4, Scheme 98). 
It was concluded that the Meyer-Schuster rearrangement was unable to be utilised in the 
synthesis of phyllaemblic acid. However, the formation of the cyclic enolboronate is very 
interesting and there are potential investigations into what chemical transformations can be 
performed on 274. Furthermore, it would be interesting to see if additional novel cyclic 
enolboronates can be formed using these conditions on different systems. 
An alternative approach looked at a new disconnection and the use of an alkyne as a latent 
nucleophile (Chapter 4, Scheme 118). The formation of alkyne 299 was successfully achieved 
from aldehyde 217. This route installed all four of the stereocentres on the cyclohexane ring. 
A convergent synthesis was developed by coupling 309 with epoxide 306. Various conditions 
were attempted (Chapter 4, Table 23), but ultimately the two fragments could not be joined 
together. There is potential for work still to be completed via increasing the reactivity of the 
epoxide. However, based on the results obtained in chapters three and four it is assumed 
that the large TBS groups are a main factor in suppressing C-C bond formation at the alkyne, 
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and as shown in chapter three an alternative protecting group strategy seems to be a 
significant synthetic challenge.  
With regards to a future total synthesis of phyllaemblic acid, if C-C bond formation can be 
achieved between the disconnection shown in (Chapter 1, Scheme 12) and a correct 
protecting group strategy can be identified, then the spiroacetalisation precursor could be 
formed.  Once this has been achieved, it is proposed that subsequent spiroacetalisation 
should be relatively straightforward due to the various conditions previously investigated on 
the structurally related natural products phyllanthocin and breynolide (Chapter 1). 
Investigations in Chapter five looked towards using the bicyclic system 79 to form the 
perhydrobenzothiophene ring found in breynolide. Two separate routes were envisaged, 
both relying on the successful formation of the α,β-unsaturated ester 374 (Chapter 5, 
Scheme 145). Conjugate addition to the double bond was successfully achieved; however, 
the uncontrollable formation of catechol 382 often proceeded due to the instability of 381 
and the tendency of elimination reactions occurring in 383 (Chapter 5, Scheme 153). This 
significantly affected the synthetic application of bicyclic ketone 79 towards the synthesis of 
the perhydrobenzothiophene ring. The oxidation of the sulfur atom would have potentially 
alleviated the problems of elimination and allowed a Dieckmann cyclisation to be carried 
out. However, oxidation of the sulfur with mCPBA was unsuccessful. It would be prudent to 
investigate the possibility of oxidising the sulfur with a different oxidising agent as only 
degradation occurred with mCPBA. If the suflur can be successfully oxidised investigations 
towards the perhydrobenzothiophene ring using the Dieckmann cyclisation could potentially 
be achieved using the conditions shown in (Table 25).       
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Experimental Section  
General experimental 
1H and 13C NMR data were recorded on a Bruker AVIII 300, Bruker AVIII 400 spectrometer. 
Spectra were recorded in deuterochloroform referenced to residual CHCl3 (
1H, 7.26 ppm) or 
CDCl3 (
13C, 77.16 ppm). Chemical shifts (δ) are reported in ppm and coupling constants (J) 
are reported in Hz. Abbreviations have been used to describe multiplicity. Mass spectra were 
recorded on Waters (Herts, UK) LCT MicroMass Electrospray Ionisation (ESI) Mass 
Spectrometer fitted with a time-of –flight (TOF) mass analyser or a Waters Synapt G2-S1 
mass spectrometer fitted with an ESI ionisation source and a TOF mass analyser. Compounds 
were diluted with a 1:1 mixture of water and methanol and are reported as (m/z (%)). HRMS 
were recorded on a LCT spectrometer using lock mass incorporated into the mobile phase. IR 
spectra were recorded neat on Perkin Elmer 100-series FT-IR spectrometer. Melting points 
were determined using open glass capillaries on a Gallenkamp melting point apparatus and 
are uncorrected. Analytical T.L.C. was carried out on Merck 60 F245 aluminium backed silica 
gel plates. Short wave UV radiation (245 nm), KMnO4 and vanillin were used to visualise 
components. Compounds were purified by flash column chromatography using Merck silica 
gel 60 (0.040-0.063 nm). THF, toluene, CH2Cl2 and CH3CN were dried by passing through 
activated alumina columns. Pyridine and triethylamine were distilled from potassium 
hydroxide. All other reagents and solvents were purchased from Aldrich, Alfa Aesar, Fisher 
Scientific, Merck or TCI Europe and were used as received. The following cooling baths were 
used; 0 °C (ice/water) and -78 °C (dry ice/acetone). All reactions in non-aqueous solvents 
were carried out under argon in oven-dried glassware. Solvents were degassed by bubbling 
argon through a needle immersed in the solvent for the stated length of time. 
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Synthesis of 2-Methoxy-2-methyl-1,3-dioxan-5-one 76 
 
Dimeric dihydroxyacetone (4.09 g, 22.7 mmol) and pTSA (50 mg, 0.26 mmol) were heated to 
60 oC in dioxane (200 mL). After the dimeric dihydroxyacetone had completely dissolved, 
trimethyl orthoacetate (60 mL, 454 mmol) was added and the solution stirred overnight at 
60 oC. The reaction was then cooled to rt, concentrated under reduced pressure to roughly a 
tenth of its original volume and then directly placed onto a silica column for purification (1:1 
petroleum ether: diethyl ether) to give title compound 76 as a colourless oil (3.61 g, 54%). Rf 
0.54 (1:1 petroleum ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
4.32 (2 H, d, J 17.2, H2a), 4.17 (2 H, d, J 17.2, H2b), 3.37 (3 H, s, H5), 1.57 
(3 H, s, H3). 
δ C (101 MHz, 
Chloroform-d) 
204.7 (C, C1), 112.5 (C, C4), 67.6 (CH2, C2), 51.4 (CH3, C5), 20.6 (CH3, 
C3). 
νmax 2951, 2840 (CH), 1740 (C=O), 1037 (C-O). 
A known compound prepared according to a literature procedure and data agrees with literature values.
154
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Synthesis of Methyl 2-(bromomethyl)acrylate 78 
 
A solution of methyl hydroxymethylacrylate (7.55 g, 65.0 mmol) in diethyl ether (200 mL) 
was cooled to 0 oC. PBr3 (3.08 mL, 32.5 mmol) was added dropwise over 10 minutes and the 
mixture was allowed to warm to rt. After 4 hr, the solution was quenched with H2O (50 mL) 
and extracted with hexane (3 x 30 mL), dried over Na2SO4, filtered and evaporated under 
reduced pressure to yield a yellow oil. Purification by column chromatography (9:1 
petroleum ether: diethyl ether) gave the title compound 78 as a clear oil (9.71 g, 83%). 
Rf 0.34 (9:1 petroleum ether: diethyl ether) visualised in KMnO4. 
δ H (400 MHz, 
Chloroform-d) 
6.33 (1 H, s, H3), 5.96 (1 H, s, H3), 4.17 (2 H, s, H1), 3.81 (3 H, s H5). 
δ C (101 MHz, 
Chloroform-d) 
165.4 (C, C4), 137.4 (C, C2), 129.3 (CH2, C3), 52.4 (CH3, C5), 29.4 (CH2, 
C1). 
MS EI+ (EI): m/z(%) = 99.0- 100% [M - 79Br], 101.1- 40% [M - 81Br], 118.9- 80% 
[M - C2H3O2], 120.9- 78% [M - C2H3O2], 149.9- 90% [M - CH3O], 148.9- 
88% [M - CH3O]. 
A known compound prepared according to a literature procedure and data agrees with literature values.
26, 155
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Synthesis of Methyl (1S,3S,7S)-3-methoxy-3-methyl-9-oxo-2,4-dioxabicyclo[3.3.1]nonane-
7-carboxylate 79 
 
A solution of dioxanone 76 (2.9 g, 19.9 mmol) in CH3CN (70 mL) was cooled to 0 
oC. 
Pyrrolidine (1.4 g, 19.9 mmol) was added and the reaction mixture stirred for 5 hr. Et3N 
(2.0 g, 19.9 mmol) was added followed by a solution of α-bromomethylacrylate 78 (3.6 g, 
19.9 mmol) in CH3CN (30 mL). After 16 hr, H2O (100 mL) was added and the reaction mixture 
stirred for 3 hr. The reaction mixture was then reduced to half volume under reduced 
pressure and then extracted with CH2Cl2 (3 x 25 mL). The combined organic extracts were 
washed with brine (25 mL), dried over Na2SO4, filtered and concentrated under reduced 
pressure. Purification by column chromatography (1:1 petroleum ether: EtOAc) gave the title 
compound 79 as a white solid (3 g, 62%). M.p. 65-67 oC. Rf 0.24 (1:1 petroleum ether: diethyl 
ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
4.17 (2 H, d, J 3.8, H4), 3.77 (3 H, s, H9), 3.27 – 3.18 (5 H, m, H6 eq & 
H2), 2.63 (1 H, app.t, J 7.0, H7), 1.98 (2 H, dd, J 14.6, 7.0, H6 ax), 1.43 
(3 H, s, H1). 
δ C (101 MHz, 
Chloroform-d) 
208.0 (C, C5), 173.7 (C, C8), 112.1 (C, C3), 75.2 (CH, C4), 52.1 (CH3, C9), 
51.1 (CH3, C2), 36.7 (CH2, C6), 34.0 (CH, C7), 19.9 (CH3, C1). 
νmax 2996, 2950, 2933 (CH), 1744 (CO2Me), 1725 (C=O). 
A known compound prepared according to a literature procedure and data agrees with literature values, 
except the product obtained was crystalline.
26
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Synthesis of Methyl (1S,3S,7R)-3-methoxy-3-methyl-9-oxo-2,4-dioxabicyclo[3.3.1]nonane-
7-carboxylate 80 
 
To a solution of methyl-2-methoxy-1,3-dioxane 79 (1 g, 4.09 mmol) in CH3CN (34 mL) was 
added DBU (0.62 g, 4.09 mmol). The reaction mixture was heated to 65 oC and stirred for 
24 hr, allowed to cool to rt, concentrated under reduced pressure and directly purified by 
column chromatography (3:1 petroleum: diethyl ether) to yield the title compound 80 as a 
white solid (1 g, 100%). Rf 0.45 (4:1 petroleum ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
4.17 (2 H, d, J 3.7, (H4), 3.69 (3 H, s, H9) 3.44 (1 H, tt, J 12.5, 4.6, H7), 
3.25 (3 H, s, H2), 2.60 (2 H, ddd, J 14.1, 6.5, 4.6, H6 eq),  
1.94 (2 H, app.t, J 14.1, H6 ax), 1.57 (3 H, s, H1).  
δ C (101 MHz, 
Chloroform-d) 
207.0 (C, C5), 174.3 (C, C8), 112.2 (C, C3), 74.7 (CH, C4), 52.2 (CH3, C2), 
51.1 (CH3, C9), 38.3 (CH2, C6), 33.4 (CH, C7), 20.2 (CH3, C1). 
νmax 3003, 2965, 2937 (CH), 1753 (CO2Me), 1730 (C=O). 
A known compound prepared according to a literature procedure and data agrees with literature values.
26
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Synthesis of 2-Isobutyl-2-((trimethylsilyl)ethynyl)-1,3-dioxan-5-one 141 
 
A solution of 160 (1.2 g, 4.75 mmol) in a 3:1 mixture of dioxane: H2O (24 mL) was treated 
with OsO4 (1-2 drops of a 4 wt% aq. solution) and NaIO4 (4.0 g, 19.0 mmol). The mixture was 
vigorously stirred at 40 oC for 4 hr then cooled to rt. The mixture was filtered and the filtrate 
added to saturated solution of sodium bisulfite, followed by a solution of NaHCO3 (25 mL of a 
0.1 M aq. solution) and extracted with CH2Cl2 (3 x 25 mL). The organic extracts were dried 
with Na2SO4, filtered and concentrated under reduced pressure. The yellow crude oil was 
purified by column chromatography (19:1 petroleum ether: diethyl ether) to first recover sm 
(70 mg), followed by the title compound 141 as a white solid (0.72 g, 63% BRSM). M.p. 41 oC. 
Rf 0.63 (9:1 petroleum ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
4.55 (2 H, d, J 19.1, H8a), 4.26 (2 H, d, J 19.1, CH2 H8
b), 2.03 (1 H, 
app.Non, J 6.5, H6), 1.81 (2 H, d, J 6.5, H5), 1.00 (6 H, d, J 6.5, H7), 0.19 
(9 H, s, H1). 
δ C (101 MHz, 
Chloroform-d) 
204.3 (C, C9), 99.0 (C, C3), 95.9 (C, C4), 94.5 (C, C2), 70.0 (CH2, C8), 48.1 
(CH2, C5), 24.4 (CH, C6), 23.9 (CH3, C7), -0.3 (CH3, C1). 
MS ES+ HRMS (ES): m/z(%) = 309.1490 [M + Na + MeOH] (calcd for 
C14H26O4NaSi: 309.1498), 309.2- 100% [M + Na + MeOH], 265.0- 30%, 
165.0- 20%. 
νmax 2959, 2873 (CH), 1736 (C=O), C≡C (stretch not visible). 
A novel compound prepared according to a modified literature procedure.
75
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Synthesis of 5-Methyl-1-(trimethylsilyl)hex-1-yn-3-one 150 
 
To a solution of BTMSA (9.94 g, 58.3 mmol) and isovaleryl chloride (6.40 g, 53.1 mmol) in 
CH2Cl2 (150 mL) cooled to 0 
oC, was added AlCl3 (8.49 g, 53.1 mmol) in small portions over 
30 min. The reaction mixture was allowed to warm to rt over 3 hr then poured onto ice. HCl 
was added (30 mL of a 1 M aqueous solution) and extracted with CH2Cl2 (3 x 25 mL). The 
combined organic extracts were dried over Na2SO4, filtered and concentrated under reduced 
pressure to afford a black oil which was purified by passing through a plug of silica (19:1 
petroleum ether: diethyl ether) to give the title compound 150 as a yellow oil (9.47 g, 98%). 
Rf 0.54 (9:1 petroleum ether: ethyl acetate) visualised in vanillin.  
δ H (400 MHz, 
Chloroform-d) 
2.36 (2 H, d, J 7.0, H5), 2.17 (1 H, app.Non, J 7.0, H6), 0.89 (6 H, d, J 7.0, 
H7), 0.17 (9 H, s, H1). 
δ C (101 MHz, 
Chloroform-d) 
187.4 (C, C4), 102.4 (C, C3), 97.2 (C, C2), 54.2 (CH2, C5), 25.0 (CH, C6), 
22.4 (CH3, C7), -0.8 (CH3, C1). 
MS TOF EI+ HRMS (EI): m/z(%) = 182.1121 [M] (calcd for C10H18OSi: 182.1127), 
125.0- 100% [M - C4H9], 140.1- 40% [M - C3H8], 167.1- 30% [M - CH3]. 
νmax 2960, 2874 (CH), 2152 (C≡C), 1673 (C=O). 
A novel compound prepared according to a modified literature procedure.
68
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Synthesis of (3,3-Dimethoxy-5-methylhex-1-yn-1-yl)trimethylsilane 154 
 
To a solution of pTSA (480 mg, 2.52 mmol) in MeOH (19 mL) was added ketone 150 (4.64 g, 
25.4 mmol) and trimethylorthoformate (3.23 g, 30.5 mmol). The mixture was stirred for 4 hr 
at rt. The reaction was quenched with K2CO3 (25 mL of a saturated aqueous solution) and 
extracted with CH2Cl2 (3 x 25 mL). The organic extracts were dried over Na2SO4, filtered, 
concentrated under reduced pressure and purified by column chromatography (99:1 
petroleum ether: diethyl ether) to give the title compound 154 as a red/brown oil (3.06 g, 
66%). Rf 0.36 (99:1 petroleum ether: diethyl ether) visualised in vanillin.   
δ H (400 MHz, Chloroform-d) 3.25 (6 H, s, H8), 1.91 (1 H, app.Non, J 6.4, H6), 1.65 (2 H, d, J 
6.4, H5), 0.95 (6 H, d, J 6.4, H7), 0.15 (9 H, s, H1). 
δ C (101 MHz, Chloroform-d) 102.0 (C, C2), 99.2 (C, C4), 90.7 (C, C3), 49.9 (CH3, C8), 45.4 
(CH2, C5), 24.6 (CH, C6), 23.8 (CH3, C7), -0.2 (CH3, C1). 
MS TOF EI+ HRMS (EI): m/z(%) = 251.1446 [M + Na] (calcd for 
C12H24O2NaSi: 251.1443), 251.1- 70% [M + Na], 197.1- 100% 
[M - OMe].  
νmax 2956, 2872, 2830 (CH), 1070 (OMe), C≡C not observed.  
A novel compound prepared according to a modified literature procedure.
156
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Synthesis of 3,3-Dimethoxy-5-methylhex-1-yne 156 
 
To a stirred solution of 154 (2.69 g, 11.8 mmol) in THF (118 mL), TBAF (11.8 mL of a 1M 
solution in THF, 11.8 mmol) was added dropwise via syringe over 5 minutes. The mixture 
was stirred for 24 hr, poured onto K2CO3 (50 mL of a saturated aqueous solution), extracted 
with Et2O (3 x 20 mL), washed with brine (25 mL), dried over MgSO4, filtered, and then 
purified by column chromatography (19:1 petroleum ether: diethyl ether) to give the title 
compound 156 as a colourless oil (0.87 g, 47%). Rf 0.61 (9:1 petroleum ether: diethyl ether) 
visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
3.30 (6 H, s, H7), 2.56 (1 H, s, H1), 1.97 (1 H, app.Non, J 6.5, H5), 1.69 
(2 H, d, J 6.5, H4), 0.98 (6 H, d, J 6.5, H6). 
δ C (101 MHz, 
Chloroform-d) 
99.3 (C, C3), 80.6 (C, C2), 74.0 (CH, C1), 50.0 (CH3, C7), 45.2 (CH2, C4), 
24.7 (CH, C5) 23.7 (CH3, C6). 
MS EI+ HRMS (EI): m/z(%) = 156.1153 [M] (calcd for C9H16O2: 156.1150), 
99.0- 100% [M - C4H9], 125.1- 90% [M - MeO], 83.0- 70%. 
νmax 3308 (C≡C-H), 2956, 2873, 2833 (CH), 2118 (C≡C). 
A novel compound.  
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Synthesis of 2-Ethynyl-2-isobutyl-1,3-dioxan-5-one 158 
 
To a solution of cyclic acetal 172 (100 mg, 0.55 mmol) in a 3:1 mixture of dioxane and water 
(5.5 mL), was added OsO4 (1-2 drops of a 4 wt% aq. solution) and NaIO4 (471 mg, 2.2 mmol). 
The reaction was vigorously stirred for 2 hr at 50 oC. The crude reaction mixture was filtered 
and added to a saturated aqueous solution of sodium bisulfite. The filtrate was then washed 
with 0.1 M NaHCO3 (3 x 10 mL), extracted with diethyl ether (3 x 10 mL), dried over MgSO4, 
filtered and the solvent removed under reduced pressure. Column chromatography (9:1 
petroleum ether: diethyl ether) gave the title compound 158 as a colourless oil (84 mg, 84%). 
Rf 0.32 (9:1 petroleum ether: diethyl ether) visualised in KMnO4. 
δ H (400 MHz, 
Chloroform-d) 
4.55 (2 H, d, J 19.1, H7a), 4.28 (2 H, d, J 19.1, H7b), 2.74 (1 H, s, H1), 2.05 
(1 H, app.Non, J 6.6, H5), 1.83 (2 H, d, J 6.6, H4), 0.99 (6 H, d, J 6.6, H6). 
δ C (101 MHz, 
Chloroform-d) 
203.9 (C, C8), 95.8 (C, C3), 78.1 (C, C2), 76.8 (CH, C1), 69.9 (CH2, C7), 
48.3 (CH2, C4), 24.3 (CH, C5), 23.8 (CH3, C6). 
MS EI+ HRMS (EI): m/z(%) = 182.0941 [M] (calcd for C10H14O3: 182.0943), 
125.0-100% [M - C4H9], 68.0- 65%. 
νmax 3273 (H-C≡C), 2958, 2874 (CH), 2110 (C≡C), 1741 (C=O). 
A novel compound. 
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Synthesis of ((2-Isobutyl-5-methylene-1,3-dioxan-2-yl)ethynyl)trimethylsilane 160 
 
To a solution of TMSOTf (8 μL, 0.04 mmol) in CH2Cl2 (0.43 mL) cooled to 0 
oC was added 150 
(392 mg, 2.15 mmol) and 167 (1 g, 4.30 mmol) at the same time. The yellow reaction mixture 
was allowed to warm to rt. After 1 hr the golden brown mixture was added to Na2CO3  
(15 mL of a saturated aqueous solution) and extracted with diethyl ether (3 x 25 mL). This 
was then dried over MgSO4, filtered and concentrated under reduced pressure. Purification 
by column chromatography (98:2 petroleum ether: diethyl ether) gave the title compound 
160 as a colourless oil (0.35 g, 89%). Rf 0.51 (99:1 petroleum ether: diethyl ether) visualised 
in anisaldehyde. 
δ H (400 MHz, 
Chloroform-d) 
4.90 (2 H, s, H10), 4.76 (2 H, d, J 13.0, H8a), 4.14 (2 H, d, J 13.0, H8b), 
2.02 (1 H, app.Non, J 6.5, H6), 1.73 (2 H, d, J 6.5, H5), 0.97 (6 H, d, J 6.5, 
H7), 0.21 (9 H, s, H1). 
δ C (101 MHz, 
Chloroform-d) 
138.9 (C, C9), 109.9 (CH2, C10), 100.3 (C, C2), 96.2 (C, C4), 93.3 (C, C3), 
66.4 (CH2, C8), 49.6 (CH2, C5), 24.3 (CH, C6), 24.0 (CH3, C7), -0.1 (CH3, 
C1). 
MS ES+ HRMS (ES): m/z(%) = 275.1444 [M + Na] (calcd for C14H24O2NaSi: 
275.1443), 275.1- 100% [M + Na], 253.1- 80% [M + H], 197.1- 90%.  
νmax 2957, 2850, 2871 (CH), 2163 (C≡C). 
A novel compound prepared according to a modified literature procedure.
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Synthesis of 2,2,8,8-Tetramethyl-5-methylene-3,7-dioxa-2,8-disilanonane 167 
 
To a solution of 2-methylene-1,3-propane diol 159 (500 mg, 5.65 mmol) and TMSCl (1.29 g, 
11.9 mmol) in CH2Cl2 (56.5 mL) cooled to 0 
oC, was added dry Et3N (1.29 g, 11.9 mmol). The 
mixture was warmed to rt, and stirred for 24 hr, poured onto H2O (25 mL) then washed with 
H2O (4 x 25 mL) and brine (1 x 25 mL). The organic fraction was dried over MgSO4, filtered 
and concentrated under reduced pressure to yield the title compound 167 as a clear oil 
(1.28 g, 97%). 
δ H (400 MHz, 
Chloroform-d) 
5.09 (2 H, s, H3), 4.13 (4 H, s, H2), 0.12 (18 H, s, H1). 
δ C (101 MHz, 
Chloroform-d) 
148.0 (C, C4), 110.5 (CH2, C3), 63.8 (CH2, C2), 0.0 (CH3, C1). 
MS EI+ HRMS (EI): m/z(%) = 232.1319 [M] (calcd for C10H24O2SSi2: 232.1315), 
129.0- 100% [M - C4H11OSi], 142.0- 70%, 147.0- 60%, 149.0- 55%.  
νmax 2958, 2901 (CH), 1660 (C=C). 
A novel compound.  
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Synthesis of 2-Ethynyl-2-isobutyl-5-methylene-1,3-dioxane 172  
 
To a solution of cyclic acetal 160 (500mg, 1.98 mmol) in MeOH (30 mL) cooled to 0 oC, was 
added a solution of K2CO3 (378 mg, 2.73 mmol) in water (8 mL). The reaction was left to stir 
for 30 minutes then the mixture was separated between NaHCO3 (0.1 M, 10 mL) and Et2O 
(10 mL). The aqueous phase was washed with diethyl ether (2 x 10 mL). The organic phase 
was dried over MgSO4, filtered and solvents were removed under reduced pressure. Column 
chromatography (19:1 petroleum ether: diethyl ether) gave the title compound 172 as a 
colourless oil (288 mg, 80%). Rf 0.64 (19:1 petroleum ether: diethyl ether) visualised in 
vanillin. 
δ H (400 MHz, 
Chloroform-d) 
4.91 (2 H, s, H9), 4.77 (2 H, d, J 13.5, H7a), 4.18 (2 H, d, J 13.5, H7b), 2.70 
(1 H, s, H1), 2.05 (1 H, app.Non, J 6.6, H5), 1.76 (2 H, d, J 6.6, H4), 0.98 
(6 H, d, J 6.6, H6). 
δ C (101 MHz, 
Chloroform-d) 
138.5 (C, C8), 110.1, (CH2, C9) 96.2 (C, C2), 79.1 (C, C3), 76.2 (CH, C1), 
66.4, (CH2, C7) 49.6 (CH2, C4), 24.2 (CH, C5) 24.0 (CH3, C6). 
MS ES+ HRMS (ES): m/z(%) = 181.1223 [M + H] (calcd for C11H17O2: 181.1229), 
213.2- 100% [M + MeOH + H], 181.1- 45% [M + H]. 
νmax 3302 (C≡C-H), 2957, 2853 (CH), 2107 (C≡C). 
A novel compound. 
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Synthesis of Methyl (4ar,5R,7r,8aS)-4a-hydroxy-2-isobutyl-3-oxooctahydro-2H-2,5-
epoxychromene-7-carboxylate 175 
 
To a solution of dioxanone 158 (143 mg, 0.78 mmol) in dry toluene (7.8 mL) with 4 Å MS 
(2 g) was added pyrrolidine (222 mg, 3.12 mmol). The mixture was stirred overnight at rt, 
filtered and then quickly washed with brine (3 x 5 mL). The reaction was extracted with 
diethyl ether (3 x 5 mL), dried over MgSO4 and the solvent was removed under reduced 
pressure. The remaining oil was then placed under vacuum (0.1 mmHg) for approximately 
1 hr to give the crude enamine as a crystalline product (161 mg.)  
A solution of the crude enamine (161 mg, 0.68 mmol) in MeCN (6.8 mL) was then cooled to 
0 oC  and methyl bromomethyl acrylate (122 mg, 0.68 mmol) was added followed by Et3N 
(69 mg, 0.68 mmol). The mixture was stirred overnight with gradual warming to rt. Water 
(5 mL) was then added and the reaction left to stir for 5 hr. The mixture was then extracted 
with CH2Cl2 (3 x 15 mL). The organic layer was dried over MgSO4, filtered and then solvents 
removed under reduced pressure. Column chromatography (1:1 petroleum ether: diethyl 
ether) gave the title compound 175 as a white solid (44 mg, 20% (over 2 steps)). M.p. 96-
98 oC. Rf 0.15 (1:1 petroleum ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
4.00 (2 H, app.t, J 1.8, H8), 3.71 (3 H, s, H12), 2.69 (2 H, dd, J 15.1, 1.8, 
H9 eq), 2.61 (2 H, s, H6), 2.57 (1 H, app.t, J 7.3, H10), 2.06 (2 H, dd, J 
15.1, 7.3, H9 ax), 1.74 (1 H, app.Non, J 6.5, H2), 1.49 (2 H, d, J 6.5, H3), 
0.87 (6 H, d, J 6.5, H1). 
OH not visible by NMR 
 160 
 
δ C (101 MHz, 
Chloroform-d) 
197.6 (C, C5), 175.0 (C, C11), 94.7 (C, C4), 74.5 (CH, C8), 63.5 (C, C7), 
52.0 (CH3, C12), 47.7 (CH2, C6), 39.1 (CH2, C3), 32.1(CH, C10), 25.8 (CH2, 
C9), 24.2 (CH3, C1), 23.3 (CH, C2). 
MS ES+ HRMS (ES): m/z(%) = 321.1329 [M + Na] (calcd for C15H22O6Na: 
321.1314), 321.1-100% [M+Na]. 
νmax 3434 (OH), 2952, 2868 (CH), 1742 (CO2Me), 1715 (C=O). 
A novel compound prepared according to a modified literature procedure.
26
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Synthesis of methyl (3ar,4R,6r,7aS,Z)-3-(bromomethylene)-2-isobutyl-3a-(pyrrolidin-1-
yl)octahydro-2,4-epoxybenzofuran-6-carboxylate 177 
 
To a solution of 158 (100 mg, 0.55 mmol) in toluene (5.5 mL) with 4 Å MS was added 
pyrrolidine (156 mg, 2.2 mmol). The mixture was left to stir under an argon atmosphere 
overnight at rt. The crude reaction mixture was filtered and quickly washed with brine 
(15 mL). The organic layers were separated, dried with MgSO4, filtered and the solvents 
removed under reduced pressure. The crude yellow oil was then placed under vacuum 
(0.1 mmHg) until it crystallised. The crude enamine was then dissolved in MeCN (3.9 mL) 
followed by the addition of bromomethyl acrylate (70 mg, 0.39 mmol) and NEt3 (39 mg, 
0.39 mmol). The reaction mixture was then heated to 50 oC and left for 12 hr. The reaction 
was quenched with H2O (5 mL) and left to stir for 5 hr, extracted with CH2Cl2 (3 x 15 mL), 
washed with brine (15 mL), dried over MgSO4 and filtered. The solvents were removed under 
reduced pressure to leave the crude product that was purified by column chromatography, 
(1:1 petroleum ether: diethyl ether) to give the title compound 177 as a white solid. (90 mg, 
39%). M.p. 133-135 oC. Rf 0.55 (8:2 diethyl ether: petroleum ether) visualised in vanillin. 
δ H (400 MHz, 
Benzene-d6) 
Product degrades 
in chloroform. 
5.56 (1 H, s, H5), 4.03 (2 H, app.t, J 1.5, H8), 3.60 (3 H, s, H12), 2.87 – 
2.72 (2 H, m, H9a), 2.41 (1 H, app.Non, J 6.4 H2), 2.35 – 2.27 (6 H, m, 
H13, H14, H3), 2.16 (1 H, tt, J 7.1, 1.6, H10), 1.39 (2 H, dd, J 14.8, 7.1, 
H9b), 1.31 – 1.25 (4 H, m, H14, H13), 1.23 (6 H, d, J 6.4, H1). 
 162 
 
δ C (101 MHz, 
Benzene-d6) 
173.6 (C, C11), 144.6 (C, C6), 105.5 (C, C7), 85.8 (CH, C5), 74.0 (CH, C8), 
68.9 (C, C4), 51.4 (CH3, C12), 46.5 (CH2, C13), 41.9 (CH2, C14) 32.2, (CH, 
C10) 25.3 (CH2, C3), 25.1 (CH3, C1), 24.5 (CH2, C9), 23.6 (CH, C2). 
MS TOF ES+ HRMS (ES): m/z(%) = 414.1283 [M + H] (calcd for C19H29NO4
79Br: 
414.1280), 414.1- 100% [M79Br], 416.1- 90% [M81Br]. 
νmax 2956, 2930, 2912, 2870 (CH), 1722 (CO2Me), 1205 (C-N), 696 (C-Br). 
A novel compound prepared according to a modified literature procedure.
26
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Synthesis of Methyl (1S,3R,4S)-3-acetoxy-4-hydroxycyclopentane-1-carboxylate 206 
 
In a Pyrex immersion well reactor a solution of bicyclic ketone 79 (100 mg, 0.4 mmol) in 
MeCN (57 mL) was degassed using argon for 15 minutes. A medium pressure mercury lamp 
was then used and the reaction stirred for 4 hr. Solvents were removed under reduced 
pressure and the crude product purified via column chromatography (1:1 petroleum ether: 
diethyl ether) to give the title compound 206 as a pale yellow oil (24 mg, 29%). Rf 0.32 (8:2 
diethyl ether: petroleum ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
5.07 (1 H, ddd, J 7.0, 5.6, 4.0, H3), 4.36 – 4.27 (1 H, m, H4), 3.66 (3 H, s, 
H10), 3.14 (1 H, tt, J 9.8, 6.6, H7), 2.28 – 2.17 (2 H, m, H5, H6/H8), 2.11 
– 1.96 (6 H, m, H1, H6/H8). 
δ C (101 MHz, 
Chloroform-d) 
176.2 (C, C9), 170.8 (C, C2), 76.3 (CH, C3), 72.6 (CH, C4), 52.1 (CH3, 
C10), 38.8 (CH, C7), 34.6 (CH2, C6/C8), 31.8 (CH2, C6/C8), 21.1 (CH3, C1). 
MS ES+ HRMS (ES): m/z(%) = 225.0733 [M + Na] (calcd for C9H14O5Na: 
225.0739), 225.1- 100% [M + Na]. 
νmax 3462 (OH), 2954 (CH), 1724 (CO2Me, C=O). 
A novel compound.  
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Synthesis of Methyl (1R,3R,4S)-3-acetoxy-4-hydroxycyclopentane-1-carboxylate 207 
 
In a Pyrex immersion well reactor a solution of bicyclic ketone 80 (100 mg, 0.4 mmol) in 
MeCN (57 mL) was degassed using argon for 15 minutes. A medium pressure mercury lamp 
was then used and the reaction stirred for 4 hr. Solvents were then removed under reduced 
pressure and the crude product purified via column chromatography (1:1 petroleum ether: 
diethyl ether) to give the title compound 207 as a colourless oil (14 mg, 17%). Rf 0.35 (8:2 
petroleum ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
4.94 (1 H, td, J 6.8, 4.3, H3), 4.19 (1 H, td, J 5.4, 4.3, H4), 3.70 (3 H, s, 
H10), 3.01 – 2.74 (2 H, m, H5, H7), 2.32 (2 H, ddd, J 14.1, 9.5, 6.9, H6, 
H8), 2.22 – 2.01 (5 H, m, H1, H6, H8).  
δ C (101 MHz, 
Chloroform-d) 
176.2 (C, C9), 171.0 (C, C2), 75.9 (CH, C3), 72.4 (CH, C4), 52.4 (CH3, 
C10), 38.3 (CH, C7), 34.5 (CH2, C8), 31.5 (CH2, C6), 21.2 (CH3, C1). 
MS ES+ HRMS (ES): m/z(%) = 225.0743 [M + Na] (calcd for C9H14O5Na: 
225.0739), 225.1- 100% [M + Na]. 
νmax 3458 (OH), 2955 (CH), 1722 (CO2Me). 
A novel compound. 
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Synthesis of Methyl (1S,3R,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-oxocyclohexane-1-
carboxylate 211 
 
To a solution of 80 (323 mg, 1.32 mmol) in methanol (13.2 mL) was added acetic acid (79 mg, 
1.32). The reaction was set to reflux for 2 days. The solution was then allowed to cool to rt 
and the solvent removed under reduced pressure co-distilled with toluene. The crude white 
solid was then dissolved in DMF (13 mL). Imidazole (741.3 mg, 3.3 mmol) was added 
followed by TBSCl (1.60 g, 3.3 mmol). The solution was then allowed to stir at rt for 2 days. 
The solvent was removed and the remaining slurry washed with brine (3 x 15 mL) and ether 
(3 x 15 mL). The ether extracts were then dried over MgSO4, filtered and solvent removed 
under reduced pressure.  Column chromatography (9:1 petroleum ether: diethyl ether) gave 
the title compound 211 as a white solid (456 mg, 83%). Rf 0.53 (9:1 Petroleum ether: diethyl 
ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
4.36 (2 H, dd, J 12.2, 6.2, H6), 3.77 (3 H, s, H10), 2.94 (1 H, tt, J 5.3, 2.4, 
H8), 2.59 (2 H, ddd, J 13.1, 6.2, 2.4, H7 eq), 1.84 (2 H, ddd, J 13.1, 12.2, 
5.3, H7 ax), 0.90 (18 H, s, H1), 0.13 (6 H, s, H3), 0.02 (6 H, s, H4). 
δ C (101 MHz, 
Chloroform-d) 
206.3 (C, C5), 174.6 (C, C9), 73.4 (CH, C6), 52.3 (CH3, C10), 37.7 (CH2, 
C7), 36.6 (CH, C8), 25.9 (CH3, C1) 18.7 (C, C2), -4.6 (CH3, C3), -5.4 (CH3, 
C4). 
νmax 2954, 2927, 2856 (CH), 1728 (C=O).  
A known compound prepared according to a PhD thesis procedure and data agrees with publication values.
91
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Synthesis of Diethyl (2-oxo-6-((triethylsilyl)oxy)hexyl)phosphonate 214 
 
To a solution of diethylmethyl phosphonate (200 mg, 1.3 mmol) in THF (10 mL) at -78 oC was 
added nBuLi (2.1 M solution in nhexane, 0.62 mL, 1.3 mmol) and the mixture was left to stir 
for 20 minutes. γ-Valerolactone (130 mg, 1.3 mmol) was added and the mixture stirred for 
1 hr with gradual warming to rt. The mixture was then cooled to -78 oC followed by the 
addition of nBuLi (2.1 M solution in nhexane, 0.62 mL, 1.3 mmol) and stirred for 20 minutes. 
TESCl (196 mg, 1.3 mmol) was then added and the mixture stirred overnight with gradual 
warming to rt.  The reaction was then quenched with a saturated aqueous solution of NH4Cl 
(15 mL) and extracted with diethyl ether (3 x 15 mL), dried over MgSO4, filtered and the 
solvents removed under reduced pressure. Column chromatography (ethyl acetate, 100%) 
gave the title compound 214 as a yellow oil (245 mg, 51%). Rf 0.25 (ethyl acetate 100%) 
visualised under UV light. 
δ H (400 MHz, 
Chloroform-d) 
4.20 – 4.07 (4 H, m, H9), 3.59 (2 H, t, J 6.3, H3), 3.06 (2 H, d, J 22.7, H8), 
2.64 (2 H, t, J 6.9, H6), 1.63 (2 H, p, J 6.9, H5), 1.57 (2 H, p, J 6.9, H4), 
1.33 (6 H, t, J 7.0, H10), 0.94 (9 H, t, J 8.0, H1), 0.58 (6 H, q, J, 8.0, H2). 
δ C (101 MHz, 
Chloroform-d) 
202.1 (C, C7), 62.6 (CH2, C9), 62.6 (CH2, C3), 43.9 (CH2, C6), 43.1 (CH2, 
C8), 41.8 (CH2, C8), 32.2 (CH2, C4), 20.0 (CH2, C5), 16.4 (CH3, C10), 6.9 
(CH3, C1), 4.5 (CH2, C2). 
MS TOF ES+ HRMS (ES): m/z(%) = 389.1893 [M + Na] (calcd for C16H35O5NaPSi: 
389.1893), 367.3- 50% [M + H], 389.2- 100% [M + Na]. 
νmax 2955, 2911, 2877 (CH), 1715 (C=O). 
A novel compound prepared according to a PhD thesis procedure, but was not fully characterised.
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Synthesis of Methyl (1S,3R,4R,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-formyl-4-
hydroxycyclohexane-1-carboxylate 217 
 
 
Anhydrous CH2Cl2 was cooled to -78
oC under an Ar atmosphere. DMSO (48 mg, 0.61 mmol) 
was added followed by oxalyl chloride (61 mg, 0.48 mmol). The mixture was stirred for 
30 minutes maintaining the temperature at -78 oC. Diol 298 (100mg, 0.22 mmol) was 
dissolved in 1 mL of anhydrous CH2Cl2 and added into the mixture. After 1 hr and 
20 minutes, triethylamine (111 mg, 1.1 mmol) was added and the reaction stirred for 1 hr 
whilst being allowed to warm to rt. An aqueous solution of saturated NH4Cl (5 mL) was 
added and the reaction extracted with diethyl ether (3 x 15 mL). The organic layers were 
combined and dried with MgSO4, filtered and the solvent removed under reduced pressure. 
Column chromatography (1:1 petroleum: diethyl ether) gave the title compound 217 as a 
white solid (96 mg, 98%). Rf 0.54 (8:2 petroleum ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
9.91 (1 H, s, H8), 3.83 (2 H, dd, J 11.5, 5.1, H5), 3.73 (3 H, s, H1), 3.03 – 
2.97 (1 H, m, H3), 2.36 (2 H, app.dt, J 14.0, 3.6, H4 eq), 2.00 (2 H, ddd, 
J 14.0, 11.5, 5.1, H4 ax), 0.83 (18 H, s, H12), 0.05 (6 H, s, H9), 0.04 (6 
H, s, H10). 
δ C (101 MHz, 
Chloroform-d) 
202.3 (CH, C8), 174.3 (C, C2), 83.2 (C, C6), 73.3 (CH, C5), 52.1 (CH3, 
C1), 36.4 (CH, C3), 33.6 (CH2, C4), 25.8 (CH3, C12), 18.1 (C, C11), -4.7 
(CH3, C9), -4.9 (CH3, C10). 
νmax
 3522 (OH), 2956, 2929, 2857, 2887 (CH), 1725 (2 x C=O). 
A known compound prepared according to a PhD thesis procedure and data agrees with publication values.
91
  
 
 168 
 
Synthesis of Methyl (1S,3R,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-
methylenecyclohexane-1-carboxylate 219 
 
To a suspension of PPh3CH3Br (697 mg, 2.0 mmol) in toluene (20 mL) was added 
nBuLi (1.9 M 
solution in nhexane, 1.02 mL, 1.95 mmol) and stirred for 30 minutes at rt. A solution of 211 
(541 mg, 1.30 mmol) in toluene (3 mL) was then added dropwise via syringe over five 
minutes. The mixture was stirred overnight. The solvent was then removed and the 
remaining crude solid dissolved in cyclohexane (15 mL). Oxalyl chloride (248 mg, 1.95 mmol) 
was then added and the mixture agitated until effervescence had ceased. The mixture was 
then filtered and the filtrate washed with diethyl ether (2 x 15 mL), saturated NaHCO3 
(2 x 15 mL) and then saturated NH4Cl (2 x 15 mL). The remaining organic layers were then 
dried with magnesium sulfate and the solvent evaporated to yield the title compound 219 as 
a white solid (421 mg, 78%). Rf 0.41 (1:1 petroleum ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
5.08 (2 H, app.t, J 1.7, H7), 4.10 (2 H, dd, J 11.5, 4.8, H5), 3.72 (3 H, s, 
H1), 2.83 (1 H, tt, J 5.4, 2.6, H3), 2.35 (2 H, ddd, J 12.8, 4.8, 2.6, H4 eq), 
1.48 (2 H, ddd, J 12.8, 11.5, 5.4, H4 ax), 0.92 (18 H, s, H11), 0.08 (6 H, s, 
H9), 0.07 (6 H, s, H8). 
δ C (101 MHz, 
Chloroform-d) 
175.2 (C, C2), 153.2 (C, C6), 103.2 (CH2, C7), 69.5 (CH, C5), 51.9 (CH3, 
C1), 38.0 (CH2, C4), 37.1 (CH, C3), 26.0 (CH3, C11), 18.6 (C, C10), -4.9 
(CH3, C9), -5.0 (CH3, C8). 
νmax
 2953, 2930, 2857, 2888 (CH), 1728 (C=O Ester). 
A known compound prepared according to a PhD thesis procedure and data agrees with publication values.
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Synthesis of Methyl 4-acetoxy-5-oxocyclohex-3-ene-1-carboxylate 223 
 
To a solution of ketone 80 (150 mg, 0.61 mmol) in MeOH (6.1 mL) was added acetic acid 
(37 mg, 0.61 mmol) and the mixture was heated at reflux for 2 days. The reaction was 
allowed to cool to rt and the solvents removed by co-distillation with toluene. To a solution 
of the crude solid in pyridine (6.1 mL) was added acetic anhydride (276 mg, 2.7 mmol) and 
DMAP (61 mg, 10 mol%). The reaction was left to stir at rt for 3 days, poured onto an ice cold 
solution of saturated NaHCO3 (15 mL) and then extracted with diethyl ether (3 x 15 mL). The 
solvent was then dried over MgSO4, filtered and the solvents removed under reduced 
pressure. The crude product was then purified via column chromatography (1:1 petroleum 
ether: diethyl ether) to give the title compound 223 as a colourless oil (60 mg, 46%). Rf 0.43 
(1:1 petroleum ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
6.52 (1 H, t, J 4.5, H6), 3.70 (3 H, s, H1), 3.15(1 H, dddd, J 12.9, 10.7, 
8.0, 4.9, H3), 2.86 – 2.67 (4 H, m, H4, H5), 2.19 (3 H, s, H10).  
δ C (101 MHz, 
Chloroform-d) 
189.2 (C, C8), 172.9 (C, C2), 168.7 (C, C9), 145.3 (C, C7), 133.6 (CH, C6), 
52.4 (CH3, C1), 39.7 (CH2, C4/C5), 39.6 (CH, C3), 27.2 (CH2, C4/C5), 20.4 
(CH3, C10). 
MS ES+ HRMS (ES): m/z(%) = 235.0589 [M + Na] (calcd for C10H12O5Na: 
235.0582), 235.1- 100% [M + Na]. 
νmax 2955 (CH), 1763 (CO2Me), 1730 (C=O), 1693 (C=O). 
A novel compound prepared according to a modified literature procedure.
157 
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Synthesis of Methyl (1S,3R,5S)-4-oxo-3,5-bis((triethylsilyl)oxy)cyclohexane-1-carboxylate 
232 
 
To a solution of bicyclic ketone 80 (500 mg, 2.05 mmol) in MeOH (20.5 mL) was added acetic 
acid (123 mg, 2.05 mmol) and the mixture set to reflux for 2 days. The reaction was then 
cooled to rt and the solvents removed under reduced pressure with toluene as an 
azeotrope. The remaining crude material was then dissolved in DMF (21 mL). TESCl (1.5 mL, 
9.0 mmol) and imidazole (614 mg, 9.0 mmol) were added and the reaction left to stir for 
2 days at rt. The reaction was then added to brine (30 mL) and extracted with diethyl ether 
(3 x 25 mL), dried over MgSO4, filtered and solvents removed under reduced pressure. 
Column chromatography (8:2 petroleum ether: diethyl ether) gave the title compound 232 
as a colourless oil (670 mg, 78%). Rf 0.43 (1:1 petroleum ether: diethyl ether) visualised in 
vanillin. 
δ H (400 MHz, 
Chloroform-d) 
4.37 (2 H, dd, J 12.1, 6.9, H5), 3.78 (3 H, s, H1), 2.92 (1 H, tt, J 5.4, 2.5, 
H3), 2.57 (2 H, ddd, J 13.4, 6.9, 2.5, H4 eq), 1.83 (2 H, ddd, J 13.4, 12.1, 
5.4, H4 ax), 0.94 (9 H, t, J 8.0, H8), 0.60 (6 H, q, J 8.0, H7). 
δ C (101 MHz, 
Chloroform-d) 
206.2 (C, C6), 174.6 (C, C2), 72.9 (CH, C5), 52.3 (CH3, C1), 38.0 (CH2, C4), 
36.6 (CH, C3), 6.8 (CH3, C8), 4.9 (CH2, C7). 
MS ES+ HRMS (ES): m/z(%) = 417.2501 [M + H] (calcd for C10H18OSi: 417.2493), 
417.3 -75% [M + H], 436.3 -80%, 439.3 -100%. 
νmax 2954, 2876, 2912 (CH), 1733 (CO2Me). 
A novel compound prepared according to a PhD thesis procedure.
91
 
 
 171 
 
Synthesis of (E)-1-Phenyl-7-((triethylsilyl)oxy)hept-1-en-3-one 240 
 
A solution of phosphonate 214 (200 mg, 0.55 mmol) was cooled to 0 oC under an argon 
atmosphere. NaH (60% in mineral oil, 22 mg, 0.55 mmol) was added and the reaction stirred 
for 20 minutes. Benzaldehyde (48 mg, 0.45 mmol) was then added via syringe and the 
reaction left to stir overnight. The crude mixture was washed with a saturated solution of 
NH4Cl (10 mL) and then extracted with diethyl ether (3 x 15 mL). The organic layer was dried 
over MgSO4, filtered and the solvent removed under reduced pressure. Column 
chromatography (9:1 petroleum ether: diethyl ether) gave the title compound 240 as a 
colourless oil (166 mg, 81%). Rf 0.34 (9:1 petroleum ether: diethyl ether) visualised in 
vanillin.  
δ H (400 MHz, 
Chloroform-d) 
7.60 – 7.51 (3 H, m, H8, 2 x Ar-H), 7.42 – 7.36 (3 H, m, 3 x Ar-H), 6.74 (1 
H, d, J 16.2, H9), 3.64 (2 H, t, J 6.4, H3), 2.70 (2 H, t, J 7.2, H6), 1.75 (1 H, 
p, J 7.2, H5/4), 1.59 (1 H, p, J 7.2, H5/4), 0.96 (9 H, t, J 7.9, H1), 0.60 (6 
H, q, J 7.9, H2). 
δ C (101 MHz, 
Chloroform-d) 
200.5 (C, C7), 142.4 (CH, C8), 134.7 (Ar-C, C10), 130.5 (Ar-C), 129.0 (Ar-
C), 128.3 (Ar-C), 126.3 (CH, C9), 62.7 (CH2, C3), 40.8 (CH2, C6), 32.5 
(CH2, C5 or 4), 21.0 (CH2, C5 or 4), 6.9 (CH3, C1), 4.5 (CH2, C2). 
MS TOF ES+ HRMS (ES): m/z(%) = 319.2106 [M + H] (calcd for C19H31O2Si: 319.2093), 
187.1- 100% [M - OSi(CH2CH3)3), 319.2- 50% [M + H]. 
νmax 2952, 26910, 2875 (CH), 1692, 1662, 1611 (C=O, C=C). 
A novel compound prepared according to a PhD thesis procedure.
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Synthesis of Methyl (1S,3R,4S,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-(hex-1-yn-1-yl)-
4-hydroxycyclohexane-1-carboxylate 250 
 
In a flame dried flask a solution of hexyne (19.7 mg, 0.24 mmol) in THF (3.9 mL) was cooled 
to -78 oC. nBuLi (1.67 M solution in nhexane, 0.14 mL, 0.24 mmol) was added via syringe and 
the mixture left to stir at -78 oC for 1 hr. Ketone 211 (100 mg, 0.24 mmol) was dissolved in 
THF (2 mL) and added dropwise to the reaction over 1 minute. The reaction was allowed to 
warm to rt and stirred for 1 hr. The reaction was then quenched with a saturated aqueous 
solution of NH4Cl (5 mL). The mixture was extracted with diethyl ether (3 x 15 mL). The 
combined organic extracts were dried with MgSO4, filtered and the solvent removed under 
reduced pressure. Column chromatography (9:1 petroleum ether: diethyl ether) gave the 
title compound 250 as a colourless oil (99 mg, 83%). Rf 0.35 (9:1 petroleum ether: diethyl 
ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
3.86 (2 H, dd, J 6.5, 3.4, H9) 3.68 (3 H, s, H17), 2.95 (1 H, s, H7), 2.90 (1 H, tt, 
J 8.3, 4.2, H15), 2.16 (1 H, t, J 7.2, H4), 2.01 (2 H, ddd, J 11.8, 8.3, 3.4, H14 
ax), 1.91 (2 H, ddd, J 11.8, 6.5, 4.2 H14 eq), 1.47 (2 H, p, J 7.2, H3), 1.36 (2 H, 
h, J 7.2, H2), 0.93 – 0.85 (21 H, m, H1, H13), 0.10 (6 H, s, H10), 0.09 (6 H, s, 
H11).  
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δ C (101 MHz, 
Chloroform-d) 
176.0 (C, C16), 85.9 (C, C5), 81.1 (C, C6), 73.8 (CH, C9) 71.4 (C, C8), 51.7 
(CH3, C17), 33.4 (CH, C15), 32.4 (CH2, C14), 30.7 (CH2, C3), 26.0 (CH3, C13), 
22.2 (CH2, C2), 18.7 (CH2, C4), 18.3 (C, C12) , 13.7 (CH3, C1), -4.5 (CH3, C10), -
4.7 (CH3, C11). 
MS ES+ HRMS (ES): m/z(%) = 521.3085 [M + Na] (calcd for C26H50O5Si2Na: 
521.3094), 521.3- 100% [M + Na]. 
νmax 3546 (OH), 2955, 2930, 2857, 2895 (CH), 1735 (CO2Me). 
A novel compound.  
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Synthesis of Methyl (1S,3R,4S,5S)-4-(hex-1-yn-1-yl)-4-hydroxy-3,5-
bis((triethylsilyl)oxy)cyclohexane-1-carboxylate 251 
 
To a solution of hexyne (19 mg, 0.23 mmol) in THF (2.4 mL) cooled to -78 oC was added nBuLi 
(2.3 M solution in nhexane, 0.1 mL, 0.23 mmol). The mixture was left to stir for 20 minutes 
then ketone 232 (100 mg, 0.23 mmol) was added and the mixture left to stir for 1 hr with 
gradual warming to rt. The reaction was quenched with an aqueous saturated solution of 
NH4Cl (5 mL) and extracted with diethyl ether (3 x 5 mL) dried over MgSO4, filtered and 
solvents removed under reduced pressure. Column chromatography (9:1 petroleum ether: 
diethyl ether) gave the title compound 251 as a colourless oil (47 mg, 41%). Rf 0.33 (9:1 
petroleum ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
3.86 (2 H, dd, J 7.1, 3.4, H11), 3.69 (3 H, s, H15), 3.04 (1 H, s, H7), 2.91 (1 H, 
tt, J 8.2, 4.3, H13), 2.17 (2 H, t, J 7.1, H4), 2.01 (2 H, ddd, J 13.6, 8.2, 3.4, H12 
eq), 1.90 (2 H, ddd, J 13.6, 7.1, 4.3, H12 ax ), 1.47 (2 H, p, J 7.1, H3), 1.37 
(2 H, h, J 7.1, H2), 0.97 (9 H, t, J 7.9, H10), 0.89 (1 H, t, J 7.1, H1), 0.63 (6 H, 
q, J 7.9, H9).  
δ C (101 MHz, 
Chloroform-d) 
176.0 (C, C14), 85.7 (C, C6), 81.1 (C, C8), 73.5 (CH, C11), 71.5 (C, C5), 51.9 
(CH3, C15), 33.6 (CH, C13), 32.4 (CH2, C12), 30.7 (CH2, C3), 22.2 (CH2, C2), 
18.7 (CH2, C4), 13.7 (CH3, C1), 7.0 (CH3, C10), 5.0 (CH2, C9). 
MS ES+ HRMS (ES): m/z(%) = 521.3085 [M + Na] (calcd for C26H50O5Si2Na: 
521.3094), 481.3- 60% [M - OH], 521.3- 100% [M + Na]. 
νmax 3545 (OH), 2954, 2876, 2912 (CH), 1735 (CO2Me). 
A novel compound. 
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Synthesis of Methyl (1S,3R,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-hydroxy-4-
((trimethylsilyl)ethynyl)cyclohexane-1-carboxylate 252 
 
In a flame dried flask a solution of trimethylsilylacetylene (22.6 mg, 0.23 mmol) in THF 
(1.9 mL) was cooled to -78 oC. nBuLi (1.73 M solution in nhexane, 0.13 mL, 0.23 mmol) was 
added via syringe and the mixture left to stir at -78 oC for 1 hr. Ketone 211 (79 mg, 
0.19 mmol) was dissolved in THF (0.5 mL) and added dropwise to the reaction over 1 minute. 
The reaction was allowed to warm to rt and stirred for 1 hr, before being quenched with a 
saturated aqueous solution of NH4Cl (5 mL). The mixture was extracted with diethyl ether 
(3 x 25 mL). The combined organic extracts were dried with MgSO4, filtered and solvent 
removed under reduced pressure. Column chromatography (19:1 petroleum ether: diethyl 
ether) gave the title compound 252 as a colourless oil (34 mg, 35%). Rf 0.67 (19:1 petroleum 
ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
3.84 (2 H, dd, J 8.6, 3.8, H6), 3.70 (3 H, s, H14), 2.88 (1 H, s, H4), 2.83-2.79 
(1 H, m, H12), 2.03 (2 H, ddd, J 13.4, 6.1, 3.8, H11 eq), 1.87 (2 H, ddd, J 13.4, 
8.6, 4.6, H11 ax), 0.91 (18 H, s, H10), 0.15 (9 H, s, H1), 0.13, (6 H, s, H7), 0.11 
(6 H, s, H8). 
δ C (101 MHz, 
Chloroform-d) 
175.6 (C, C13), 107.4 (C, C3), 88.9 (C, C2), 73.1 (CH, C6), 72.8 (C, C5), 51.9 
(CH3, C14), 34.5 (CH, C12), 31.5 (CH2, C11), 26.1 (CH3, C10), 18.3 (C, C9), 0.1 
(CH3, C1), -4.3 (CH3, C7), -4.6 (CH3, C8). 
MS EI+ HRMS (EI): m/z(%) = 537.2878 [M + Na] (calcd for C25H50O5Si3Na: 537.2864), 
537.2- 100% [M + Na]. 
νmax 3545 (OH), 2954, 2930, 2896 (CH), 1735 (CO2Me). 
A novel compound.  
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Synthesis of Methyl (1S,3R,5S)-3,4,5-tris((tert-butyldimethylsilyl)oxy)-4-(hex-1-yn-1-
yl)cyclohexane-1-carboxylate 253 
 
A solution of 250 (40 mg, 0.08 mmol) in CH2Cl2 (0.7 mL) was cooled to 0 
oC. TBSOTf (85 mg, 
0.32 mmol) was added with 2,6-lutidine (34 mg, 0.32 mmol). The reaction was left to stir at 
rt for 2 hr. The reaction was then poured into an aqueous saturated solution of NH4Cl (5 mL) 
and extracted with diethyl ether (3 x 15 mL). The organic extracts were dried with MgSO4 
and the solvent was removed under reduced pressure. Column chromatography (99:1 
petroleum ether: diethyl ether) gave the title compound 253 as a white crystalline solid 
(42 mg, 86%). M.p. 40-42 oC. Rf 0.82 (9:1 petroleum ether: diethyl ether) visualised in 
vanillin. 
δ H (400 MHz, 
Chloroform-d) 
3.69 (3 H, s, H19), 3.54 (2 H, dd, J 11.4, 4.3, H11), 2.64 (1 H, tt, J 5.5, 2.5, 
H17), 2.15 (2 H, t, J 7.3, H4), 1.92 (2 H, app.dt, J 12.9, 2.5, H16 eq), 1.84 
(2 H, ddd, J 12.9, 11.4, 5.5, H16 ax), 1.48 (2 H, p, J 7.3, H3), 1.38 (2 H, h, J 
7.3, H2), 0.91 (18 H, s, H15), 0.89 (11 H, s, H10 & H1), 0.17 (6 H, s, H8), 
0.10 (6 H, s, H12), 0.09 (6 H, s, H13). 
δ C (101 MHz, 
Chloroform-d) 
175.5 (C, C18), 84.8 (C, C5), 82.5 (C, C6), 76.4 (C, C7), 74.4 (CH, C11), 51.7 
(CH3,C19), 36.6 (CH, C17), 30.6 (CH2, C3), 30.1 (CH2, C16), 26.2 (CH3, C15), 
26.1 (CH3, C10), 22.5 (CH2, C2), 19.0 (CH2, C12), 18.9 (CH3, C13), 18.4 (CH2, 
C4), 13.7 (CH3, C1), -2.3 (CH3, C8), -4.0 (C12), -4.8 (C13). 
MS EI+ HRMS (EI): m/z(%) = 635.3956 [M + Na] (calcd for C32H64O5Si3Na: 
635.3959), 635.4- 100% [M + Na]. 
νmax 2954, 2929, 2856, 2891, 2856 (CH), 1736 (C=O). C≡C not seen. 
A novel compound.  
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Synthesis of 2-Phenyloct-3-yn-2-ol 268 
 
A solution of hexyne (409 mg, 4.99 mmol) in dry THF (49 mL) was cooled to -78 oC. nBuLi 
(2.09 M solution in nhexane, 2.39 mL, 4.99 mmol) was added dropwise over 5 minutes. The 
mixture was stirred for 30 minutes then acetophenone (500 mg, 4.16 mmol) was added. The 
reaction was allowed to warm to rt and stirred for a further 45 minutes. The reaction was 
then quenched using a saturated solution of NH4Cl (25 mL), extracted with diethyl ether 
(3 x 20 mL) dried over MgSO4 and the solvent removed under reduced pressure. The crude 
product was purified via column chromatography (9:1 petroleum ether: diethyl ether) to 
give the title compound 268 as a colourless oil (603 mg, 72%). Rf 0.27 (9:1 petroleum ether: 
diethyl ether) visualised in KMnO4. 
δ H (400 MHz, 
Chloroform-d) 
7.70 – 7.62 (2 H, m, Ar-H), 7.41 – 7.24 (3 H, m, Ar-H), 2.40 – 2.32 (1 H, 
m, H9), 2.29 (2 H, d, J 7.3, H4), 1.75 (3 H, s, H8), 1.55 (2 H, p, J 7.3, H3), 
1.44 (2 H, h, J 7.3, H2), 0.94 (3 H, t, J 7.3, H1). 
δ C (101 MHz, 
Chloroform-d) 
146.4 (Ar-C), 128.3 (Ar-C), 127.6 (Ar-C), 125.1 (Ar-C), 85.8 (C, C5), 83.9 
(C, C6), 70.2 (C, C7), 33.7 (CH3, C8), 30.9 (CH2, C3), 22.1 (CH2, C2), 18.6 
(CH2, C4), 13.7 (CH3, C1). 
MS ES+ (ES): m/z(%) = 185.1- 50% [M + H - H2O], 225.1- 100% [M + Na]. 
A known compound prepared according to a literature procedure and data agrees with literature values.
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Synthesis of Oct-1-en-3-yn-2-ylbenzene 269 
 
To a solution of propargylic alcohol 268 (100 mg, 0.49 mmol) in toluene (4.9 mL) was added 
MeOH (15.7 mg, 0.49 mmol) and AuPPh3NTf2 (3.6 mg, 1 mol%). The reaction was stirred at rt 
for 3 hr and then the solvent was removed under reduced pressure. The remaining residue 
was then directly purified via column chromatography (9:1 petroleum ether: diethyl ether) 
to give the title compound 269 as an oil (11 mg, 12%). Rf 0.74 (9:1 petroleum ether: diethyl 
ether) visualised in KMnO4. 
δ H (400 MHz, 
Chloroform-d) 
7.70 – 7.62 (2 H, m, Ar-H), 7.40 – 7.27 (3 H, m, Ar-H), 5.84 (1 H, bs, H8), 
5.58 (1 H, bs, H8), 2.42 (2 H, t, J 7.1, H4), 1.60 (2 H, p, J 7.1, H3), 1.49 
(2 H, h, J 7.1, H2), 0.96 (3 H, t, J 7.1, H1). 
δ C (101 MHz, 
Chloroform-d) 
138.0 (C, C7), 131.2 (Ar-C), 128.4 (Ar-C), 128.2 (Ar-C), 126.2 (Ar-C), 
119.5 (CH2, C8) 92.2 (C, C6), 79.9 (C, C5), 31.0 (CH2, C3), 22.2 (CH2, C2), 
19.3 (CH2, C4), 13.8 (CH3, C1). 
MS ES+ (ES): m/z(%) = 185.1- 100% [M + H]. 
A known compound prepared according to a modified literature procedure
110
 and data agrees with literature 
values.
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Synthesis of 2,2,3-Trimethylnon-4-yn-3-ol  270 
 
A solution of hexyne (493 mg, 6 mmol) in THF (49 mL) was cooled to -78 oC. nBuLi (2.5 M 
solution in nhexane, 2.8 mL, 6 mmol) was added dropwise over 5 minutes. The mixture was 
then left to stir for 20 minutes. 2,2-dimethyl1-3-butanone (500 mg, 6 mmol) was added and 
the reaction mixture stirred for 2 hr with gradual warming to rt. The reaction was then 
quenched using a saturated solution of NH4Cl (25 mL), extracted with diethyl ether 
(3 x 20 mL) dried over MgSO4 and the solvent removed under reduced pressure. The crude 
product was purified by column chromatography (9:1 petroleum ether: diethyl ether) which 
gave the title compound 270 as a colourless oil (549 mg, 60%). Rf 0.56 (9:1 petroleum ether: 
diethyl ether) visualised in KMnO4. 
δ H (400 MHz, 
Chloroform-d) 
2.20 (2 H, t, J 6.9, H4), 1.65 (1 H, s, H9), 1.53 – 1.37 (7 H, m, H3, H2, 
H8), 1.03 (9 H, s, H11), 0.91 (3 H, t, J 7.2, H1). 
δ C (101 MHz, 
Chloroform-d) 
84.3 (C, C6), 83.9 (C, C5), 74.1 (C, C7), 38.4 (C, C10), 31.0 (CH2, C3), 25.5 
(CH3, C8), 25.3 (CH3, C11), 22.1 (CH2, C2), 18.5 (CH2, C4), 13.7 (CH3, C1). 
MS ES+ (ES): m/z(%) = 165.2- 100% [M + H - H2O], 197.2- 70% [M + H - H2O + 
MeOH]. 
A known compound prepared according to a literature procedure and data agrees with literature values.
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Synthesis of (E)-2,2,3-Trimethylnon-3-en-5-one 271 
 
To a solution of propargylic alcohol 270 (100 mg, 0.54 mmol) in toluene (0.54 mL) was added 
MeOH (17 mg, 0.54 mmol) and AuPPh3NTf2 (3.9 mg, 1 mol%). The mixture was stirred for 
4 hr at rt then purified directly by column chromatography (99:1 petroleum ether: diethyl 
ether) to give the title compound 271 as a colourless oil (35 mg, 68% BRSM). Rf 0.56 (9:1 
petroleum ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
6.10 (1 H, d, J 1.1, H6), 2.43 (2 H, t, J 7.4, H4), 2.10 (3 H, d, J 1.1, H7), 
1.55 (2 H, p, J 7.4, H3), 1.30 (2 H, h, J 7.4, H2), 1.09 (9 H, s, H10), 0.89 (3 
H, t, J 7.4, H1). 
δ C (101 MHz, 
Chloroform-d) 
202.6 (C, C5), 165.3 (C, C8), 120.3 (CH, C6), 44.6 (CH2, C4), 37.9 (C, C9), 
28.7 (CH3, C10), 26.6 (CH2, C3), 22.6 (CH2, C2), 15.8 (CH3, C7), 14.1 (CH3, 
C1). 
MS ES+ (ES): m/z(%) = 183.1- 100% [M + H], 205.1- 10% [M + Na]. 
A known compound prepared according to a literature procedure and data agrees with literature values.
110
 
  
 181 
 
Synthesis of Methyl (4S,6R)-2-butyl-4-methoxy-4,5,6,7-tetrahydrobenzofuran-6-
carboxylate 272 
 
To a solution of propargylic alcohol 250 (100mg, 0.2 mmol) in toluene was added MeOH 
(6.4 mg, 0.2 mmol) and AuPPh3NTf2 (7.4 mg, 5 mol%).  The reaction was stirred overnight, 
followed by the addition of H2O (3.6 mg, 0.2 mmol). The mixture was again allowed to stir 
overnight. The crude reaction mixture was then extracted with CH2Cl2 (3 x 5 mL), dried over 
MgSO4, filtered and the solvent removed under reduced pressure. The crude mixture was 
purified via column chromatography (1:1 petroleum ether: diethylether) to give the title 
compound 272 (14 mg, 26%) as a colourless oil. Rf 0.19 (9:1 petroleum ether: diethyl ether). 
δ H (400 MHz, 
Chloroform-d) 
5.95 (1 H, s, H6), 4.22 (1 H, app.t, J 3.4, H8), 3.73 (3 H, s, H15), 3.40 (3 H, s, 
H9), 3.10 (1 H, dddd, J 12.6, 11.3, 5.6, 2.7, H13), 2.90 (1 H, dd, J 16.5, 5.6, 
H11 eq), 2.72 (1 H, dd, J 16.5, 11.3, H11 ax), 2.56 (2 H, t, J 7.6, H4), 2.39 
(1 H, app.dt, J 13.9, 2.7, H12 eq), 1.76 (1 H, ddd, J 13.9, 12.6, 3.4, H12 ax), 
1.59 (2 H, p, J 7.6, H3), 1.36 (2 H, h, J 7.6, H2), 0.92 (3 H, t, J 7.6, H1). 
δ C (101 MHz, 
Chloroform-d) 
175.5 (C, C14), 155.8 (C, C5), 149.4 (C, C10), 117.6 (C, C7), 105.1 (CH, C6), 
71.1(CH, C8), 56.6 (CH3, C9), 52.1 (CH3, C15), 36.1 (CH, C13), 31.4 (CH2 C12), 
30.3 (CH2, C3), 27.9 (CH2, C4), 26.0 (CH2, C4), 22.4 (CH2, C2), 14.0 (CH3, C1). 
MS ES+ HRMS (ES): m/z(%) = 235.1342 [M] (calcd for C14H19O3: 235.1334),  
235.1- 100% [M - OMe]. 
νmax 2955, 2929, 2861, 2819 (CH), 1735 (C=O), 1637 (C=C). 
A novel compound prepared according to a modified literature procedure.
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Synthesis of Methyl (1S,3R,4S,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-hydroxy-4-(2-
oxohexyl)cyclohexane-1-carboxylate 273 
 
To a solution of propargylic alcohol 250 (67mg, 0.13 mmol) in toluene (0.13 mL) was added 
AuPPh3NTf2 (2 mg, 0.23 mmol) and MeOH (4.2 mg, 0.23 mmol). The mixture was stirred 
overnight at rt. The solvent was evaporated under reduced pressure and the remaining 
residue purified directly using column chromatography (9:1 petroleum ether: diethyl ether) 
to give the title compound 273 as a colourless oil (10 mg, 12% BRSM). Rf 0.29 (9:1 petroleum 
ether: diethyl ether) visualised in vanillin.   
δ H (400 MHz, 
Chloroform-d) 
3.98 (2 H, dd, J 9.8, 4.7, H9), 3.73 (3 H, s, H17), 2.77 (1 H, tt, J 9.8, 4.7, 
H15), 2.73 (2 H, s, H6), 2.40 (2 H, t, J 7.5, H4), 2.00 (2 H, dt, J 13.2, 4.7, 
H14 eq), 1.90 (2 H, ddd, J 13.2, 9.8, 4.7, H14 ax), 1.57 (1 H, bs, H7), 1.49 
(2 H, p, J 7.3, H3), 1.29 (2 H, h, J 7.3, H2), 0.93 – 0.85 (21 H, m, H1, 
H13), 0.08 (6 H, s, H10), 0.01 (6 H, s, H11). 
δ C (101 MHz, 
Chloroform-d) 
209.8 (C, C5), 175.2 (C, C16), 75.3 (C, C8) , 70.8 (CH, C9), 52.0 (CH3, 
C17), 46.0 (CH2, C6), 44.0 (CH2, C4), 35.5 (CH, C15), 30.9 (CH2, C14), 
26.1 (CH3, C13), 25.7 (CH2, C3), 22.4 (C, C12), 18.2 (CH2, C2), 14.0 (CH3, 
C1), -4.2 (C10), -4.7 (C11). 
MS ES+ HRMS (ES): m/z(%) = 517.3373 [M + H] (calcd for C26H53O6Si2: 
517.3381), 367.2- 100% [M - OH - OTBS - H], 517.3- 80% [M + H]. 
νmax 3554 (OH), 2954, 2930, 2857, 2895 (CH), 1735 (CO2Me), 1713 (C=O). 
A novel compound prepared according to a modified literature procedure.
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Synthesis of Methyl (7R,9s,11S)-4-butyl-7,11-bis((tert-butyldimethylsilyl)oxy)-2-phenyl-
1,3-dioxa-2-boraspiro[5.5]undec-4-ene-9-carboxylate 274 
 
To a solution of 250 (349 mg, 0.7 mmol) in toluene (0.7 mL) was added phenylboronic acid 
(85 mg, 0.7 mmol) and PPh3AuNTf2 (5 mol%). The reaction was left to stir overnight at rt. The 
crude mixture had the solvent removed under reduced pressure and the remaining residue 
purified directly by column chromatography (9:1 petroleum ether: diethyl ether) to give the 
title compound 274 as a white solid (268 mg, 64%). M.p. 33-35 oC. Rf: 0.69 (9:1 petroleum 
ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Benzene-d6) 
8.32 – 8.24 (2 H, m, Ar-H), 7.41 – 7.33 (3 H, m, Ar-H), 4.44 (1 H, s, H6), 
3.77 (2 H, dd, J 9.9, 6.1, H8), 3.46 (3 H, s, H16), 2.73 – 2.51 (1 H, m, 
H14), 2.36 (2 H, t, J 7.3, H4), 2.33 – 2.21 (4 H, m, H13 ax & eq), 1.79 
(2 H, p, J 7.3, H3), 1.49 (2 H, h, J 7.3, H2), 1.05 (3 H, t, J 7.3, H1), 1.01 
(18 H, s, H12), 0.23 (6 H, s, H9), 0.21 (6 H, s, H10). 
δ C (101 MHz, 
Benzene-d6) 
174.8 (C, C15), 153.1 (C, C5), 134.7 (Ar-C), 131.2 (Ar-C), 128.2 (Ar-C), 
127.9 (Ar-C), 103.1 (CH, C6), 80.2 (C, C7), 72.5 (CH, C8), 51.3 (CH3, C16), 
36.9 (CH, C14), 34.4 (CH2, C4), 30.3 (CH2, C13), 28.8 (CH2, C3), 25.9 
(CH3, C12), 23.1 (CH2, C2), 18.2 (C, C11), 14.2 (CH3, C1), -4.0 (CH3, C9) , -
4.51 (CH3, C10). 
11B NMR δ (128 
MHz, C6D6) 
10.8 (B).  
MS ES+ HRMS (ES): m/z(%) = 603.3713 [M + H] (calcd for C32H56O6Si2
11B: 
603.3708), 603.4- 100% [M11B + H], 602.4-20% [M10B + H]. 
νmax 2929, 2954, 2857, 2895 (CH), 1734 (C=O Ester), 1696 (C=C enol 
boronate stretch). 
A novel compound prepared according to a modified literature procedure.
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Synthesis of Methyl (1S,3R,4R,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-(hex-1-yn-1-yl)-
4-hydroxycyclohexane-1-carboxylate 275 
 
A solution of hexyne (238 mg, 2.9 mmol) was dissolved in dry toluene (24 mL) and cooled to 
-78 oC. nBuLi (2.29 M solution in nhexane, 1.26 mL, 2.9 mmol) was added dropwise and the 
reaction left to stir for 20 min. 211 (1 g, 2.39 mmol) was then added and the reaction left to 
stir for 2 hr with gradual warming to rt. The solution was quenched with a saturated solution 
of NH4Cl (15 mL) and extracted with diethyl ether (3 x 15 mL). The organics were separated, 
dried over MgSO4, filtered, and the solvents were removed under reduced pressure. The 
crude product was purified via column chromatography (9:1 petroleum ether: diethyl ether) 
to yield the title compound 275 as a colourless oil (54 mg, 5%) and (464 mg, 39% of 256).  Rf 
0.56 (19:1 petroleum ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
3.70 (3 H, s, H1), 3.53 (2 H, dd, J 11.5, 4.3, H5), 2.69 (1 H, tt, J 5.4, 2.5, H3), 
2.65 (1 H, s, H7), 2.27 – 2.19 (2 H, m, H10), 2.13 (2 H, ddd, J 13.4, 4.3, 2.5, 
H4 eq), 1.81 (2 H, ddd, J 13.4, 11.5, 5.4, H4 ax), 1.51 – 1.41 (4 H, m, H11, 
H12), 0.90 (21 H, s, H17, H13), 0.09 (6 H, s, H14), 0.09 (6 H, s, H15). 
δ C (101 MHz, 
Chloroform-d) 
175.0 (C, C2), 87.2 (C, C8), 78.4 (C, C9), 77.6 (C, C6), 73.4 (CH, C5), 51.9 (CH3, 
C1), 36.5 (CH, C3), 33.2 (CH2, C4), 31.0 (CH2, C11 or 12), 25.9 (CH3, C17), 
21.9 (CH2, C11 or 12), 18.6 (CH2, C10), 18.2 (C, C16), 13.7 (CH3, C13), -4.4 
(CH3, C14), -4.5 (CH3, C15). 
MS ES+ HRMS (ES): m/z(%) = 521.3103 [M + Na] (calcd for C26H50O5Si2Na: 
521.3094), 349.2- 100% [M - OTBS - OH + H], 481.3- 30% [M - OH], 521.3- 
20% [M + Na]. 
νmax 3595 (CH), 2954, 2930, 2856 (CH), 1736 (CO2Me). 
A novel compound.   
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Synthesis of Methyl (4R,6R)-2-butyl-4-hydroxy-4,5,6,7-tetrahydrobenzofuran-6-
carboxylate 278 
 
To a solution of propargylic alcohol 251 (160 mg, 0.32 mmol) in toluene (0.3 mL) was added 
phenyl boronic acid (39 mg, 0.32 mmol) and PPh3AuNTf2 (10 mol%). The mixture was left to 
stir overnight at rt. The solvent was removed under reduced pressure and the remaining 
residue purified directly by column chromatography (3:7 diethyl ether: petroleum ether) to 
give the title compound 278 as a colourless oil (14 mg, 17%). Rf 0.63 (3:7 diethyl ether: 
petroleum ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
5.96 (1 H, s, H6), 4.51 (1 H, app.t, J 3.0, H9), 3.13 (1 H, dddd, J 12.4, 11.2, 
5.6, 3.1, H13), 3.76 (3H, s, H15), 2.88 (1 H, dd, J 16.4, 5.6, H11 eq), 2.73 (1 
H, dd, J 16.4, 11.2, H11 ax), 2.54 (2 H, t, J 7.6, H4), 2.40 (1 H, app.dt, J 13.9, 
3.1, H12 eq), 1.82 (1 H, ddd, J 13.9, 12.4, 3.0, H12 ax), 1.63 – 1.52 (3 H, m, 
H3, H10), 1.36 (2 H, s, J 7.4, H2), 0.91 (3 H, t, J 7.4, H1). 
δ C (101 MHz, 
Chloroform-d) 
175.5 (C, C14), 155.9 (C, C5), 149.4 (C, C8), 118.0 (C, C7), 104.5 (CH, C6), 
67.6 (CH, C9), 52.1 (CH3, C15), 36.0 (CH, C13), 32.4 (CH2, C12), 30.3 (CH2, 
C3), 27.9 (CH2, C4), 25.8 (CH2, C11), 22.4 (CH2, C2), 13.9 (CH3, C1). 
MS TOF ES+ HRMS (ES): m/z(%) = 235.1317 [M + OH] (calcd for C14H29O3: 235.1334), 
102.1- 100%, 203.0- 70%, 204.0- 80%. 
νmax 3454 (OH), 2953, 2928, 2859 (CH), 1728 (C=O). 
A novel compound prepared according to a modified literature procedure.
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Synthesis of (2,3,4,5-Tetrafluorophenyl)boronic acid  281 
 
A solution of diisopropylamine (1.2g, 8.3 mmol) in THF (12.5 mL) was cooled to -78 oC. nBuLi 
(2.4 M solution in nhexane, 3.6 mL, 8.3 mmol) was added and the mixture was stirred for 
5 minutes. The resulting solution of LDA was added dropwise over 5 minutes to a solution of 
tetrafluorobenzene (1g, 6.6 mmol) in THF 37.5 (mL) at -78 oC, and stirred for 1 hr. Whilst 
maintaining the mixture at -78 oC, the solution was then transferred via cannula (cooled to -
78 oC by swabbing the cannula with cotton wool dipped in dry ice and acetone) to a solution 
of B(OMe)3 (1g, 10 mmol) in THF (12.5 mL) at -78 
oC. The reaction was left to stir overnight 
with gradual warming to rt. The crude mixture was then added to a saturated aqueous 
solution of NH4Cl (30 mL) and the mixture extracted with diethyl ether (3 x 30 mL), dried 
over MgSO4, filtered and the solvent removed under reduced pressure. The crude material 
was then recrystallised from boiling water and 1 drop of conc. HCl to give the title compound 
281 as a white crystalline product (325 mg, 25%). 
δ H (300 MHz, DMSO-d6 
with 1 drop of D2O) 
6.29 (1 H, dddd, J 10.4, 8.9, 4.6, 2.7, H1).  
δ F (282 MHz, 
Methylene Chloride-d2) 
-135.85 – -136.27 (m), -139.22 – -139.80 (m), -151.36 – -151.90 
(m), -156.86 – -157.36 (m). 
MS ES- (ES): m/z(%) = 193.1 -100% [M]. 
A known compound prepared according to a literature procedure and data agrees with literature values 
including the inability to obtain a 
13
C NMR. 
118, 161
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Synthesis of 1,1-Diphenylhept-2-yn-1-ol 282 
 
To a solution of hexyne (419 mg, 5.1 mmol) in THF (1.14 mL) at -78 oC was added nBuLi 
(2.29 M solution in nhexane, 2.2 mL, 5.1 mmol). The mixture was allowed to stir for 
20 minutes followed by the addition of benzophenone (250 mg, 1.37 mmol). The reaction 
was stirred for 3 hr with gradual warming to rt. The mixture was then quenched by the 
addition of a saturated aqueous solution of NH4Cl (5 mL) extracted with ethyl acetate 
(3 x 10 mL), dried with MgSO4, filtered and then solvents removed under reduced pressure. 
Column chromatography (9:1 petroleum ether: diethyl ether) gave the title compound 282 
as a colourless oil (246 mg, 67%). Rf 0.37 (9:1 petroleum ether: diethyl ether) visualised in 
KMnO4.  
δ H (300 MHz, 
Chloroform-d) 
7.60 – 7.50 (4 H, m, Ar-H), 7.32 – 7.13 (6 H, m, Ar-H), 2.65 (1 H, s, H7), 
2.28 (2 H, t, J 7.0, H4), 1.52 (2 H, p, J 7.0, H3), 1.39 (2 H, h, J 7.0, H2), 
0.87 (3H, t J 7.0, H1). 
δ C (101 MHz, 
Chloroform-d) 
145.6 (C) 128.2 (C) 127.5 (C) 126.0 (C) 88.4 (C) 83.1 (C) 74.6 (C) 30.8 (C) 
22.1 (C) 18.6 (C) 13.6 (C). 
MS TOF AP+ (AP): m/z(%) = 264.2- 100% [M], 265.2- 90% [M - H]. 
A known compound prepared according to a literature procedure and data agrees with literature values.
158
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Synthesis of 1,1-Diphenylhept-1-en-3-one 283 
 
To a solution of propargylic alcohol 282 (50 mg, 0.19 mmol) in toluene (0.5 mL) was added 
2,3,4,5-tetrafluorophenylboronic acid (7 mg, 0.038 mmol). The reaction was left overnight at 
25 oC. The solvent was removed by reduced pressure and the residue directly purified by 
column chromatography (9:1 petroleum ether: diethyl ether) to give the title compound 283 
as a colourless oil (25 mg, 50%). Rf 0.49 (9:1 petroleum ether: diethyl ether) visualised in 
vanillin.  
δ H (300 MHz, 
Chloroform-d) 
7.87 – 7.15 (10 H, m, Ar-H), 6.59 (1 H, s, H6), 2.24 (2 H, t, J 7.3, H4), 
1.48 (2 H, p, J 7.3, H3), 1.19 (2H, h, J 7.3, H2), 0.81 (3H, t, J 7.3, H1). 
δ C (101 MHz, 
Chloroform-d) 
202.7, 153.2, 141.1, 139.2, 132.5, 130.2, 129.4, 128.6, 128.5, 128.4, 
126.8, 43.0, 26.6, 22.4, 13.9. 
MS AP+ (AP): m/z(%) = 265.2- 100% [M + H]. 
νmax 3058, 2957, 2930, 2872 (CH), 1658 (C=C-C=O). 
A known compound prepared according to a modified literature procedure
110
 data in agreement with literature 
values.
116
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Synthesis of Methyl (1R,3R,4R,5S)-4-(hex-1-yn-1-yl)-3,4-dihydroxy-5-
((triethylsilyl)oxy)cyclohexane-1-carboxylate 284 
 
To a solution of propargyl alcohol 251 (67 mg, 0.13 mmol) in toluene (0.3 mL) was added 
2,3,4,5-tetrafluoroboronic acid (25 mg, 0.13 mmol). The mixture was stirred overnight at 
25 oC. The solvent was then removed under reduced pressure and the residue purified 
directly by column chromatography (8:2 petroleum ether: diethyl ether) to give the title 
compound 284 as an oil (15 mg, 30%). Rf 0.56 (8:2 petroleum ether: diethyl ether) visualised 
in KMnO4. 
δ H (400 MHz, 
Chloroform-d) 
4.06 (1 H, dt, J 4.1, 1.9, H10), 3.87 (1 H, dt, J 8.0, 3.2, H11), 3.70 (3 H, s, 
H18), 3.46 (1 H, d, J 10.4, H7), 3.23 (1 H, s, H9), 2.96 – 2.83 (1 H, m, 
H16), 2.24 – 2.10 (5 H, m, H4, H14 eq, H15 ax/eq), 1.98 (1 H, dt, J 14.4, 
4.1, H14 ax), 1.48 (2 H, p, J 7.1, H3), 1.38 (2 H, h, J 7.1, H2), 0.98 (9 H, t, 
J 7.5, H13), 0.89 (3 H, t, J 7.1, H1), 0.66 (6 H, q, J 7.5, H12).  
δ C (101 MHz, 
Chloroform-d) 
175.7 (C, C17), 88.1 (C, C5) , 79.2 (C, C6), 75.6 (CH, C10), 74.6 (CH, C11), 
70.0 (C, C8), 52.0 (CH3, C18), 33.1 (CH2, C14), 32.5 (CH2, C15), 31.9 (CH, 
C16), 30.6 (CH2, C3), 22.2 (CH2, C2), 18.6 (CH2, C4), 13.7 (CH3, C1), 6.9 
(CH3, C13), 4.81 (CH2, C12). 
MS TOF ES+ HRMS (ES): m/z(%) = 407.2219 [M + Na] (calcd for C20H36O5SiNa: 
407.2230), 407.2- 60% [M + Na], 791.5- 100% [M + M]. 
νmax 3484 (OH), 2956, 2877 (CH), 1736 (C=O). 
A novel compound prepared according to a modified literature procedure.
118 
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Synthesis of (3-((Trichloromethyl)sulfinyl)hepta-alene-1,1-diyl)dibenzene 295 
 
To a solution of propargyl alcohol 283 (100 mg, 0.38 mmol) in CH2Cl2 (3.8 mL) cooled to          
-78 oC was added SClCCl3 (41 μL, 0.38 mmol) and Et3N (52 μL, 0.38 mmol). The mixture was 
stirred overnight with gradual warming to rt. The mixture was then added to brine (10 mL) 
and extracted with diethyl ether (3 x 10 mL), dried over MgSO4, filtered and the solvents 
removed under reduced pressure. Column chromatography (9:1 petroleum ether: diethyl 
ether) gave the title compound 295 as a yellow oil (122 mg, 78%). Rf 0.36 (9:1 petroleum 
ether: diethyl ether) visualised in KMnO4. 
δ H (400 MHz, 
Chloroform-d) 
7.43 – 7.32 (10 H, m, Ar-H), 2.68 (1 H, ddd, J 15.7, 9.3, 6.4, H4), 2.56 
(1 H, ddd, J 15.7, 9.2, 5.9, H4), 1.72 – 1.49 (2 H, m, H3), 1.38 (2 H, h, J 
7.4, H2), 0.87 (3 H, t, J 7.4, H1). 
δ C (101 MHz, 
Chloroform-d) 
207.1 (C, C6), 134.2 (Ar-C), 128.9 (Ar-C), 128.8 (Ar-C), 128.7 (Ar-C), 
119.9 (C, C7), 114.0 (C, C5), 108.8 (C, C8), 30.4 (CH2, C4), 25.1 (CH2, C3), 
22.3 (CH2, C2), 13.8 (CH3, C1). 
MS TOF ES+ HRMS (ES): m/z(%) = 247.1489 [M- Cl3CSO] (calcd for C19H19: 247.1487), 
247.2- 100% [M - Cl3CSO]. 
νmax 3059, 2958, 2930, 2871 (CH). 
A novel compound prepared according to a modified literature procedure.
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Synthesis of Methyl (1S,3R,4R,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-hydroxy-4-
(hydroxymethyl)cyclohexane-1-carboxylate 298 
 
To a solution of alkene 219 (269 mg, 0.65 mmol) in acetone (2.6 mL), water (2.6 mL) and 
tbutanol (1.3 mL) was added NMO (83 mg, 0.71 mmol) followed by OsO4 (2 drops of a 4% 
w/v in water). The mixture was then heated to 45 oC for 2 hr. The reaction was then 
quenched with a saturated aqueous sodium bisulfite solution (10 mL) and extracted with 
ethyl acetate (3 x 15 mL). The organic layers were combined washed with 1 M HCl (10 mL) 
and brine (10 mL) then dried over MgSO4, filtered and the solvent removed under reduced 
pressure column chromatography (1:1 petroleum ether: diethyl ether) to afford the title 
compound 298 as a white solid (163 mg, 56%). Rf 0.43 (1:1 petroleum ether: diethyl ether) 
visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
3.91 (2 H, d, J 6.2, H8), 3.72 (2H, dd, J 11.7, 4.5, H5), 3.71 (3H, s, H1) 
3.16 (1 H, t, J 6.2, H13), 3.05 (1 H, s, H7), 2.76 (1 H, tt, J 5.4, 3.0, H3), 
2.21 (2 H, app.dt, J 13.6, 3.0, H4 eq), 1.61 (2 H, ddd, J 13.6, 11.7, 5.4, 
H4 ax), 0.89 (18 H, s, H12), 0.12 (6 H, s, H9), 0.10 (6 H, s, H10). 
δ C (101 MHz, 
Chloroform-d) 
174.6 (C, C2), 75.3 (C, C6), 74.3 (CH, C5), 61.6 (CH2, C8), 52.0 (CH3, C1), 
36.3 (CH, C3), 32.8 (CH2, C4), 25.9 (CH3, C12), 18.1 (C, C11), -4.7 (CH3, 
C9), -4.8 (CH3, C10). 
νmax
 3487 (OH), 2954, 2929, 2857, 2890 (CH), 1723 (C=O Ester). 
A known compound prepared according to a PhD thesis procedure and data agrees with publication values.
91
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Synthesis of Methyl (1S,3R,4R,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-ethynyl-4-
hydroxycyclohexane-1-carboxylate 299 
 
To a solution of Ohira-Bestmann reagent (23 mg, 0.12 mmol) in MeOH (1.1 mL) was added 
aldehyde 217 (50 mg, 0.11 mmol). K2CO3 (30 mg, 0.22 mmol) was then added and the 
reaction stirred at rt for 1 hr. The reaction was then added to brine (10 mL) and extracted 
with diethyl ether (3 x 15 mL). The combined organic extracts were dried with MgSO4, 
filtered and the solvent removed under reduced pressure. The crude residue was purified by 
column chromatography (9:1 petroleum ether: diethyl ether) to yield the title compound 
299 as a white crystalline solid (30mg, 62%). M.p. 63-65 oC. Rf 0.26 (9:1 petroleum ether: 
diethyl ether).  
δ H (400 MHz, 
Chloroform-d) 
3.71 (3 H, s, H1), 3.58 (2 H, dd, J 11.8, 4.4, H5), 2.78 (1 H, s, H7), 2.73 (1 
H, tt, J 5.5, 2.5, H3), 2.39 (1 H, s, H9), 2.18 (2 H, ddd, J 13.5, 4.4, 2.5, H4 
eq), 1.85 (2 H, ddd, J 13.5, 11.8, 5.5, H4 ax), 0.91 (18 H, s, H13), 0.11 (6 
H, s, H11), 0.10 (6 H, s, H10). 
δ C (101 MHz, 
Chloroform-d) 
174.9 (C, C2), 81.5 (C, C8), 78.4 (C, C6), 74.8 (CH, C9), 73.1 (CH, C5), 
52.0 (CH3, C1), 36.5 (CH, C3), 33.0 (CH2, C4), 25.9 (CH3, C13), 18.3 (C, 
C12), -4.4 (CH3, C11), -4.5 (CH3, C10). 
MS ES+ HRMS (ES): m/z(%) = 465.2460 [M + Na] (calcd for C22H42O5NaSi2: 
465.2468), 465.2- 100% [M + Na]. 
νmax
 3307 (C≡C-H), 2951, 2929, 2856, 2888 (CH), 1736 (CO2Me). 
A novel compound prepared according to a modified literature procedure.
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Synthesis of Methyl (1S,3R,4R,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-hydroxy-4-(1-
hydroxyhept-2-yn-1-yl)cyclohexane-1-carboxylate 300 
 
To a solution of hexyne (18 mg, 0.22 mmol) in toluene (11 mL) cooled to –78 OC, nBuLi 
(2.29 M solution in nhexane, 96 μL, 0.22 mmol) was added and the mixture left to stir for 
20 minutes. Aldehyde 217 (50 mg, 0.11 mmol) was added and the mixture stirred for 2 hr 
with gradual warming to rt.  The reaction was then quenched with saturated aqueous NH4Cl 
(15 mL) and extracted with diethyl ether (3 x 5 mL), dried over MgSO4, filtered and solvent 
removed under reduced pressure to give the title compound 300 as an oil (10 mg, 40%). 
Rf 0.33 (1:1 petroleum ether: diethyl ether) visualised in vanillin.   
δ H (400 MHz, 
Chloroform-d) 
4.85 (1 H, app.t, J 2.0, H8), 3.96 (2 H, dt, J 12.3, 3.3, H5), 3.68 (3 H, s, 
H1), 3.04 (1 H, tt, J 9.9, 5.5, H3), 2.24 (2 H, td, J 7.3, 2.0, H12), 2.03 – 
1.91 (4 H, m, H4 ax/eq), 1.51 (2 H, p, J 7.3, H13), 1.40 (2 H, h, J 7.3, 
H14), 0.92 (3 H, t, J 7.3, H15), 0.91 (18 H, s, H9) 0.89 (18 H, s, H9), 0.10 
(3 H, s, H16), 0.09 (3 H, s, H16), 0.08 (3 H, s, H16), 0.08 (3 H, s, H16). 
H7, H9 not visible. 1:1 mixture of diastereoisomers 
δ C (101 MHz, 
Chloroform-d) 
191.7 (C, C2), 88.7 (C), 78.7 (C), 74.8 (C), 69.6 (C5), 64.8 (CH, C8), 51.8 
(CH3, C1), 32.9 (CH2, C4), 32.1 (CH2, C13), 30.8 (C, C17), 26.1 (C, C2), 
22.2 (CH2, C12), 18.7 (C), 18.2 (CH3, C15), 13.7 (C), -4.7 (C), -4.8 (C). 
MS ES+ HRMS (ES): m/z(%) = 529.3386 [M + H] (calcd for C27H53O6Si2: 
529.3381), 551.3- 100% [M + Na], 511.3- 60% [M + H - H2O], 529.3- 
40% [M + H]. 
A novel compound. 
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Synthesis of Methyl (1S,3R,4R,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-hydroxy-4-
vinylcyclohexane-1-carboxylate 301 
 
To a suspension of CH3PPh3Br (57 mg, 0.17) in toluene (1.1 mL) was added 
nBuLi (2.29 M 
solution in nhexane, 4 μL, 0.17 mmol). The mixture was then stirred at rt for 20 minutes. 
Aldehyde 217 (50 mg, 0.11 mmol) was added and the reaction left to stir for 1 hr at rt. The 
solvents were then removed under reduced pressure and the remaining material re-
suspended in cyclohexane (5 mL). Oxalyl chloride (14 μL, 0.17 mmol) was added and the 
reaction swirled until effervescence had stopped. The mixture was then washed with 
NaHCO2 (2 x 15 mL) and NH4Cl (2 x 15 mL), extracted with diethyl ether (3 x 15 mL), dried 
over MgSO4, filtered and the solvents removed under reduced pressure to give the title 
compound 301 as a colourless oil (7 mg, 14%). Rf 0.46 (9:1 petroleum ether: diethyl ether) 
visualised in vanillin.  
δ H (400 MHz, 
Chloroform-d) 
6.15 (1 H, dd, J 17.4, 11.1, H8), 5.44 (1 H, dd, J 17.4, 2.0, H9 cis), 5.31 (1 
H, dd, J 11.1, 2.0, H9 trans), 3.71 (3 H, s, H1), 3.63 (2 H, dd, J 10.7, 4.2, 
H5), 2.85 – 2.76 (1 H, m, H3), 2.21 – 2.11 (2 H, m, H4 eq), 1.68 (2 H, 
ddd, J 13.7, 10.7, 5.2, H4 ax), 0.87 (18 H, s, H13), 0.08 (12 H, s, 
H10/H11). 
δ C (101 MHz, 
Chloroform-d) 
175.2 (C), 136.3 (C), 117.3 (C), 73.9 (C), 51.9 (C), 35.9 (C), 32.9 (C), 29.9 
(C), 25.9 (C), 18.3 (C), -4.5 (C), -4.6 (C).  
MS ES+ HRMS (ES): m/z(%) = 467.2629 [M + Na] (calcd for C22H44O5NaSi2: 
467.2625), 467.3- 100% [M + Na]. 
νmax 3482 (OH), 2955, 2930, 2857 (CH), 1735 (C=O Ester). 
A novel compound. 
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Synthesis of Methyl (1S,3R,5S)-3,4,5-tris((tert-butyldimethylsilyl)oxy)-4-(2-
oxohexanoyl)cyclohexane-1-carboxylate 302 
 
A solution of 253 (40 mg, 0.065 mmol) in CH2Cl2 (2 mL) and MeCN (2 mL) was added to a 
solution of NaIO4 (0.038 mmol, 5.4 mmol) in water (3 mL). The mixture was stirred before 
the addition of RuCl3.xH2O (0.038 mmol, 5.4 mmol) as a solution in water (1 mL). The 
reaction was stirred for 1.5 hr and filtered through a pad of silica. The filtrate was extracted 
with CH2Cl2 (3 x 15 mL). The organic extracts were dried with MgSO4, filtered and the solvent 
removed under reduced pressure. Column chromatography (9:1 petroleum ether: diethyl 
ether) gave the title compound 302 as a yellow oil (22 mg, 52%). Rf 0.48 (19:1 petroleum 
ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
4.51 (2 H, dd, J 11.9, 4.4, H11), 3.77 (3 H, s, H19), 2.77 (2 H, t, J 7.3, H4), 
2.75 – 2.72 (1 H, m, H17), 2.05 (2 H, ddd, J 12.7, 4.4, 2.2, H16 eq), 1.96 (2 H, 
ddd, J 12.7, 11.9, 5.5, H16 ax), 1.51 (2 H, p, J 7.3, H3), 1.33 (2 H, h, J 7.3, H2), 
0.93 (9 H, s, H10), 0.90 (3 H, t, J 7.3, H1), 0.79 (18 H, s, H15), 0.18 (6 H, s, 
H12), 0.03 (6 H, s, H13), -0.11 (6 H, s, H8). 
δ C (101 MHz, 
Chloroform-d) 
198.8 (C, C5/6), 196.6 (C, C5/6), 175.0 (C, C18), 89.5 (C, C7), 72.2 (CH, C11),  
52.1 (CH3, C19), 38.0 (CH2, C4), 36.8 (CH, C17), 29.9 (CH2, C16), 26.9 (CH3, 
C10), 26.0 (CH3, C15), 24.9 (CH2, C3), 22.3 (CH2, C2), 20.0 (C, C9), 18.1 (C, 
C14), 14.0 (CH3, C1), -1.50 (CH3, C8), -4.09 (CH3, C12), -4.54 (CH3, C13). 
MS ES+ HRMS (ES): m/z(%) = 667.3862 [M + Na] (calcd for C32H64O7NaSi3: 
667.3858), 513.3- 100 % [M - OTBS], 667.4- 50 % [M + Na]. 
νmax 2956, 2930, 2857, 2896 (CH), 1736 (C=O), 1715 (CO2Me). 
A novel compound prepared according to a modified literature procedure.
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Synthesis of tert-Butyl((2R)-2-(oxiran-2-yl)propoxy)diphenylsilane 306 
 
To a solution of alkene 391 (1.26g, 3.88 mmol) in dry CH2Cl2 (39 mL) was added mCPBA (77% 
w/w 1.6 g, 9.3 mmol) under argon. The resultant solution was stirred for 15 minutes at 0 oC 
then allowed to stir overnight at rt. The mixture was diluted with water (25 mL) and 
extracted with ethyl acetate (3 x 25 mL). The organic layer was washed with brine (25 mL) 
and dried over MgSO4, filtered and the solvent removed under reduced pressure to afford a 
white powder which was then purified by column chromatography (19:1 petroleum ether: 
diethyl ether) to afford the title compound 306 as a colourless oil in quantitative yield. 
Rf 0.33 (19:1 petroleum ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
(1:1 Mixture of 
diastereoisomers) 
7.73 – 7.63 (4 H, m, Ar-H), 7.49 – 7.34 (6 H, m, Ar-H), 3.75 (1 H, dd, J 
9.9, 5.3, H3, diast1), 3.70 (1 H, dd, J 9.9, 4.8, H3, diast1), 3.68 – 3.59 
(2 H, m, H3, diast2), 2.99 (1 H, ddd, J 6.9, 4.0, 2.8, H6, diast1), 2.87 (1 H, 
ddd, J 6.8, 4.0, 2.7, H6, diast2), 2.76 (2 H, ddd, J 9.3, 5.0, 4.0, H7, 
diast1), 2.61 (1 H, dd, J 5.0, 2.7,H7, diast2), 2.55 (1 H, dd, J 5.1, 2.8, H7, 
diast2), 1.68 – 1.49 (2 H, m, H4), 1.07 (18 H, d, J 4.6, H1), 1.01 (6 H, d, J 
6.8, H5). 
δ C (101 MHz, 
Chloroform-d) 
(1:1 Mixture of 
diastereoisomers) 
135.7 (Ar-C), 135.6 (Ar-C), 133.8 (Ar-C), 133.8 (Ar-C), 133.7 (Ar-C), 
129.8 (Ar-C), 129.7 (Ar-C), 127.8 (Ar-C), 127.7 (Ar-C), 66.5 (C3), 66.2 
(C3), 55.2 (C6), 54.1 (C6), 47.0 (C7), 45.8 (C7), 39.2 (C4), 38.6 (C4), 26.9 
(C1), 19.4 (C2), 19.3 (C2), 13.4 (C5), 12.7 (C5). 
νmax 3071 (CH epoxide), 2930, 2899 (CH).  
A known compound prepared according to a literature procedure.
127
 Data is correct but literature has data 
missing from 
1
H NMR. Data agrees with literature values.
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Synthesis of (2R,3R)-1-((tert-Butyldiphenylsilyl)oxy)-2-methyl-6-(trimethylsilyl)hex-5-
yn-3-ol and (2R,3S)-1-((tert-Butyldiphenylsilyl)oxy)-2-methyl-6-(trimethylsilyl)hex-5-yn-
3-ol 307 
 
A solution of trimethylsilylacetylene (367 mg, 3.74 mmol) in dry THF (5.3 mL) was cooled to   
-78 oC. nBuLi (1.9 M solution in nhexane, 1.68 mL, 3.21 mmol) was added and the reaction 
left to stir for 20 minutes. The reaction was then allowed to warm to 0 oC followed by the 
addition of BF3.OEt2 (0.26 mL, 2.14 mmol) and a solution of epoxide 306 (365 mg, 
1.07 mmol) in dry THF (5.3 mL). The reaction was then stirred for 1 hr with gradual warming 
to rt, before being quenched with a saturated aqueous solution of NH4Cl (10 mL) and then 
extracted with diethyl ether (3 x 15 mL). The organic extracts were combined, dried over 
MgSO4, filtered and the solvent removed under reduced pressure. The crude oil was then 
purified by column chromatography (9:1 petroleum ether: diethyl ether) to give firstly (R)(R) 
(141 mg, 30%) Rf 0.33 followed by (R)(S) Rf 0.29 (66 mg, 14%), along with mixed fractions of 
(263 mg) visualised in vanillin. 
(R)(R) 
Diastereomer  
 
δ H (400 MHz, 
Chloroform-d) 
7.72 – 7.64 (4 H, m, Ar-H), 7.47 – 7.35 (6 H, m, Ar-H), 3.79 (1 H, dd, J 10.3, 
4.3, H4), 3.79 – 3.70 (1 H, m, H6), 3.67 (1 H, dd, J 10.3, 6.5, H4), 3.50 – 
3.43 (1 H, m, H6), 2.51 (2 H, dq, J 17.0, 4.8, H9), 2.02 – 1.91 (1 H, m, H5), 
1.06 (9 H, s, H11), 0.91 (3 H, d, J 7.0, H8), 0.16 (9 H, s, H1). 
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δ C (101 MHz, 
Chloroform-d) 
135.7 (Ar-C), 135.7 (Ar-C), 133.2 (Ar-C), 130.0 (Ar-C), 127.9 (Ar-C), 103.8 
(C, C3), 87.1 (C, C2), 73.8 (CH, C5), 67.7 (CH2, C9), 39.3 (CH, C7), 27.0 
(CH3, C11), 26.8 (CH2, C4), 19.3 (C, C10), 13.7 (CH3, C8), 0.3 (CH3, C1). 
MS ES+ (ES): m/z(%) = 461.2- 100% [M + Na], 421.2- 80% [M + H - H2O]. 
(S)(R) 
Diastereomer  
 
δ H (400 MHz, 
Chloroform-d) 
 
 
 
7.71 – 7.63 (4 H, m, Ar-H), 7.47 – 7.36 (6 H, m, Ar-H), 4.04 (1 H, tt, J 6.5, 
2.7, H5), 3.76 (1 H, dd, J 10.1, 4.1, H9), 3.69 (1 H, dd, J 10.1, 5.4, H9), 2.88 
(1 H, s, H6), 2.51 (1 H, dd, J 16.8, 6.5, H4), 2.42 (1 H, dd, J 16.8, 7.1, H4), 
1.93 (1 H, dddd, J 7.1, 5.4, 4.1, 2.7, H7), 1.07 (9 H, s, H11), 0.97 (3 H, d, J 
7.1, H8) 0.14 (9 H, s, H1). 
δ C (101 MHz, 
Chloroform-d) 
135.7 (Ar-C), 133.3 (Ar-C), 133.2 (Ar-C), 123.0 (Ar-C), 127.9 (Ar-C), 103.9 
(C, C3), 87.0 (C, C2), 72.4 (CH, C5), 68.3 (CH2, C9), 38.5 (CH, C7), 27.0 
(CH3, C11), 26.2 (CH2, C4), 191 (C, C10), 10.3 (CH3, C8), 0.23 (CH3, C1). 
A known compound prepared according to a literature procedure.
127
 Data is correct but literature has data 
missing from 
1
H NMR. 
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Synthesis of Methyl (1S,3R,4R,5S)-3,4,5-tris((tert-butyldimethylsilyl)oxy)-4-
ethynylcyclohexane-1-carboxylate 309 
 
A solution of 299 (68 mg, 0.15 mmol) in dry CH2Cl2 (1.5 mL) was cooled to 0 
oC. 2,6-lutidine 
(192.8 mg, 1.8 mmol) was added dropwise followed by the addition of TBS-OTf (476 mg, 
1.8 mmol). The mixture was warmed to rt overnight. The crude mixture was extracted with 
CH2Cl2 (3 x 10 mL), dried with MgSO4, filtered and the solvent removed under reduced 
pressure. Column chromatography (99:1 petroleum ether: diethyl ether) gave the title 
compound 309 as a white crystalline material (60 mg, 72%). M.p. 51-53 oC. Rf 0.71 (99:1 
petroleum ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
3.79 (2 H, t, J 2.4, H8), 3.67 (3 H, s, H16), 3.08 (1 H, tt, J 12.1, 3.3, H14), 
2.41 (1 H, s, H1), 2.01 – 1.77 (4 H, m, H13 ax/eq), 0.90 (18 H, s, H12) 
0.86 (9 H, s, H7), 0.19 (6H, s, H5), 0.10 (6 H, s, H9), 0.07 (6 H, s, H10). 
δ C (101 MHz, 
Chloroform-d) 
177.1 (C, C15), 86.8 (C, C4), 76.1 (CH, C2), 73.9 (CH, C8), 72.4 (C, C3), 
51.7 (CH3, C16), 32.3 (CH2, C13), 31.0 (CH, C14), 26.2 (CH3, C12), 26.0 
(CH3, C7), 18.4 (C, C6), 18.3 (C, C11), -2.75, (CH3, C5), -3.94 (CH3, C9), -
4.88 (CH3, C10). 
MS ES+ HRMS (ES): m/z(%) = 579.3328 [M + Na] (calcd for C28H56O5NaSi3: 
579.3333), 579.3- 100% [M + Na]. 
νmax 3307 (C≡CH), 2951, 2929, 2856, 2889 (CH), 1736 (C=O Ester). 
A novel compound. 
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Synthesis of Methyl (1S,3S,7R)-3-methoxy-3-methyl-9-oxo-7-(phenylselenyl)-2,4-
dioxabicyclo[3.3.1]nonane-7-carboxylate 379 
 
To a solution of DIPA (304 mg, 3 mmol) in THF (10 mL) cooled to -78 oC was added nBuLi (2M 
solution in nhexane, 1.5 mL, 3 mmol). The solution was stirred for 5 minutes then ketone 79 
(500 mg, 2 mmol) was added and the mixture stirred for 20 minutes at -78 oC. A solution of 
PhSeBr (708 mg, 3 mmol) in THF (10 mL) was then added dropwise over 5 minutes whilst 
maintaining the temperature at -78 oC. The mixture was allowed to warm to rt and then 
added to brine (25 mL), extracted with diethyl ether (3 x 25 mL), dried over MgSO4, filtered 
and the solvents removed under reduced pressure. Column chromatography (1:1 petroleum 
ether: diethyl ether) gave the title compound 379 as an off-white solid (710 mg, 89%). 
M.p. 78-80 oC. Rf 0.33 (1:1 petroleum ether: diethyl ether) visualised in KMnO4.  
δ H (400 MHz, 
Chloroform-d) 
7.58 – 7.27 (5 H, m, H5), 4.11 (2 H, m, H3), 3.66 (3 H, s, H6), 3.37 (2 H, 
m, H4 ax/eq), 3.18 (3 H, s, H1), 2.22 (2 H, dt, J 14.8, 2.9, H4 eq/ax), 1.38 
(3 H, s, H2). 
δ C (101 MHz, 
Chloroform-d) 
206.9 (C, C8), 172.4 (C, C10), 138.1 (C-Ar, C5), 130.0 (C-Ar, C5), 129.1 
(C-Ar, C5), 126.3 (C-Ar, C5), 112.1 (C, C7), 75.1 (CH, C3), 52.2 (CH3, C6), 
51.1 (CH3, C1), 44.0 (CH2, C4), 19.7 (CH3, C2). (CH, C9) signal not 
observed. 
MS TOF ES+ HRMS (ES): m/z(%) = 423.0330 [M + Na] (calcd for C17H20O6Na
80Se: 
423.0323), 423.0- 100% [M + Na], 421.1- 50% [M 78Se + Na], 
419.1- 30% [M76Se + Na]. 
νmax 3010 (CH), 2945 (CH), 2837 (CH), 1747 (C=O), 1718 (C=O). 
A novel compound prepared according to a modified literature procedure.
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Synthesis of Methyl (3S,5S)-3-methoxy-3-methyl-9-oxo-2,4-dioxabicyclo[3.3.1]non-6-ene-
7-carboxylate 381 
 
A solution of phenyl selenide 379 (300 mg, 0.75 mmol) in CH2Cl2 (7.5 mL) was cooled to 0 
oC. 
A solution of H2O2 in water (8.8 M, 0.34 mL, 3 mmol) was then added via syringe. The 
mixture was stirred for 45 minutes and then added to a saturated solution of Na2S2O3 
(10 mL). The mixture was then extracted with CH2Cl2 (3 x 10 mL) dried over MgSO4 and the 
solvent removed under reduced pressure. Column chromatography (7:3 petroleum ether: 
diethyl ether) gave the title compound 381 as a white solid (151 mg, 83%). M.p. 44-46 oC. 
Rf 0.54 (7:3 petroleum ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
7.05 (1 H, app.dd, J 6.1, 2.7, H7), 4.33 (1 H, app.q, J 2.7, H4), 4.21 (1 H, 
dd, J 6.1, 2.7, H6), 3.77 (3 H, s, H11), 3.27 (3 H, s, H2), 3.23 (1 H, dd, J 
18.3, 2.7, H8), 2.79 (1 H, dt, J 18.3, 2.7, H8), 1.52 (3 H, s, H1). 
δ C (101 MHz, 
Chloroform-d) 
205.3 (C, C5), 166.2 (C, C10), 136.9 (CH, C7), 131.7 (C, C9), 111.2 (C, 
C3), 73.0 (CH, C4), 68.3 (CH, C6), 52.5 (CH3, C11), 51.2 (CH3, C2), 37.7 
(CH2, C8), 20.5 (CH3, C1). 
MS TOF ES+ HRMS (ES): m/z(%) = 251.0525 [M + Na - CH2] (calcd for C10H12O6Na: 
251.0532), 251.0- 100% [M + Na - CH2]. 
νmax 3009, 2952, 2844 (CH), 1756 (C=O), 1713 (CO2Me). 
A novel compound prepared according to a modified literature procedure.
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Synthesis of Methyl 3,4-dihydroxybenzoate 382 
 
Product isolated from synthesis of methyl (3S,5S)-3-methoxy-3-methyl-9-oxo-2,4-
dioxabicyclo[3.3.1]non-6-ene-7-carboxylate and methyl (3S,5R,6R,7R)-3-methoxy-6-((2-
methoxy-2-oxoethyl)thio)-3-methyl-9-oxo-2,4-dioxabicyclo[3.3.1]nonane-7-carboxylate.  
Rf 0.26 (ethyl acetate) visualised in vanillin. 
δ H (400 MHz, 
Methanol-d4) 
7.43 – 7.36 (2 H, m, H8/H4), 6.81 – 6.74 (2 H, m, H7), 3.81 (3 H, s, H1), 
3.29 (2 H, s, H6/H5). 
δ C (101 MHz, 
Methanol-d4) 
169.0 (C, C2), 151.8 (Ar-C, C6 or 5), 146.3 (Ar-C, C6 or 5), 123.8 (Ar-C, 
C8 or 4), 122.7 (Ar-C, C3), 117.6 (Ar-C, C8 or 4), 116.0 (Ar-C, C7), 52.4 
(CH3, C1). 
TOF MS ES+ (ES): m/z(%) = 169.1- 100% [M + H], 168.1- 100% [M]. 
A known compound prepared according to a literature procedure and data agrees with literature values.
148
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Synthesis of Methyl (3S,5R,6R,7S)-3-methoxy-6-((2-methoxy-2-oxoethyl)thio)-3-methyl-9-
oxo-2,4-dioxabicyclo[3.3.1]nonane-7-carboxylate 383 
 
To a solution of alkene 381 (94 mg, 0.39 mmol) in CH2Cl2 (3.9 mL) was added methyl 
thioglycolate (0.17 mL, 1.95 mmol) and Et3N (0.27 mL, 1.95 mmol). The solution was stirred 
overnight at rt. The reaction mixture was then reduced to half volume in vacuo and purified 
directly by column chromatography (4:1 diethyl ether: petroleum ether) to give the title 
compound 383 as an off-white solid (110 mg, 81%). M.p. 63-65 oC. Rf 0.13 (1:1 petroleum 
ether: diethyl ether) visualised in KMnO4. 
δ H (400 MHz, 
Benzene-d6) 
4.72 (1 H, ddd, J 4.0, 2.7, 1.2, H8), 4.39 (1 H, dd, J 4.0, 2.7, H6), 4.03 (1 H, 
app.p, J 4.3, 2.4, 1.7, H4), 3.41 (3 H, s, H14), 3.22 (3 H, s, H11), 2.96 – 2.84 
(5 H, m, H12, H9, H1) 2.75 (1 H, d, J 15.1, H12), 2.56 (1 H, dt, J 6.9, 1.7, H7 
eq/ax), 1.98 (1 H, ddd, J 15.1, 6.9, 1.7, H7 ax/eq), 1.32 (3 H, s, H1). 
δ C (101 MHz, 
Benzene-d6) 
202.6 (C, C5), 171.5 (C, C10), 169.9 (C, C13), 112.6 (C, C3), 77.0 (CH, C6), 
75.0 (CH, C4), 51.9 (CH3, C14), 51.6 (CH3, C11), 50.9 (CH3, C1), 50.6 (CH, 
C8), 41.4 (CH, C9), 33.4 (CH2, C12), 33.1 (CH2, C7), 20.1 (CH3, C2). 
MS TOF ES+ HRMS (ES): m/z(%) = 371.0770 [M + Na] (calcd for C14H20O8NaS: 
371.0777), 371.2- 100% [M + Na]. 
νmax 2952, 2841 (CH), 1731 (C=O). 
A novel compound prepared according to a modified literature procedure.
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Synthesis of Methyl (3S,5R,6R,7R)-3-methoxy-6-((2-methoxy-2-oxoethyl)thio)-3-methyl-
9-oxo-2,4-dioxabicyclo[3.3.1]nonane-7-carboxylate 384 
 
To a solution of 383 (50 mg, 0.14 mmol) in toluene (1.4 mL) was added DBU (21.3 mg, 
0.14 mmol) and the mixture stirred for 1 hr at rt. The solvent was removed by reduced 
pressure and the residue purified by column chromatography (8:2 diethyl ether: petroleum 
ether) to give the title compound 384 as a colourless oil (16 mg, 32%). Rf 0.53 (8:2 diethyl 
ether: petroleum ether) visualised in KMnO4. 
δ H (400 MHz, 
Chloroform-d) 
4.24 (1 H, dd, J 4.4, 2.9, H6), 4.15 (1 H, ddd, J 4.4, 2.7, 1.5, H4), 4.02 
(1 H, app.ddd, J 4.5, 2.9, H8), 3.94 (1 H, dt, J 12.6, 4.5, H9), 3.74 (3 H, s, 
H11), 3.74 (3 H, s, H14), 3.33 (1 H, d, J 15.0, H12), 3.26 (3 H, s, H1), 3.22 
(1 H, d, J 15.0, H12), 2.48 (1 H, app.dtd, J 14.6, 4.4, 2.7, H7 eq), 2.06 
(1 H, ddd, J 14.6, 12.6, 1.5, H7 ax), 1.57 (3 H, s, H2). 
δ C (101 MHz, 
Chloroform-d) 
202.5 (C, C5), 172.1 (C, C10), 170.2 (C, C13), 112.7 (C, C3), 76.9 (CH, 
C6), 74.3 (CH, C4), 52.7 (CH3, C14), 52.3 (CH3, C11), 52.1 (CH, C8), 51.2 
(CH3, C1), 38.1 (CH, C9), 34.0 (CH2, C12), 33.5 (CH2, C7), 20.2 (CH3, C2). 
MS TOF ES+ HRMS (ES): m/z(%) = 371.0776 [M + Na] (calcd for C14H20O8NaS: 
371.0777), 371.1- 100% [M + Na]. 
νmax 2953 (CH), 1734 (C=O). 
A novel compound prepared according to a modified literature procedure.
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Synthesis of Methyl 5-hydroxy-2-((2-methoxy-2-oxoethyl)thio)benzoate 385 
 
To a solution of 383 (25 mg, 0.07 mmol) in CH2Cl2 (0.7 mL) at 0 
oC was added TiCl4 (13.3 μg, 
0.07 mmol). The mixture was stirred for 1 hr at 0 oC, then Et3N (7 mg, 0.07 mmol) was added 
and the mixture allowed to warm to rt. The mixture was then directly purified by column 
chromatography (8:2 diethyl ether: petroleum ether) to give the title compound 385 as a 
yellow oil (9 mg, 50%). Rf 0.44 (8:2 diethyl ether: petroleum ether) visualised in KMnO4. 
δ H (400 MHz, 
Chloroform-d) 
8.23 (1 H, d, J 2.1, H10), 8.15 (1 H, s, H12 exchanges with D2O), 7.97 
(1 H, dd, J 8.6, 2.1, H9), 7.02 (1 H, d, J 8.6, H8), 3.88 (3 H, s, H7), 3.73 (3 
H, s, H1), 3.53 (2 H, s, H3). 
δ C (101 MHz, 
Chloroform-d) 
171.7 (C, C2), 166.2 (C, C6), 162.1 (C, C11), 139.0 (Ar-C, C9), 133.8 (Ar-
C, C10), 123.0 (Ar-C, C5), 118.5 (Ar-C, C4), 116.1 (Ar-C, C8), 53.3 (CH3, 
C7), 52.1 (CH3, C1), 39.3 (CH2, C3). 
MS TOF ES+ HRMS (ES): m/z(%) = 279.0290 [M + Na] (calcd for C11H12O5NaS: 
279.0303), 279.1- 100% [M + Na]. 
νmax 3261 (OH), 2959, 2912 (CH), 2426 (S-Ar). 
A novel compound. 
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Synthesis of Methyl 2-(hydroxymethyl)acrylate 387 
 
Paraformaldehyde (3.50 g, 117 mmol) was dissolved in a 1:1 mixture of 1,4-dioxane: H2O 
(16 mL). The solution was stirred for 45 minutes at rt. Methyl acrylate (21.0 mL, 233 mmol) 
and DABCO (13.1 g, 117 mmol) were added and the reaction mixture was vigorously stirred 
for 72 hr. Brine (50 mL) was added and the aqueous layer was extracted with diethyl ether 
(3 x 25 mL). The combined organic layers were washed with brine (25 mL), dried over Na2SO4 
filtered and evaporated under reduced pressure. The crude product was purified by column 
chromatography (1:1 petroleum ether: diethyl ether) to yield the title compound 387 as a 
colourless oil (7.66 g, 56%). Rf (0.29 petroleum ether: diethyl ether) visualised in KMnO4. 
δ H (400 MHz, 
Chloroform-d) 
6.24 (1 H, s, H4), 5.83 (1 H, s, H4), 4.31 (2 H, d, J 6.4, H2), 3.77 (3 H, s, 
H6), 2.57 (1 H, t, J 6.4, H1). 
δ C (101 MHz, 
Chloroform-d) 
166.8 (C, C5), 139.4 (C, C3), 125.9 (CH2, C4), 62.5 (CH2, C2), 52.0 (CH3, 
C6). 
νmax 3444 (OH), 2955 (CH), 1716 (C=O). 
A known compound prepared according to a literature procedure.
169
 Data agrees with literature values.
170
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Synthesis of Methyl (R)-3-((tert-butyldiphenylsilyl)oxy)-2-methylpropanoate 388 
 
To a stirred solution of methyl (R)-3-hydroxy-2-methylpropionate (1 g, 8.46 mmol) and 
imidazole (1.26 g, 18.61 mmol) in dry CH2Cl2 (42 mL) was added TBDPSCl (2.8 g, 10.15 mmol) 
at 0 oC. After the ice bath was removed the reaction mixture was diluted with water and 
extracted with CH2Cl2 (3 x 15 mL). The organic layer was washed with brine (15 mL), dried 
over magnesium sulfate and filtered. The solvent was then removed under vacuum and the 
crude product purified by column chromatography (99:1 petroleum: diethyl ether) to yield 
the title compound 388 as a colourless oil in quantitative yield. Rf 0.55 (8:2 petroleum ether: 
diethyl ether) visualised in KMnO4. 
δ H (400 MHz, 
Chloroform-d) 
7.70 – 7.63 (4 H, m, Ar-H), 7.48 – 7.34 (6 H, m, Ar-H), 3.88 – 3.71 (2 H, 
m, H3), 3.70 (3 H, s, H7), 2.73 (1 H, app.h, J 6.2, H4), 1.17 (3 H, d, J 6.2, 
H5), 1.05 (9 H, s, H1). 
δ C (101 MHz, 
Chloroform-d) 
175.5 (C, C6), 135.7 (Ar-C), 133.7 (Ar-C), 133.6 (Ar-C), 129.8 (Ar-C), 
127.8 (Ar-C), 66.1 (CH2, C3), 51.7 (CH3, C7), 42.5 (CH, C4), 26.9 (C, C2), 
19.4 (CH3, C1), 13.6 (CH3, C5). 
νmax 3071, 2932, 2858 (CH), 1738 (CO2Me), 700 (Si-C). 
A known compound prepared according to a literature procedure.
127
 Data is correct but literature has data 
missing from 
1
H NMR. Data agrees with literature values.
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Synthesis of (S)-3-((tert-Butyldiphenylsilyl)oxy)-2-methylpropan-1-ol 389 
 
To a solution of ester 388 (100 mg, 0.28 mmol) dissolved in dry toluene (2.8 mL) was added 
DIBAL (1.0 M in toluene, 0.56 mL, 0.56 mmol) at -78 oC under argon. Stirring was continued 
for 1 hr after which Rochelle’s salt (2 mL of a saturated solution) was added and the reaction 
allowed to warm to rt. The mixture was then extracted with ethyl acetate (3 x 5 mL), dried 
over MgSO4, filtered and the solvent removed under reduced pressure. The crude product 
was purified by column chromatography (4:1 petroleum ether: diethyl ether) to give the title 
compound 389 as a colourless oil (68 mg, 74%). Rf 0.12 (8:2 petroleum ether: diethyl ether) 
visualised in KMnO4. 
δ H (400 MHz, 
Chloroform-d) 
7.74 – 7.64 (4 H, m, Ar-H), 7.49 – 7.36 (6 H, m, Ar-H), 3.77 – 3.57 (4 H, 
m, H3, H6), 2.78 (1 H, bs, H7), 2.01 (1 H, m, H4), 1.08 (9 H, s, H1), 0.84 
(3 H, d, J 7.0, H5). 
δ C (101 MHz, 
Chloroform-d) 
135.7 (Ar-C), 133.3 (Ar-C), 129.9 (Ar-C), 127.9 (Ar-C), 68.8 (CH2, C3 or 
6), 67.7 (CH2, C3 or 6), 37.5 (CH, C4), 27.0 (CH3, C1), 19.3 (C, C2), 13.3 
(CH3, C5) 
νmax 3360 (OH), 3071, 2958, 2930, 2858 (CH), 699 (Si-Ph). 
A known compound prepared according to a literature procedure.
127
 Data is correct but literature has data 
missing from 
1
H NMR. Data agrees with literature values.
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Synthesis of (R)-3-((tert-Butyldiphenylsilyl)oxy)-2-methylpropanal 390 
 
Freshly distilled oxalyl chloride (0.45 mL, 5.28 mmol) in CH2Cl2 (52. 8 mL) was cooled to          
-78 oC. Freshly distilled DMSO (0.48 mL, 6.72 mmol) in a solution of CH2Cl2 (15 mL) was 
slowly added and the reaction stirred for 5 minutes. A solution of alcohol 389 (800 mg, 
2.4 mmol) dissolved in CH2Cl2 (15 mL) was added dropwise over 5 minutes and the reaction 
stirred for 1 hr 20 minutes maintaining the temperature at -78 oC. Et3N (1.2 g, 12 mmol) was 
then added and the reaction allowed to warm to rt. The mixture was quenched with a 
saturated aqueous solution of NaHCO3 (10 mL) and the mixture extracted with CH2Cl2 
(3 x 25 mL). The solvent was dried over MgSO4, filtered and the solvent removed under 
reduced pressure to give a crude product which was purified by column chromatography 
(9:1 petroleum ether: diethyl ether) to give the title compound 390 as a colourless oil 
(676 mg, 86%). Rf 0.38 (8:2 petroleum ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
9.78 (1 H, d, J 1.6, H6), 7.69 – 7.62 (4 H, m, Ar-H), 7.49 – 7.38 (6 H, m, 
Ar-H), 3.96 – 3.81 (2 H, m, H3), 2.62 – 2.53 (1 H, m, H4), 1.11 (3 H, d, J 
7.0, H5), 1.05 (9 H, s, H1). 
δ C (101 MHz, 
Chloroform-d) 
204.5 (C6), 135.7 (Ar-C), 133.3 (Ar-C), 129.9 (Ar-C), 127.9 (Ar-C), 64.3 
(C3), 49.0 (C4), 26.9 (C1), 19.4 (C2), 10.5 (C5). 
νmax 2931, 2858, 2175 (CH), 1732 (CHO). 
A known compound prepared according to a literature procedure.
127
 Data is correct but literature has data 
missing from 
1
H NMR. Data agrees with literature values.
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Synthesis of (S)-tert-Butyl((2-methylbut-3-en-1-yl)oxy)diphenylsilane 391 
 
To a stirred suspension of methyltriphenylphosphonium bromide (22.4 mg, 0.62 mmol) in 
THF (6.2 mL) was added nBuLi (1.78 M solution in nhexane, 0.43 mL, 0.78 mmol) under argon 
at 0 oC. The resulting mixture was stirred for 20 minutes, followed by the addition of a 
solution of aldehyde 390 (100 mg, 0.31 mmol) in THF (6.2 mL). The reaction was stirred for 
15 minutes at 0 oC followed by 45 minutes at rt. Saturated aqueous NH4Cl (15 mL) was added 
and the mixture extracted with ethyl acetate (3 x 15 mL). The organic layers were washed 
with brine, dried over MgSO4, filtered and the solvent removed under reduced pressure to 
yield a crude product that was purified via column chromatography (9:1 petroleum ether: 
diethyl ether) to yield the title compound 391 as a colourless oil (85 mg, 84%). Rf 0.36 (9:1 
petroleum ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
7.73 – 7.61 (4 H, m, Ar-H), 7.50 – 7.30 (6 H, m, Ar-H), 5.81 (1 H, ddd, J 
17.3, 10.4, 6.9, H6), 5.09 – 4.89 (2 H, m, H7), 3.58 (1H, dd, J 9.7, 6.2, 
H3a), 3.50 (1 H, dd, J 9.7, 6.2, H3b), 2.50 – 2.29 (1 H, m, H4), 1.06 (9 H, s, 
H1), 1.04 (3 H, d, J 6.8 H5). 
δ C (101 MHz, 
Chloroform-d) 
141.5 (CH, C6) 135.8 (Ar-C), 134.1 (Ar-C), 129.7 (Ar-C), 127.7 (Ar-C), 
114.2 (CH2, C7), 68.7 (CH2, C3), 40.4 (CH, C4), 27.0 (CH3, C1), 19.5 (C, 
C2), 16.3 (CH3, C5). 
νmax 3071, 2959, 2930, 2858, 2896 (CH), 1641 (C=C), 698 (Si-C). 
A known compound prepared according to a literature procedure.
127
 Data is correct but literature has data 
missing from 
1
H NMR. Data agrees with literature values.
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Synthesis of (2S,3R)-1-((tert-Butyldiphenylsilyl)oxy)-2-methylhex-5-yn-3-ol 392   
 
Alkyne 308 (87 mg, 0.2 mmol) was dissolved in MeOH (2 mL), K2CO3 (55 mg, 0.4 mmol) was 
added and the reaction mixture left to stir at rt for 3 hr. The reaction was then added to 
brine (10 mL) and extracted with CH2Cl2 (3 x 10 mL). The organic fractions were combined 
and dried over MgSO4, filtered and solvents removed under reduced pressure. Column 
chromatography (9:1 petroleum ether: diethyl ether) gave the title compound 392 as a 
colourless oil (75 mg, 73%). Rf 0.20 (9:1 petroleum ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
7.71 – 7.66 (4 H, m, Ar-H), 7.48 – 7.37 (6 H, m, Ar-H), 3.83 – 3.74 (3 H, 
m, H8, H5, H4), 3.66 (1 H, dd, J 10.3, 7.2, H8), 2.53 (1 H, ddd, J 16.8, 4.4, 
2.7, H3), 2.43 (1 H, ddd, J 16.8, 6.1, 2.7, H3), 2.04 (1 H, t, J 2.7, H1), 1.99 
(1 H, dq, J 7.1, 4.2, H6), 1.07 (18 H, s, H10), 0.88 (3 H, d, J 7.1, H7). 
δ C (101 MHz, 
Chloroform-d) 
135.8 (Ar-C), 133.0 (Ar-C), 130.0 (Ar-C), 127.9 (Ar-C), 81.3 (C, C2), 74.1 
(CH, C4), 70.4 (C1), 68.2 (CH2, C8), 39.1 (CH, C6), 27.0 (CH3, C10), 25.3 
(CH2, C3), 19.3 (C, C9), 13.6 (CH3, C7). 
MS ES+ HRMS (ES): m/z(%) = 389.1906 [M + Na] (calcd for C23H30O2NaSi: 
389.1913), 389.2- 100% [M + Na]. 
νmax
 3477 (OH), 3307 (C≡C-H), 2960, 2931, 2858 (CH), 700 (Si-Ph). 
A novel compound. 
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Synthesis of Chloro(triphenylphosphine)gold(I) 393 
 
To a solution of NaAuCl4 (250 mg, 0.63 mmol) in water (5 mL) cooled to 0 
oC was added 2-
thio-ethanol (250 mg, 2.0 mmol) over 45 minutes. PPh3 (132 mg, 0.50 mmol) in ethanol 
(5 mL) was then added over 1 hr and the reaction left to stir for 15 minutes. The precipitate 
that formed was then filtered and dried to give the title compound 393 as a white solid 
(217 mg, 70%). 
δ H (300 MHz, 
Chloroform-d) 
7.59 – 7.42 (15 H, m, Ar-H). 
δ P (121 MHz, 
Chloroform-d) 
33.2 P. 
MS ES+ (ES): m/z(%) = 500.1 [M - Cl + H], 721.2 [M - Cl + PPh3], 953.0 [M + 
PPh3]. 
A known compound prepared according to a literature procedure and data agrees with literature values.
175
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Synthesis of Methyl (1R,3R,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-oxocyclohexane-1-
carboxylate 394 
 
To a solution of ketone 80 (150 mg, 0.61 mmol) in MeOH (6.1 mL) was added acetic acid 
(35 μL, 0.61 mmol) and the mixture heated to reflux for 2 days. The reaction was then cooled 
to rt and the solvents removed by co-distillation with toluene. The crude solid was then 
dissolved in DMF (6.1 mL) to which was added TBSCl (405 mg, 2.7 mmol) and imidazole 
(183 mg, 2.7 mmol). The reaction was stirred for 2 days at rt. The mixture was then added to 
brine (25 mL) and extracted with diethyl ether (3 x 25 mL), dried over MgSO4, filtered and 
the solvents removed under reduced pressure. Column chromatography (9:1 petroleum 
ether: diethyl ether) gave the title compound 394 as a clear oil (190 mg, 75%). Rf 0.48 (1:1 
petroleum ether: diethyl ether) visualised in vanillin. 
δ H (400 MHz, 
Chloroform-d) 
4.20 (2 H, dd, J 11.5, 5.8, H5), 3.71 (3 H, s, H1), 2.82 (1 H, tt, J 12.9, 3.0, H3), 
2.44 (2 H, ddd, J 11.5, 5.8, 3.0, H4 eq), 1.86 (2 H, app.q, J 12.9, H4 ax), 0.89 
(18 H, s, H10), 0.13 (6 H, s, H7), 0.01 (6 H, s, H8). 
δ C (101 MHz, 
Chloroform-d) 
205.7 (C, C6), 173.4 (C, C2), 74.5 (CH, C5), 52.3 (CH3, C1), 38.9 (CH2, C4), 
37.6 (CH, C3), 25.9 (CH3, C10), 18.6 (C, C9), -4.4 (CH3, C7), -5.4 (CH3, C8). 
MS ES+ HRMS (ES): m/z(%) = 417.2501 [M + H] (calcd for C20H41O5Si2: 417.2493), 
269.2- 100% [M - OTBS - O], 285.2- 80% [M - OTBS], 399.3- 90% [M - O], 
417.3- 40% [M + H]. 
νmax 2929 (CH), 2949 (CH), 2856 (CH), 2882 (CH), 1748 (CO2Me), 1718 (C=O). 
A novel compound prepared according to a PhD thesis procedure.
91
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Synthesis of Triphenylphosphinegold triflimidate 395 
 
To a solution of Ph3PAuCl in CH2Cl2 (2.5 mL) was added AgNTf2 (25 mg, 0.06 mmol). The 
reaction was stirred for 15 minutes at rt then filtered through a pad of celite. The solvent 
was removed under reduced pressure to give the title compound 394 as a white crystalline 
solid (40 mg, 90%). 
δ H (300 MHz, 
Chloroform-d) 
7.63 –7.44 (15 H, m). 
δ F (282 MHz, 
Chloroform-d) 
-75.48. 
δ P (121 MHz, 
Chloroform-d) 
30.33. 
MS ES+ (ES): m/z(%) = 721.2- 100% [M - F]. 
A known compound prepared according to a literature procedure and data agrees with literature values.
176
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Synthesis of Dimethyl (1-diazo-2-oxopropyl)phosphonate 396 
 
Dimethyl 2-oxopropylphosphonate (500 mg, 3.01 mmol) was dissolved in dry THF (8 mL) and 
cooled to 0 oC. NaH (60% in mineral oil, 144 mg, 3.61 mmol) was added and the reaction 
mixture left to stir for 1 hr. A solution of 4-acetamidobenzenesulfonyl azide (800 mg, 
3.31 mmol) in THF (4 mL) was then added to the crude reaction mixture dropwise over 
10 minutes and left to stir for 2 hr with gradual warming to rt. The reaction mixture was then 
filtered through celite. The solvent was removed under reduced pressure and the crude 
product purified via column chromatography (ethyl acetate) to give the title compound 396 
as a yellow oil (420 mg, 73%).  Rf 0.23 (ethyl acetate) visualised under UV light. 
δ H (300 MHz, 
Chloroform-d) 
3.83 (6 H, d, JHp 11.9, H1), 2.25 (3 H, s, H5). 
δ C (101 MHz, 
Chloroform-d) 
189.9 (C, C4), 125.6 (C, C3), 53.6 (CH3, C1), 27.2 (CH3, C5). 
δ P (122 MHz, 
Chloroform-d) 
14.3 (P2). 
νmax 2221, 2117 (N=N, C=N), 1654 (C=O). 
A known compound prepared according to a literature procedure and data agrees with literature values.
177, 178
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Appendices  
Crystallographic data  
X-ray for 175  
Crystallised from slow evaporation from CH2Cl2 and Hexane (1:1) 
 
 
Table 1 Crystal data and structure refinement for 175 
Identification code MPK3-262 
Empirical formula C15H22O6 
Formula weight 298.32 
Temperature/K 100.15 
Crystal system triclinic 
Space group P-1 
a/Å 8.9894(5) 
b/Å 13.2792(8) 
c/Å 19.0407(13) 
α/° 84.876(6) 
β/° 87.433(6) 
γ/° 79.098(6) 
Volume/Å3 2222.1(2) 
Z 6 
ρcalcg/cm
3 1.338 
μ/mm-1 0.103 
F(000) 960.0 
Crystal size/mm3 0.19 × 0.06 × 0.01 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/° 6.044 to 54.966 
Index ranges -11 ≤ h ≤ 11, -15 ≤ k ≤ 17, -24 ≤ l ≤ 24 
Reflections collected 29761 
Independent reflections 10173 [Rint = 0.0322, Rsigma = 0.0415] 
Data/restraints/parameters 10173/0/606 
Goodness-of-fit on F2 1.059 
Final R indexes [I>=2σ (I)] R1 = 0.0477, wR2 = 0.1263 
Final R indexes [all data] R1 = 0.0821, wR2 = 0.1423 
Largest diff. peak/hole / e Å-3 0.37/-0.29 
 217 
 
X-ray for 177  
Crystallised from slow evaporation from CH2Cl2 and Hexane (1:1) 
 
Table 1 Crystal data and structure refinement for 177 
Identification code MPK_288 
Empirical formula C19H28BrNO4 
Formula weight 414.33 
Temperature/K 100.15 
Crystal system monoclinic 
Space group I2/a 
a/Å 17.4828(2) 
b/Å 11.60060(11) 
c/Å 18.3644(2) 
α/° 90 
β/° 101.2536(12) 
γ/° 90 
Volume/Å3 3652.91(7) 
Z 8 
ρcalcg/cm
3 1.507 
μ/mm-1 3.267 
F(000) 1728.0 
Crystal size/mm3 0.18 × 0.177 × 0.125 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 12.716 to 140.122 
Index ranges -19 ≤ h ≤ 21, -13 ≤ k ≤ 14, -21 ≤ l ≤ 22 
Reflections collected 6618 
Independent reflections 3412 [Rint = 0.0132, Rsigma = 0.0168] 
Data/restraints/parameters 3412/0/229 
Goodness-of-fit on F2 1.076 
Final R indexes [I>=2σ (I)] R1 = 0.0243, wR2 = 0.0619 
Final R indexes [all data] R1 = 0.0254, wR2 = 0.0626 
Largest diff. peak/hole / e Å-3 0.73/-0.36 
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X-ray for 253  
Crystallised from slow evaporation from CH2Cl2 and Hexane (1:1) 
 
Table 1 Crystal data and structure refinement for 253 
Identification code MPK_366 
Empirical formula C32H64O5Si3 
Formula weight 613.1 
Temperature/K 100.01(10) 
Crystal system triclinic 
Space group P-1 
a/Å 11.9365(4) 
b/Å 12.5296(3) 
c/Å 15.1663(5) 
α/° 75.771(2) 
ß/° 67.468(3) 
γ/° 65.100(3) 
Volume/Å3 1890.67(11) 
Z 2 
ρcalcg /cm3 1.077 
µ/mm-1 1.412 
F(000) 676 
Crystal size/mm3 0.2556 × 0.2188 × 0.1667 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 6.342 to 146.802 
Index ranges -14 ≤ h ≤ 14, -15 ≤ k ≤ 15, -18 ≤ l ≤ 18 
Reflections collected 68475 
Independent reflections 7529 [Rint = 0.0199, Rsigma = 0.0092] 
Data/restraints/parameters 7529/0/378 
Goodness-of-fit on F2 1.047 
Final R indexes [I>=2 σ (I)] R1 = 0.0296, wR2 = 0.0791 
Final R indexes [all data] R1 = 0.0308, wR2 = 0.0800 
Largest diff. peak/hole / e Å-3 0.42/-0.24 
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X-ray for 274  
Crystallised from slow evaporation from CH2Cl2 and Hexane (1:1) 
 
Table 1 Crystal data and structure refinement for 274 
Identification code MPK_7-569 
Empirical formula C32H55BO6Si2 
Formula weight 602.75 
Temperature/K 99.97(17) 
Crystal system triclinic 
Space group P-1 
a/Å 11.2926(3) 
b/Å 17.6773(4) 
c/Å 19.8735(5) 
α/° 101.118(2) 
β/° 98.960(2) 
γ/° 107.432(2) 
Volume/Å3 3616.08(17) 
Z 4 
ρcalcg/cm
3 1.107 
μ/mm-1 1.186 
F(000) 1312.0 
Crystal size/mm3 0.3037 × 0.1819 × 0.1667 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 5.418 to 148.978 
Index ranges -10 ≤ h ≤ 14, -22 ≤ k ≤ 20, -24 ≤ l ≤ 24 
Reflections collected 51067 
Independent reflections 14790 [Rint = 0.0329, Rsigma = 0.0331] 
Data/restraints/parameters 14790/0/763 
Goodness-of-fit on F2 1.018 
Final R indexes [I>=2σ (I)] R1 = 0.0410, wR2 = 0.0986 
Final R indexes [all data] R1 = 0.0521, wR2 = 0.1068 
Largest diff. peak/hole / e Å-3 0.59/-0.47 
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X-ray for 300  
Crystallised from slow evaporation from CH2Cl2 and Hexane (1:1) 
 
Table 1 Crystal data and structure refinement for 300 
Identification code  MPK_443 
Empirical formula  C22H42O5Si2 
Formula weight  442.73 
Temperature  99.97(11) K 
Wavelength  1.5418 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 6.4792(3) Å = 99.123(3)°. 
 b = 12.1150(5) Å = 94.664(3)°. 
 c = 17.0386(7) Å  = 95.240(3)°. 
Volume 1308.76(10) Å3 
Z 2 
Density (calculated) 1.123 Mg/m3 
Absorption coefficient 1.446 mm-1 
F(000) 484 
Crystal size 0.120 x 0.050 x 0.030 mm3 
Theta range for data collection 6.895 to 66.597°. 
Index ranges -7 ≤ h ≤ 7, -14 ≤ k ≤ 14, -20 ≤ l ≤ 20 
Reflections collected 18306 
Independent reflections 4613 [Rint = 0.0865] 
Completeness to theta = 67.680° 97.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.61694 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4613 / 2 / 276 
Goodness-of-fit on F2 1.204 
Final R indices [I>2 σ (I)] R1 = 0.0916, wR2 = 0.2175 
R indices (all data) R1 = 0.1173, wR2 = 0.2247 
Largest diff. peak and hole 0.423 and -0.458 e.Å-3 
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X-ray for 383  
Crystallised from slow evaporation from CH2Cl2 and Hexane (1:1) 
 
 
Table 1 Crystal data and structure refinement for 383 
Identification code MPK 737 
Empirical formula C14H20O8S 
Formula weight 348.36 
Temperature/K 100.00(10) 
Crystal system triclinic 
Space group P-1 
a/Å 6.71588(18) 
b/Å 8.2594(2) 
c/Å 14.7967(4) 
α/° 98.207(2) 
β/° 92.755(2) 
γ/° 99.715(2) 
Volume/Å3 798.52(4) 
Z 2 
ρcalcg/cm
3 1.449 
μ/mm-1 0.242 
F(000) 368.0 
Crystal size/mm3 0.2885 × 0.2131 × 0.1936 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/° 6.144 to 52.742 
Index ranges -8 ≤ h ≤ 8, -10 ≤ k ≤ 10, -18 ≤ l ≤ 18 
Reflections collected 32848 
Independent reflections 3279 [Rint = 0.0281, Rsigma = 0.0139] 
Data/restraints/parameters 3279/0/212 
Goodness-of-fit on F2 1.060 
Final R indexes [I>=2σ (I)] R1 = 0.0291, wR2 = 0.0692 
Final R indexes [all data] R1 = 0.0333, wR2 = 0.0721 
Largest diff. peak/hole / e Å-3 0.37/-0.26 
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NMR spectra  
 
  
2-Methoxy-2-methyl-1,3-dioxan-5-one 76 
 223 
 
 
  
Methyl 2-(bromomethyl)acrylate 78 
 224 
 
 
 
Methyl (1S,3S,7S)-3-methoxy-3-methyl-9-oxo-2,4-dioxabicyclo[3.3.1]nonane-7-carboxylate 79 
 225 
 
 
Methyl (1S,3S,7R)-3-methoxy-3-methyl-9-oxo-2,4-dioxabicyclo[3.3.1]nonane-7-carboxylate 80 
 
 226 
 
 
2-Isobutyl-2-((trimethylsilyl)ethynyl)-1,3-dioxan-5-one 141 
 227 
 
 
5-Methyl-1-(trimethylsilyl)hex-1-yn-3-one 150 
 228 
 
 
  
(3,3-Dimethoxy-5-methylhex-1-yn-1-yl)trimethylsilane 154 
 229 
 
 
 
  
3,3-Dimethoxy-5-methylhex-1-yne 156 
 230 
 
 
 
  
2-Ethynyl-2-isobutyl-1,3-dioxan-5-one 158 
 231 
 
 
 
((2-Isobutyl-5-methylene-1,3-dioxan-2-yl)ethynyl)trimethylsilane 160 
 232 
 
 
 
 
2,2,8,8-Tetramethyl-5-methylene-3,7-dioxa-2,8-disilanonane 167 
 233 
 
 
 
 
2-Ethynyl-2-isobutyl-5-methylene-1,3-dioxane 172 
 234 
 
 
 
 
Methyl (4’R,5R,7R,8S)-4-hydroxy-2-isobutyl-3-oxooctahydro-2H-2,5-epoxychromene-7-
carboxylate 175 
 235 
 
 
 
  
Methyl (3’R,4R,6R,7S,Z)-3-(bromomethylene)-2-isobutyl-3-(pyrrolidin-1-yl)octahydro-2,4-
epoxybenzofuran-6-carboxylate 177 
 236 
 
 
 
  
Methyl (1S,3R,4S)-3-acetoxy-4-
hydroxycyclopentane-1-carboxylate 206 
 237 
 
 
 
  
Methyl (1R,3R,4S)-3-acetoxy-4-
hydroxycyclopentane-1-carboxylate 207 
 238 
 
 
Methyl (1s,3R,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-oxocyclohexane-1-carboxylate 211 
 239 
 
 
Diethyl (2-oxo-6-
((triethylsilyl)oxy)hexyl)phosphonate 214 
 240 
 
 
  
Methyl (1S,3R,4R,5S)-3,5-bis((tert-
butyldimethylsilyl)oxy)-4-formyl-4-
hydroxycyclohexane-1-carboxylate 217 
 241 
 
 
  
Methyl (1S,3R,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-
methylenecyclohexane-1-carboxylate 219 
 242 
 
 
Methyl 4-acetoxy-5-oxocyclohex-3-
ene-1-carboxylate 223 
 243 
 
 
Methyl (1S,3R,5S)-4-oxo-3,5-
bis((triethylsilyl)oxy)cyclohexane-1-carboxylate 232 
 244 
 
 
 
(E)-1-Phenyl-7-((triethylsilyl)oxy)hept-
1-en-3-one 240 
 245 
 
 
 
  
(1S,3R,4s,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-(hex-1-yn-1-yl)-4-
hydroxycyclohexane-1-carboxylate 250 
 246 
 
 
 
  
Methyl (1S,3R,4S,5S)-4-(hex-1-yn-1-
yl)-4-hydroxy-3,5-
bis((triethylsilyl)oxy)cyclohexane-1-
carboxylate 251 
 247 
 
 
 
  
(1S,3R,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-hydroxy-4-
((trimethylsilyl)ethynyl)cyclohexane-1-carboxylate 252 
 248 
 
 
 
  
Methyl (1S,3R,5S)-3,4,5-tris((tert-butyldimethylsilyl)oxy)-4-
(hex-1-yn-1-yl)cyclohexane-1-carboxylate 253 
 249 
 
 
 
  
2-Phenyloct-3-yn-2-ol 268 
 250 
 
 
 
  
Oct-1-en-3-yn-2-ylbenzene 269 
 251 
 
 
  
2,2,3-Trimethylnon-4-yn-3-ol 270 
 252 
 
 
 
  
(Z)-2,2,3-Trimethylnon-3-en-5-one 271 
 253 
 
 
 
  
Methyl (4S,6R)-2-butyl-4-methoxy-
4,5,6,7-tetrahydrobenzofuran-6-
carboxylate 272 
 254 
 
 
 
 
Methyl (1S,3R,4S,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-
hydroxy-4-(2-oxohexyl)cyclohexane-1-carboxylate 273 
 255 
 
 
 
  
Methyl (7R,9S,11S)-4-butyl-7,11-bis((tert-butyldimethylsilyl)oxy)-2-phenyl-
1,3-dioxa-2-boraspiro[5.5]undec-4-ene-9-carboxylate 274 
 256 
 
 
 
  
Methyl (1S,3R,4r,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-(hex-1-yn-1-
yl)-4-hydroxycyclohexane-1-carboxylate 275 
 257 
 
 
 
  
Methyl (4R,6R)-2-butyl-4-hydroxy-
4,5,6,7-tetrahydrobenzofuran-6-
carboxylate 278 
 258 
 
 
 
  
(2,3,4,5-Tetrafluorophenyl)boronic acid 281 
 259 
 
 
 
 
1,1-Diphenylhept-2-yn-1-ol 282 
 260 
 
 
 
  
1,1-Diphenylhept-1-en-3-one 283 
 261 
 
 
 
  
Methyl (1R,3R,4R,5S)-4-(hex-1-yn-1-yl)-3,4-dihydroxy-5-
((triethylsilyl)oxy)cyclohexane-1-carboxylate 284 
 262 
 
 
 
  
(3-((Trichloromethyl)sulfinyl)hepta-
alene-1,1-diyl)dibenzene 295 
 263 
 
 
 
  
Methyl (1S,3R,4R,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-
hydroxy-4-(hydroxymethyl)cyclohexane-1-carboxylate 298 
 264 
 
 
 
  
Methyl (1S,3R,4R,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-
ethynyl-4-hydroxycyclohexane-1-carboxylate 299 
 265 
 
 
 
  
Methyl (1S,3R,4R,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-hydroxy-
4-(1-hydroxyhept-2-yn-1-yl)cyclohexane-1-carboxylate 300 
 266 
 
 
 
 
Methyl (1S,3R,4R,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-hydroxy-4-
vinylcyclohexane-1-carboxylate 301 
 267 
 
 
 
  
Methyl (1S,3R,5S)-3,4,5-tris((tert-butyldimethylsilyl)oxy)-4-(2-
oxohexanoyl)cyclohexane-1-carboxylate 302 
 268 
 
 
 
  
tert-Butyl((2R)-2-(oxiran-2-yl)propoxy)diphenylsilane 306 
 269 
 
 
 
  
(2R,3S)-1-((tert-Butyldiphenylsilyl)oxy)-2-methyl-6-
(trimethylsilyl)hex-5-yn-3-ol 307 
 270 
 
 
 
 
(2R,3R)-1-((tert-Butyldiphenylsilyl)oxy)-2-methyl-6-(trimethylsilyl)hex-5-
yn-3-ol 308 
 271 
 
 
 
  
Methyl (1S,3R,4S,5S)-3,4,5-tris((tert-butyldimethylsilyl)oxy)-4-
ethynylcyclohexane-1-carboxylate 309 
 272 
 
 
 
 
Methyl (1S,3S,7R)-3-methoxy-3-methyl-9-
oxo-7-(phenylselenyl)-2,4-
dioxabicyclo[3.3.1]nonane-7-carboxylate 379 
 273 
 
 
 
  
Methyl (3S,5S)-3-methoxy-3-methyl-
9-oxo-2,4-dioxabicyclo[3.3.1]non-6-
ene-7-carboxylate 381 
 274 
 
 
 
  
Methyl 3,4-dihydroxybenzoate 382 
 275 
 
 
 
 
Methyl (3S,5R,6R,7S)-3-methoxy-6-((2-
methoxy-2-oxoethyl)thio)-3-methyl-9-oxo-2,4-
dioxabicyclo[3.3.1]nonane-7-carboxylate 383 
 276 
 
 
 
 
Methyl (3S,5R,6R,7R)-3-methoxy-6-((2-methoxy-2-
oxoethyl)thio)-3-methyl-9-oxo-2,4-
dioxabicyclo[3.3.1]nonane-7-carboxylate 384 
 277 
 
 
 
 
Methyl 5-hydroxy-2-((2-methoxy-2-
oxoethyl)thio)benzoate 385 
 278 
 
 
 
  
Methyl 2-(hydroxymethyl)acrylate 387 
 279 
 
 
 
 
Methyl (R)-3-((tert-butyldiphenylsilyl)oxy)-2-
methylpropanoate 388 
 280 
 
 
 
 
(S)-3-((tert-Butyldiphenylsilyl)oxy)-2-methylpropan-1-ol 389 
 281 
 
 
 
 
(R)-3-((tert-Butyldiphenylsilyl)oxy)-2-methylpropanal 390 
 282 
 
 
 
(S)-tert-Butyl((2-methylbut-3-en-1-yl)oxy)diphenylsilane 391 
 283 
 
 
 
(2S,3R)-1-((tert-Butyldiphenylsilyl)oxy)-2-methylhex-5-yn-3-ol 392 
 284 
 
 
 
  
Chloro(triphenylphosphine)gold(I) 393 
 285 
 
 
 
 
Methyl (1R,3R,5S)-3,5-bis((tert-
butyldimethylsilyl)oxy)-4-
oxocyclohexane-1-carboxylate 394 
 286 
 
 
 
 
Triphenylphosphinegold triflimidate 395 
 287 
 
 
 
Dimethyl (1-diazo-2-oxopropyl)phosphonate 396 
 288 
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